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1. PREFACE 
Metabolic myopathies are diseases where muscle dysfunction acts as one of the major 
symptoms, usually caused by genetic defects or hormonal dysfunction. These myopathies 
comprise several subgroup diseases resulting from defects in biochemical energy metabolism. 
Mitochondrial Myopathy (MM) is one of these subgroups. Initial research to unravel 
underlying mechanisms started in the late 1980’s with the discovery of large scale 
mitochondrial DNA (mtDNA) mutations. During the past decades, the primordial focus was of 
course the severe phenotype of this disease, whereby less attention was given to mild types 
of this myopathy. An important symptom in this MM population is a disturbed peripheral 
oxygenation pattern at muscle level, resulting from mitochondrial malfunctioning. 
Interestingly, the last two decades, several studies have investigated muscle abnormalities in 
another patient population as well, i.e. Chronic Fatigue Syndrome (CFS). This latter disease is 
based on exclusion criteria and requires four out of eight minor criteria for diagnosis. It is 
remarkable however, that muscle pain, post-exertional malaise, and muscle fatigue are 
included in these criteria. A number of papers have already focused on a putative disturbed 
peripheral oxygenation pattern in these CFS patients, however, with contrasting results. In 
this dissertation we aimed to focus on peripheral oxygenation in both patient and healthy 
populations. To investigate in particular how patients with a disturbed oxygenation pattern, 
probably due to mitochondrial malfunctioning, could be identified in a non-exhaustive and 
non-invasive way. Because both diseases are quite “young” and little is known about eventual 
mild phenotypes of mitochondrial myopathy, we wanted to make a contribution in this 
scientific area by developing a screening tool to identify such patients. In the first part of this 
dissertation, we aimed to present a short introduction about peripheral oxygenation in 
healthy subjects from a historical perspective. Consequently, in the second part of the 
introduction, a description of both MM and CFS diseases and their exercise tolerance 
spectrum is presented as well as peripheral oxygenation patterns in these patient populations.  
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2. PERIPHERAL OXYGEN CONSUMPTION DURING EXERCISE: THE FICK PRINCIPLE 
The history of studying oxidative metabolism at whole body level and in peripheral tissues has 
initially been dominated by two eminent physiologists named Adolf Eugen Fick (1829- 1901) 
and August Krogh (1874- 1949). More than one century ago, Adolf Eugen Fick died in Belgium, 
leaving behind a physiological heritage about oxygen (O2) diffusion and measuring cardiac 
output (Q). As he was the first scientist capable of measuring Q, the formula to calculate this 
was called the Fick principle. Essentially, this Fick principle includes blood flow to an organ or 
tissue which can be calculated if the following information is known. (i) The amount (ml) of 
oxygen consumption (VO2) per unit time, (ii) the oxygen concentration of arterial blood 
supplying the organ or tissue (representing oxygenated blood concentration) and (iii) the 
oxygen concentration of venous blood leaving the organ or tissue. As such, the following 
equation could be made: VO2= Q* Da-vO2 , where Da-vO2 represents arteriovenous O2 
difference. Interestingly, this method was not only applicable at whole body level, but could 
be used in multiple human body systems. At muscle level for example, peripheral oxygen 
consumption (VO2m) can be calculated from muscle perfusion (Qm) and muscle O2 extraction 
(Da-vO2). Hence, when exercise is initiated, O2 demand at muscle level will increase as a 
consequence of a higher skeletal muscle metabolic rate whereby the oxidative metabolism 
will predominantly be activated when rhythmic dynamic contractions are sustained. In this 
case, VO2m will increase by increasing both Da-vO2 and/or Qm, which is of crucial importance to 
have an expanded passage of O2, free fatty acids (FFA) and glucose at muscle level. The O2 
requirements of contracting skeletal muscle may increase up to a 100-fold compared to 
resting conditions.  
 
This leads us to another eminent scientist who has done revolutionary physiological research 
with respect to muscle oxygenation. Auguste Krogh and his wife Marie Krogh studied the O2 
cascade presuming that the capillaries were the primary site for O2 exchange between blood 
and tissue. This belief was based on the fact that capillaries have a high surface to volume 
ratio and that O2 transit time is relatively long. In 1920, Auguste Krogh even won a Nobel Prize 
in Physiology or Medicine for the mechanisms of oxygen regulation of the capillaries in skeletal 
muscle tissue. In Figure 1, a picture of Professor Krogh is presented as well as one of his figures 
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of capillary recruitment. According to this theory, capillaries regulate blood-muscle O2 flux and 
muscle energetics, thereby assigning a largely supportive role for the residual vascular system 
(Krogh 1919a,b, 1920b). This laid the foundation for Krogh and Ehrlang’s very elegant 
mathematical model concerning muscle oxygenation which is physiologically still widely 
accepted today. Basically, Krogh and Ehrlang’s model has led to two important axioms 
regarding peripheral oxygenation. (i) Intramuscular partial O2 pressure (PO2) will decrease 
when the distance of red blood cells (RBCs), located in the capillaries, is increased. (ii) There 
are more ‘open’ capillaries during and after aerobic exercise compared to resting conditions, 
thereby increasing RBC flux to the activated muscle and decreasing O2 diffusion distances. 
Hence, in contracting muscles, more capillaries will be recruited in order to increase the blood-
muscle O2, glucose and free fatty acids (FFA) flux and to reduce intramuscular PO2 by 
shortening capillary to mitochondrial diffusion distances. A key concept regarding this 
‘capillary recruitment’ is the contractile capability of these capillaries to be able to close-off 
during resting conditions. Krogh himself recognized two major problems using his surgical 
coloring technique inside the capillaries (Krogh 1919a,b), i.e. the extreme surgical 
interventions which possibly influence the perfusion pressures and the clumping together of 
the India ink particles, used as an observable marker in the capillaries. 
 
 
Fig. 1: A picture of Auguste Krogh (left) and one of his first figures concerning the capillary recruitment 
theory (right) (Krogh 1919a,b). 
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With great respect to Auguste Krogh’s early observations, it is very interesting to question 
what we know now, one century later. His notion “capillary recruitment” during exercise is 
still widely accepted and described in physiological textbooks (Astrand and Rodahl, 1986; 
Mcardle et al., 2007) and contemporary studies (Parthasarathi and Lipowsky, 1999; Baron et 
al., 2000; Wheatley et al., 2004; Clark et al., 2008) to explain peripheral oxygenation. Despite 
impressive technological advances to study microcirculation and muscle haemodynamics, this 
existent dogma is very difficult to abandon (Poole and Musch, 2010). Compelling evidence 
from the last two decades requires consideration of new models for blood-myocyte O2 
exchange in exercising muscle. Poole et al. (2011) summarized most of this evidence in a very 
clear review concerning peripheral muscle oxygenation.  
 
Firstly, there is overwhelming evidence demonstrating muscle RBC flux at rest in more than 
80% of the capillaries in rat extensor digitorum longus (Anderson et al., 1997), diaphragm 
(Kindig and Poole, 1998) and spinotrapezius (Hudlicka et al., 1982; Kindig et al., 2002) muscles 
as well as in hamster sartorius and cremaster (Damon and Duling, 1984), rabbit tenuissimus 
(Vrielink et al., 1987) and cat sartorius (Burton and Johnson, 1972) muscles. Also, it has been 
shown that microvascular hematocrit in resting muscle capillaries is far below systemic 
(Klitzman and Duling, 1979; Sarelius and Duling, 1982; Desjardins and Duling, 1987; 1990; 
Poole et al., 1997; Frisbee and Barclay, 1998; Kindig and Poole, 1998; 2001; Kindig et al., 2002; 
Copp et al., 2009). Hence, the perfusion in most of the capillaries during resting conditions 
with a low microvascular hematocrit is an indication for a flux at rest of predominantly blood 
plasma. When exercise is initiated, haemoglobin will be increased up to two- or threefold at 
muscle capillary level indicating a differential blood flow (i.e. more RBC flux- less plasma) 
during exercise (Kindig et al., 2002; Copp et al., 2009). The “classical” view of hypoxic initiated 
capillary recruitment was never more clearly shown as in the images of Parthasarathi and 
Lipowsky (1999), presented here in Figure 2. According to the classical view, the drop in PO2 
in Figure 2b will stimulate capillaries to open, thereby increasing capillary RBC flux and 
decreasing blood- myocyte O2 diffusion distances and increasing intramuscular PO2. However, 
some issues can be raised towards this classical view, which assumes capillaries to close off at 
rest. Firstly, muscle capillaries are enormously fragile vessels and do not contain any 
contractile capability (Poole et al., 2011). Secondly, PO2 values (in Figure 2b) of 35 mmHg are 
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supposed to be hypoxic while resting muscle cytosolic normoxia values are around 17 mmHg 
(Whalen et al., 1974, 1976). Despite these early findings of an intracellular cytosolic PO2 of 17 
mmHg, there is a general consensus that cytosolic intracellular PO2 values are even lower (3-
7 mmHg) (Gayeski et al., 1991; Gnaiger et al., 1998; Wittenberg et al., 1989). Consequently, 
Figure 2b represents actually a hyperoxic condition at capillary muscle level. Instead of the 
hypoxic induced capillary recruitment from Figure 2a to Figure 2b as an indication for 
recruitment of non-flowing capillaries at rest, this may rather show a hyperoxic induced 
vasoconstriction from right (2b) to left (2a). 
 
Fig. 2: The images of Parthasarathi and Lipowsky (1999) of the resting cremaster muscle using 
fluorescently labelled plasma at PO2 conditions of 130 mmHg (a) and 35 mmHg (b).  
 
 
A second point that challenges the “classical view” is the fact that low intramuscular PO2 is a 
trigger for increased capillary RBC flux, thereby shortening capillary-to-mitochondria diffusion 
distance (Poole et al., 2011). Surprisingly, intramuscular PO2 during exercise was constantly 
very low, indicating a functional O2 depleted region during exercise between capillaries and 
the mitochondrial reticulum (Gayeski and Honig, 1985, 1987; Honig et al., 1997; Voter and 
Gayeski, 1995; Richardsson et al., 1995a,b, 1998). Moreover, it has been shown that a 
decrease in diffusion distance between capillaries and mitochondria has absolutely no 
influence on capillary-to-mitochondrial PO2 gradient, demonstrating that muscle diffusion 
capacity is independent from capillary density (Bebout et al., 1993; Hepple et al., 2000). 
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According to some modelling studies, it is more likely that the amount of RBCs flowing nearby 
the muscle fibers, rather than capillary density, are determining intramuscular O2 diffusion 
(Federspiel and Popel, 1986; Groebe and Thews, 1990). However, if capillary density is higher, 
there will be a higher capacity for RBC flux surrounding the muscles. Hence, the first 
physiological axiom of Krogh and Ehrlang’s modelling study is contradicted with convincing 
evidence. 
 
If capillary recruitment does not take place during exercise, the question of how blood-
myocyte O2 flux increases during exercise must be answered distinctively. Five hypothetical 
mechanisms which are consistent with present scientific evidence are presented in Figure 3 
(Poole et al., 2011). (1) When skeletal muscle contractions are initiated during exercise, RBC 
flux may abundantly increase in the capillaries. (2) Consequently, capillary hematocrit 
increases from 15% in resting condition to approximately 45% during exercise, indicating a 
differential blood flow in both conditions (blood plasma vs RBC’s) (Klitzman and Duling, 1979; 
Kindig et al., 2002; Copp et al., 2009). (3) When RBC flux during exercise is thus increased up 
to threefold and fractional O2 extraction increases from approximately 25% to 80%, 
longitudinal capillary recruitment will occur in order to maintain the increased O2 exchange 
capacity. (4) As mentioned before, the extremely low intramyocyt PO2 seems an important 
“O2 depleted region” for myoglobin O2 desaturation in order to improve intramuscular O2 
passive diffusion (Gayeski and Honig, 1985, 1987; Honig et al., 1997; Voter and Gayeski, 1995; 
Richardsson et al., 1995a,b; 1998). (5) The main regulator of capillary haemodynamics could 
be its endothelial surface layer (glycolax) whereas mechanical alterations of this layer, for 
example during exercise, may be important to change blood-myocyte O2 flux. It has already 
been shown that elimination (Desjardins and Duling, 1990) or modification of the endothelial 
surface layer (glycolax) by hyperglycemia (Zuurbier et al., 2005), changes capillary hematocrit 
and haemodynamics profoundly. 
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Fig. 3: Hypothetical mechanisms for a differential approach towards capillary haemodynamics 
compared to the classical view of capillary recruitment (Poole et al., 2011). 
 
 
In a century full of major technological and microscopic advancements, the “classical” theory 
of capillary recruitment during exercise maintains to be dogmatic in human physiology. With 
great respect to the enormous accomplishments of Adolf Eugen Fick and Auguste Krogh, it is 
of major importance to stay critical and challenge these dogmatic theories. Especially because 
these observations are of great interest in pathological populations, where peripheral 
oxygenation is limited due to microvascular and/or muscle deficiencies. Therefore, it remains 
crucial to gain more insights on these peripheral oxygenation mechanisms. 
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3.  PERIPHERAL OXYGENATION IN CLINICAL POPULATIONS 
Some clinical populations can be recognized by an altered peripheral oxygenation pattern. 
One example of a pathology where peripheral oxygenation pattern is disturbed as a 
consequence of mitochondrial malfunctioning, is Mitochondrial Myopathy (MM). Oxygen 
consumption and peripheral oxygenation during exercise are even frequently used as a 
diagnostic tool in this population. The pathogenesis of this disease, as well as peripheral 
oxygenation patterns in these MM patients are discussed below. Less obvious is the 
connection between a disturbed peripheral oxygenation pattern and Chronic Fatigue 
Syndrome (CFS). However, seen the fact that exercise intolerance and muscle pain and 
weakness are of frequent occurrence in most CFS patients, multiple studies have started 
focusing on muscle abnormalities. Recently, the Institute of Medicine (2015) have even 
proposed Severe Exercise Intolerance Syndrome (SEID) as a new label for these group of 
patients, thereby emphasizing the crucial importance of these exercise related problems.  
3.1 Mitochondrial myopathy 
3.1.1 Prevalence, aetiology and diagnosis  
Mitochondrial diseases are multisystem disorders clinically characterized by a large variety of 
signs and symptoms as a consequence of (severe) mitochondrial dysfunction. The prevalence 
of mitochondrial disorders is 1/5000 live births (Thorburn, 2004), whereas the prevalence of 
pathogenic mitochondrial DNA (mtDNA)-mutations is reported as high as 1/200 live births 
(DiMauro, 2011; Elliott et al., 2008). Initial research to investigate mitochondrial diseases 
began in the late 1980’s with the discovery of large scale mtDNA mutations and point 
mutations as a cause of some severe diseases (Colombo et al., 1988; Sing et al., 1989; Tanaka 
et al., 1991).  
 
Mitochondria are the sole cell organelles controlled by a dual genome system (mitochondrial 
and nuclear). Thirteen of the 87 structural proteins in these complexes are encoded by the 
mitochondrial genome (mtDNA), whereas approximately 1500 nuclear encoded genes (nDNA) 
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are thought to play a role in the synthesis of these complexes (Calvo et al., 2006). The location 
of mtDNA and nDNA in the cell is presented in Figure 4. 
Fig. 4: Schematic presentation of where nDNA and mtDNA is located in the cell. 
 
One deletion or mutation in an important mtDNA or nDNA sequence, responsible for one of 
these complexes or enzymes, may have severe consequences on mitochondrial functioning. 
Pathogenic mtDNA mutations are usually heteroplasmic, which means that a mixture of 
pathogenic mutant and healthy wild-type mtDNA can be found within the same cell. The 
amount of wild-type mtDNA can vary from tissue to tissue whereas tissue failure is expected 
when the amount of pathogenic mutant mtDNA is higher than 60-85% (“threshold 
phenomenon”) (Goodfellow, 2014). This threshold depends on which mutation is present in 
which cell type (Durham et al., 2007). A cell type with a higher O2 dependence, e.g. muscle 
tissue, will exceed this threshold sooner in comparison with other tissues. Clinical phenotypes 
that can be associated with a specific OXPHOS defect genotype vary enormously. Some 
genotypes are associated with a specific phenotype such as Mitochondrial 
Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS), Myoclonic Epilepsy 
with Ragged Red Fibres (MERRF), and Alpers-Huttenlocher. Unfortunately, the correlation 
between genotype and clinical phenotype is poor in most patients (Tarnopolsky and Raha, 
2005). Considering the fact that mitochondria are crucial in several physiological processes 
and are present in many tissues -all possessing a different “threshold phenomenon”-, an 
enormous heterogeneity can be observed in the spectrum of mitochondrial diseases. In case 
skeletal muscle tissue is the predominantly affected tissue, the term mitochondrial myopathy 
(MM) is used.  
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The gold standard for diagnosing OXPHOS defects in MM patients remains a morphological, 
histochemical and biochemical analysis of skeletal muscle biopsy samples (Bourgeois and 
Tarnoplosky, 2004) . One of the clinical features, indicative for MM, are ragged red fibres (RRF) 
in skeletal muscle tissue after red dye infusion in biopsy samples. In Figure 5, an example is 
presented of healthy skeletal muscle tissue and skeletal muscle tissue where ragged red fibers 
are abundantly present. This histopathological hallmark is a result of a compensatory 
mitochondrial proliferation at the ultra-structural muscle fibre level as a consequence of the 
intracellular mitochondrial impairment. Moreover, paracrystalline inclusions will be created, 
representing the crystallization of mitochondrial creatine kinase. As such, elevated creatine 
kinase (CK) values in venous blood samples are a common feature in MM patients.  
Fig. 5: A typical example of a healthy skeletal muscle biopsy sample (a) and ragged red fibres in a 
skeletal muscle biopsy sample (b), indicative for mitochondrial myopathy.  
 
For practical reasons, however, it is not feasible to perform a skeletal muscle biopsy in each 
patient suffering from exercise intolerance and/or excessive fatigue. There is a need for a non-
invasive and non-exhaustive screening tool (Tarnopolsky et al., 1998). Several cycle ergometry 
protocols while measuring VO2 kinetics, lactate values and blood flow have been proposed in 
the literature as screening tool for detection of MM patients. However, the results of these 
a b 
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tests were variable (Dandurand et al., 1995; Dysgaard-Jeppesen et al., 2003; Finsterer and 
Milvay, 2004; Grassi et al., 2009; Siciliano et al., 1999; Taivassalo et al., 2003). Three major 
problems could be identified when using whole body exercise tests as a screening tool. (i) 
These tests lack sensitivity (63% - 75%) and specificity (70% - 90%) to replace the skeletal 
muscle biopsy method (Tarnopolsky, 2004), in particular because in this way, 25% - 37% of the 
people will get a wrong diagnosis and 10% - 30% are not correctly excluded from having MM. 
(ii) Whole body maximal exercise induces a high cardiorespiratory load which can be 
dangerous as cardiomyopathy is a frequent symptom in this MM population. (iii) A good 
correlation between heteroplasmy level and exercise (in)tolerance was observed, indicating 
that individuals with a low heteroplasmy level will show no exercise intolerance and will be 
falsely declared healthy (Jeppesen et al., 2003b). Hence, while exercise intolerance and 
excessive fatigue are key features of this pathology, muscle biopsy remains the gold standard 
for diagnosis. 
3.1.2 Exercise tolerance spectrum in mitochondrial myopathies 
As mentioned before, the aerobic production of ATP in skeletal muscle tissue, which takes 
place in the mitochondria, is (severely) reduced. The severity of this mitochondrial 
malfunctioning depends on which mutation and what amount of mutant mtDNA is present 
within the myocytes. At whole body level, tachycardia and dyspnoea are frequently occurring 
symptoms in this patient population (Haller and Vissing, 2009). Moreover, some studies have 
shown a significantly reduced maximal workload and peak oxygen consumption (VO2peak) 
during an incremental cycle protocol in MM patients compared to healthy control subjects 
(Taivassalo et al., 2003; Dysgaard-Jeppesen et al., 2003; Grassi et al., 2009). The reduced VO2 
in these patients is a result of a decrease in Q and/or Da-vO2 while a normal physiological 
response to incremental exercise intensity is an increased VO2, resulting from an increased Q 
and Da-vO2. These previously mentioned symptoms do, however, occur in other patient 
populations and chronic inactive subjects as well. It may be interesting to look for 
commonalities and divergences between these populations and the MM group. Mitochondrial 
dysfunction is a feature that has been hypothesized in other pathologies like cerebral palsy 
(Peterson et al., 2012), metabolic syndrome (Hawley and Lessard, 2007; Boushel et al., 2007), 
Chronic Obstructive Pulmonary Disease (COPD) (Gagnon et al., 2014), Peripheral Arterial 
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Occlusive Disease (PAOD) (Pipinos et al., 1999), Chronic Fatigue Syndrome (CFS) (Smits et al., 
2011),... The frequently asked question considering this mitochondrial dysfunction as a 
disease hallmark, was the fact whether this presumed dysfunction primarily originated from 
the pathology or not. This was in particular because these patient populations were generally 
recognized as physically inactive subjects (Peterson et al., 2012; Pipinos et al., 1999; Batista- 
Amorin et al., 2014; Gagnon et al., 2014; Hawley and Lessard, 2007; Boushel et al., 2007; Smits 
et al., 2011). A significant decline in physical activity could be a secondary cause for reduced 
muscle mitochondrial functioning (Boushel et al., 2007). Hence, it has been shown that chronic 
inactivity leads to a decreased mitochondrial density and citrate synthase activity whereas 
oxidative phosphorylation (mitochondrial function) remains intact (Boushel et al., 2007; Hood 
et al., 2006). A disturbed oxidative phosphorylation (mitochondrial dysfunction), which does 
not occur in physically inactive subjects, is the central diagnostic hallmark in MM patients. As 
such, a reduced mitochondrial density and a disturbed mitochondrial functioning could be a 
discriminating factor between muscle dysfunction as a consequence from chronic physical 
inactivity and MM. In MM patients, there is a disturbed peripheral oxygenation where O2 
extraction will be blunted as a consequence of mitochondrial dysfunction at muscle level. 
Subsequently, Q will abundantly increase in order to compensate this reduced Da-vO2 
(Taivassalo et al., 2003). A majority of MM patients exhibited such a blunted ability to increase 
Da-vO2, resulting in a so called “hyperkinetic circulatory response” (Haller and Vissing, 2009; 
Taivassalo et al., 2002; Taivassalo et al., 2003). Such a hyperkinetic circulatory response is a 
second hallmark that differs MM patients from physically inactive subjects, where O2 supply 
was rather limited. The disturbed Q relation in MM patients is presented in Figure 6. 
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Fig. 6: A schematic presentation of this hyperkinetic circulatory response to exercise. In Figure A, the 
increase in VO2 is presented in MM patients and healthy subjects with increasing intensity. in figure B, 
a hyperkinetic cardiovascular response was found in MM patients as an attempt to compensate the 
reduced O2 extraction (Tarnopolsky et al., 2005). 
 
 
In addition, abnormal high Respiratory Exchange Ratio’s (RER) were found in MM patients 
indicating an excessive carbon dioxide (CO2) production (Taivassalo et al., 2003). This excessive 
CO2 production may be a result of an increased bicarbonate buffering of protons in MM 
patients, probably due to elevated anaerobic energy delivery. Lactic acidosis has often been 
used as an indicator of impaired oxidative metabolism and as a diagnostic tool to screen 
mitochondrial disorders (Tarnopolsky and Raha, 2005). When mitochondrial dysfunction 
impairs the aerobic production of ATP, ATP will be produced using anaerobic glycolytic 
pathways, where glucose and glycogen will be converted to lactate and protons. 
Consequently, this increased amount of protons will bind to bicarbonate resulting in an 
elevated CO2 production. Another anaerobic pathway to produce ATP, is the phosphocreatine 
pathway, where creatine acts as a transporter to deliver phosphates in the myocyte. The 
aerobic energy system is the main regulator of phosphocreatine recovery when exercise is 
finished. In MM patients, this post exercise phosphocreatine (PCr) recovery kinetics, will be 
delayed as a consequence of the malfunctioning mitochondria (Barbirolly et al., 1995; Fabrizi 
et al., 1996; Matthews et al., 1991).  
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3.1.3 Peripheral oxygenation in mitochondrial myopathies 
Considering the three problems we acknowledged before (i.e. sensitivity and specificity (i), 
danger of cardiomyopathy when performing whole body exercise (ii) and the problem of lower 
heteroplasmy levels in one subject (iii)), non-exhaustive exercise tests on isolated muscles 
should be preferred. In this way, peripheral oxygenation of investigated muscles are studied 
to gain more insight in peripheral adaptations and disturbed physiological responses to 
exercise. Hence, some forearm screening tests were developed to investigate peripheral 
oxygenation in small muscles, thereby imposing a low cardiovascular load (Hänisch et al., 
2006; Jensen et al., 2002; Taivassalo et al., 2002; Van Beekvelt et al., 1999). All these studies, 
except Van Beekvelt et al. (1999), used venous blood samples to observe O2 desaturation 
values during exercise. Van Beekvelt et al. (1999) was, to our knowledge, the only study that 
non-invasively measured muscle VO2 (VO2m) for comparison between MM patients and 
healthy subjects using NIRS. However, some methodological concerns can be raised with the 
interpretation of the absolute NIRS values and the influence of subcutaneous adipose tissue 
in this study (Van Beekvelt et al., 2001). The overall finding was that O2 desaturation during 
and after exercise was significantly reduced in the MM population, indicating an impaired O2 
extraction at microvascular level. The heterogeneity of the desaturation values within the MM 
patients was however, quite large (Hänisch et al., 2006; Jensen et al., 2002; Taivassalo et al., 
2001). 
It is well known that peripheral oxygenation of skeletal muscles is limited in this MM patient 
population due to mitochondrial defects. Previously, it was mentioned that physical inactivity, 
which is a possible consequence of this mitochondrial dysfunction could deteriorate disease 
severity by a decreasing mitochondrial density (Taivassalo et al., 2006). However, 
contradicting results in pathologic mtDNA amount have been found in training studies, with 
an overall improvement in O2 extraction, VO2peak, peak work capacity and a normalisation of 
the hyperdynamic cardiovascular response (Taivassalo et al., 2001; Taivassalo et al., 2006). In 
Taivassalo et al. (2001), the mutation load of pathogenic mtDNA was increased after a training 
program while this was not the case in Taivassalo et al. (2006) with the same intensities. It was 
hypothesized that the severity of the lower mean mutation load (65 % vs 55 %) was 
responsible for this divergence (Taivassalo et al., 2006). The inverse relation between mtDNA 
PART I: GENERAL INTRODUCTION 
 
 17 
mutation load and skeletal muscle oxidative capacity implicates a disturbed relation between 
O2 delivery and O2 consumption during exercise. In MM patients, O2 delivery relative to O2 
consumption can be three times as big as in healthy subjects (Taivassalo et al., 2002). 
Additionally, in a recent study, it has been observed that MM patients possess a mean capillary 
area 2.5 fold higher than healthy control subjects. This phenomenon is presented more clearly 
in Figure 7. A maladaptive capillarization is thus stimulated by the presence of an impaired 
mitochondrial metabolism. It is also important to mention that the extent to which this 
capillary density has increased, is directly associated with the severity of the disease 
(Taivassalo et al., 2012). Hence, Jeppesen et al. (2006) found no increase of capillary 
abundance in muscle fibres of MM patients with a more preserved phenotype. Taivassalo et 
al. (2012) suggested that a central mechanism could be responsible for the increased amount 
of capillaries surrounding oxygen deficient muscle fibres. According to this suggestion, PGC 1α 
has been postulated to be such a central controlled activator of mitochondrial biogenesis (Lin 
et al., 2005). Moreover, PGC 1α seems to augment capillary angiogenesis by increasing 
Vascular Endothelial Growth Factor (VEGF). This increase in VEGF was stimulated by co-
activation of the Oestrogen Related Receptor-α (ERR-α) (Arany et al., 2008). The fact that MM 
patients showed an elevated PGC 1α amount (Adhihetty et al., 2007), probably due to the 
typical mitochondrial proliferation in ragged red fibres, could be a possible explanation for this 
disproportionate capillary density.  
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Fig. 7: A schematic presentation of the relation between capillary area and the amount of deficient 
muscle fibers in MM patients (Taivassalo et al., 2012). 
 
 
 
In this section, sufficient evidence was provided to show that nDNA or mtDNA mutations and 
deletions may severely affect mitochondrial respiration, thereby restraining aerobic energy 
delivery. When exercise intolerance and excessive fatigue are the general symptoms, MM 
should be suspected in patients. Despite some general distinctions which are frequently 
occurring in physical inactive subjects and other diseases like COPD, PAOD, CVS, …(e.g. lower 
VO2peak, tachycardia, dyspnoe, elevated serum lactate values,…), it seems that an altered 
peripheral oxygenation is the most striking symptom in this patient population. As such, a 
disproportional muscle perfusion and capillary area has been observed in MM patients as a 
consequence of the limited O2 extraction at muscle level. These effects are however, less 
pronounced in MM patients with a lower mutation load. Considering the fact that this is quite 
a “young” research area, little is known about these mild mitochondrial diseases. Moreover, 
the majority of the screening tests, discussed in this part, were intensive or invasive protocols. 
A standard non-invasive and non-exhaustive test protocol which measures skeletal muscle 
perfusion and O2 extraction would be of great interest as a screening tool or follow up of these 
patients. 
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3.2 Chronic Fatigue Syndrome (CFS) 
3.2.1 Prevalence, aetiology and diagnosis  
Different syndromal definitions have been developed for the description of Chronic Fatigue 
Syndrome (CFS). Of these, the CDC criteria (Center for Disease Control and Prevention) 
(Fukuda et al., 1994) are most frequently used. It has led to different labels, including myalgic 
encephalomyelitis (ME) and more recently, severe exercise intolerance syndrome (SEID) 
(Institute of Medicine, 2015). This depends, among other considerations, on the framework 
which was used for aetiology and pathogenesis. A major factor in this variability consists of 
the focus on a pure biological or biopsychosocial model. Hence, a wide prevalence range has 
been reported between 0.006% and 3%, depending on which criteria are used for diagnosis. 
Moreover, epidemiological studies reveal that Caucasian women, older than 30 years, are 
especially susceptible for developing CFS (Afari et al., 2003).  
CFS is characterized by unexplained fatigue lasting for longer than six months which is not due 
to continuing exertion and does not improve by rest. Essentially, the presence of an underlying 
disease needs to be excluded (Fukuda et al., 1994). Besides this major criterion of long lasting 
unexplained fatigue, a diagnosis of CFS requires at least 4 out of 8 minor criteria. These minor 
criteria include post-exertional malaise lasting for at least 24 h, sore throat, tender cervical or 
axillary lymph nodes, muscle pain, multi-joint pain without swelling or redness, headache of a 
new type, pattern or severity, memory and concentration impairment and unrefreshing sleep 
(Fukuda et al., 1994). Also, fibromyalgia (FM) has been frequently diagnosed as a comorbidity 
for CFS (Buchwald and Garrity, 1994; Buchwald, 1996). This disorder can be described as 
widespread and chronic muscle pain in different tender points. Possible muscle abnormalities 
have been studied extensively in both CFS and FM pathogenesis. 
The aetiology of CFS remains controversial and largely unknown. There are different 
hypotheses, either focusing on psychologic (Abbey et al., 1991) or biologic determinants 
(Myhill et al., 2009; Morris and Maes, 2014). The controversy on causes of CFS continues in 
the absence of compelling evidence for a particular aetiology. This is illustrated by the analysis 
of possible causes of post-exertional malaise, major feature of this illness. Many hypothetical 
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mechanisms have been postulated in the past, to explain the reduced exercise capacity and 
post-exertional malaise in CFS patients. These speculative mechanisms have often been 
related to autonomic dysfunction or central sensitisation which could have major implications 
on exercise tolerance and recovery. Central sensitisation can be defined as a hyperexcitability 
of the central nervous system with an inadequate pain inhibition after exercise (Meeus et al., 
2013). It represents an increased “central” response to “peripheral” stimuli, thereby 
generating hyperalgesia (increased pain from a stimulus that usually provokes pain) and 
allodynia (pain due to a stimulus that does not usually provoke pain). Nosologically, according 
to Clauw (2010), Central Sensitisation Syndrome (CSS) might be even more appropriate to use 
than CFS/FM in this patient population, in particular in a subpopulation with predominantly 
FM and pain as presenting symptom. Many speculative mechanisms have been investigated 
as possible sources for this inadequate pain modulation after exercise. As such, Brain Derived 
Neurotrophic Factor (BDNF) has been postulated as a key feature in this chronic pain situation 
as it plays a major role in nociception (Nugruha et al., 2012). BDNF belongs to the 
neurotrophine family, which is involved in different neuroplasticity processes like modulating 
mood and pain perception. It has been shown that inhibition of BDNF signal transduction can 
inhibit central pain sensitisation (Kerr et al., 1999; Pezet et al., 2002). Although this central 
sensitisation model has been studied extensively the last few years, it cannot explain all the 
CFS symptoms (i.e. postexertional malaise and muscle stiffness) (Kulshreshtha and Deepak, 
2013). Autonomic dysfunction comprises the symptoms and effects that could be related to 
the inadequate functioning of the autonomic nervous system (ortho- and parasympathetic 
functioning) and is another explanatory hypothesis for some syndromal manifestations. This 
autonomic dysregulation may originate from an altered and inadequate stress response, 
probably due to chronic stress (Meeus et al., 2014). Chronic stress owns the ability to reduce 
parasympathetic activity. Despite contradictory reports about autonomic dysregulation, it 
might be interesting to make a clear distinction between CFS patients and CFS patients with a 
fibromyalgia comorbidity when focussing on autonomic dysregulation (Kulshrestha and 
Deepak, 2013). There is a general scientific consensus about the sympathetic “hyper” activity 
and/or parasympathetic dysfunction in both populations (Reyes del Paso et al., 2012; Frith et 
al., 2012; Meeus et al., 2013). The difference between both populations, however, might be 
due to the deficits in pain inhibition to acute stressors by the cardiovascular system in the FM 
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and not in the CFS population (Meeus et al., 2013; Reyes del Paso et al., 2011). In FM patients, 
a decreased stroke volume, myocardial contractility and baroreceptor sensitivity has been 
determined (Reyes del Paso et al., 2010; 2011). This is quite important as the cardiac 
baroreflex system is an important mediator in the relationship between blood pressure 
(autonomic nervous system) and pain (central sensitisation). Hence, it has been shown that 
experimental activation (stretch) of the baroreceptors induces antinociceptive effects (Rau 
and Elbert; 2001). Although differences have been found between CFS/FM patients and 
healthy control subjects with respect to autonomic dysfunction or central sensitisation, it 
remains unclear what causes these syndromal disturbances. Various hypothetical aetiologies 
have been proposed in the literature, i.e. psychological (stress), neuroendocrinological, 
virological and immunological mechanisms (Van Cauwenbergh et al., 2014). Many 
neuroendocrinological alterations have been observed in CFS/FM patients such as increases 
in nerve growth factor and BDNF and decreases in serotonine, norepinephrine and dopamine 
(Clauw et al., 2010). Furthermore, in a systematic review of Nijs et al. (2014), studies on the 
responses to exercise were systematically and qualitatively analyzed to draw some 
conclusions concerning these possible immunologic and metabolic causes of this post-
exertional malaise and fatigue. The conclusions were threefold: (i) There is no sufficient 
evidence for a post exercise decreased amount in cytokines in CFS patients. (ii) CFS patients 
have a more pronounced response in the complement system with a higher elastase amount 
after exercise. Elastase is a proteolytic enzyme produced by monocytes and neutrophils during 
inflammatory responses. A higher amount after exercise is thus an indication for an excessive 
inflammatory response. (iii) More and more evidence exists for an earlier and longer lasting 
oxidative stress during and after exercise in these CFS patients. However, these observations 
rather describe effects than a true cause. A more logical approach is to integrate different 
factors into a biopsychosocial explanatory model, incorporating vulnerability, triggering and 
perpetuating factors. This holistic approach (Wessely et al., 1999; Mariman et al., 2013) can 
be translated in practice into a multidisciplinary assessment and includes internal medicine 
assessment, psychodiagnostic screening, rehabilitation assessment and polysomnygraphy 
combined with a multiple sleep latency test in order to screen for primary or comorbid sleep 
disorders. Subsequently, a diagnostic decision will be made in a multidisciplinary discussion 
(Wessely et al., 1999; Mariman et al., 2013). An organigram of the diagnostic process is 
presented in Figure 8. 
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Fig. 8: Diagnostic process of patients with long lasting, unexplained fatigue. Full lines indicate 
systematic, interrupted lines indicate optional steps (Mariman et al., 2013). 
 
3.2.2 Exercise tolerance spectrum in CFS patients 
Exercise intolerance and post-exertional malaise are major symptoms in CFS patients. 
Moreover, all symptoms will deteriorate during and after (intensive) exercise, indicating 
exercise related abnormalities in these patients (Nijs et al., 2014). These general symptoms 
are combined with a perceived muscle weakness and pain in many CFS patients (Fulle et al., 
2000). Nonetheless these clear symptom descriptions, contrasting results have been found 
regarding reduced muscle strength (Fulcher and white, 2000; Kent-Braun et al., 1993) and 
VO2max values during exercise. A reason for this lacking uniformity could be the possible 
existence of a subgroup suffering from an intracellular immune deregulation which could be 
related to a reduced exercise capacity. Snell et al. (2002) showed that CFS patients with such 
a deregulated immune pathway (2’, 5’ oligoadenylaat (2-5A) synthetase/RNA L-pathway) had 
a significantly reduced exercise capacity compared to CFS patients with normal intracellular 
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immune function. The underlying hypothetical mechanism for this association could be that 
such a deregulated immune pathway could lead to a channelopathy by affecting the ATP 
sensitive potassium channels, thereby inducing muscle weakness (Nijs et al., 2004). When 
investigations report VO2max in these patient populations, caution is advised when interpreting 
these results. Especially because reaching VO2max requires a “levelling of” and it has been 
shown that CFS patients are not able to reach this “levelling of” (Astorino et al., 2000; Day et 
al., 2003). Therefore, the use of “VO2peak” values in this context would be more appropriate. 
Some studies showed normal values for aerobic power in CFS patients (Sisto et al., 1996; 
Rowbottom et al., 1998; Kent-Braun et al., 1993) while others demonstrated a reduced 
aerobic capacity (Montague et al., 1989; De Becker et al., 2000). The latter study of De Becker 
et al. (2000) was carried out on a large sample size of 427 CFS patients, thereby challenging 
the methodological problem of a limited number of patients. Peak heart rate as well as heart 
rate at the anaerobic threshold during an incremental exercise protocol was significantly 
decreased in CFS patients, thereby indicating a suboptimal cardiac functioning. A speculative 
reason for this reduced cardiac function could be a disturbed autonomic system or a viral 
presence in CFS patients (Pagani et al., 1994). Ortho- and parasympathetic dysregulation (i.e. 
reduced parasympathetic and elevated ortohosympathetic activity) could explain an 
increased resting heart rate and a significantly reduced peak heart rate during exhaustive 
exercise (Cordero et al., 1996; Freeman and Komaroff, 1997; Pagani et al., 1994; Wilke et al., 
1998). Furthermore, increased plasma lactate concentrations were found during submaximal 
exercise in CFS (Riley et al.,1990). Another feature characterizing the differential response 
towards fatiguing exercise is a delayed recovery in a CFS population (Paul et al., 1998; Meeus 
et al., 2014). A majority of CFS patients (with and without FM comorbidity) are complaining 
about muscle fatigue and an abnormal recovery after exercise, especially in the upper limb 
muscles (Ickmans et al., 2014). Hence, a significantly decreased recovery ratio was found after 
exhaustive handgrip exercise in the CFS populations with FM comorbidity. In contradiction 
with previous studies, no significant differences in recovery were found in the CFS population 
without FM comorbidity (Ickmans et al., 2014), indicating that conclusions are not readily 
generalizable over the whole spectrum of CFS with or without FM. The frequent contradictions 
on features of exercise intolerance may be due to heterogeneity in the CFS cohort or to a 
secondary cause, i.e. chronic inactivity. As was mentioned in previous part, these musculo-
skeletal and cardiovascular manifestations are frequently occurring in other (physically 
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inactive) patient populations as well. Nevertheless, exercise intolerance and excessive fatigue 
are primary characteristics in this patient group with severe daytime dysfunction. 
3.2.3 Peripheral oxygenation in CFS patients 
The reduced exercise capacity in combination with muscle pain and weakness as a major 
symptom suggests a possible key role of skeletal muscle as a hotspot for this disease. As some 
studies found significant differences in VO2max values between CFS patients and healthy 
control subjects, a disturbed peripheral oxygenation was suspected (McCully et al., 2003). 
There are three good reasons to investigate eventual peripheral oxygenation abnormalities in 
CFS patients. (i) As elucidated previously, there is moderate evidence for an increased and 
earlier production of oxidative stress (Reactive Oxygen Species (ROS)) in CFS patients, 
indicative for a possible mitochondrial dysfunction (Nijs et al., 2014; Fulle et al., 2000; Morris 
and Maes, 2014).(ii) A slower phosphocreatine (Pcr) recovery ratio after exercise was 
observed in CFS patients (McCully et al., 1996; McCully and Natelson; 1999), indicative for 
reductions in oxidative metabolism as well. (iii) The autonomous nervous system 
dysregulation (Montague et al., 1988) and vasomotor inactivity (Jones et al., 2010) could alter 
skeletal muscle blood flow during exercise. 
Notwithstanding these hypothetical statements, contrasting results have been found when 
focusing on peripheral muscle oxygenation (McCully et al., 2003). Some studies showed a 
disturbed muscle metabolism (Arnold et al.,1984; Wagenmakers et al., 1988; Fulle et al., 2000) 
while others found no abnormalities (Kent-Braun et al., 1993; Barnes et al., 1993). Likewise, 
some studies found a reduced skeletal muscle blood flow during exercise in CFS patients 
(Bennett et al., 1991; McCully et al.,1996, 2004; McCully and Natelson, 1999) while others 
found no different pattern (McCully et al., 2003). A speculative explanation for this reduced 
skeletal muscle blood flow during and after exercise could be a reduced capillary density in 
CFS patients or an autonomous nervous system dysregulation (Lindh et al., 1995; Montague 
et al., 1988). Taking into account the mechanisms of peripheral oxygenation, this means that 
there will be a limited delivery of O2 at muscle level compared to healthy control subjects. 
Furthermore, this reduced capillary density was found in combination with a larger proportion 
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of muscle fibre type II in CFS and FM patients (Lindh et al., 1995; Pietrangelo et al., 2009). 
These results were, however, not replicated in Smits et al. (2011), where equal muscle fibre 
type I and II composition were found in skeletal muscle biopsies of CFS patients and healthy 
control subjects. In the latter study, a decreased citrate synthase activity was found in CFS 
patients, indicating a reduced mitochondrial density. This finding does not differentiate 
between CFS as primary cause or physical inactivity as a secondary for reduced mitochondrial 
density.  
Possible reasons for these divergent findings concerning peripheral oxygenation are threefold. 
First of all, there are some major differences in methodological set up between studies to 
investigate muscle oxidative function in these patients, ranging from skeletal muscle biopsy 
samples in resting conditions (Fulle et al., 2000) to P-MRS spectrometry in resting conditions 
(Arnold et al., 1984) but also during or after exercise (Barnes et al., 1993; McCully and 
Natelson, 1999; McCully et al., 2003,2004), which is important to challenge the oxidative 
system. Secondly, skeletal muscle biopsy is the only gold standard method in order to 
demonstrate skeletal muscle oxidative dysfunction (Bourgeois and Tarnoplosky, 2004). A third 
possibility to explain the different findings is the heterogeneity within the investigated CFS 
population and the possible mediating factor of chronic inactivity. In a lot of previously 
mentioned studies, this heterogeneous oxygenation response of the CFS patients has been 
presented as an explanation for not finding significant differences (McCully et al., 2003, 2004; 
McCully and Natelson, 1999; Barnes et al., 1993). Recently, Miller et al. (2015) found reduced 
oxygenation responses using NIRS in CFS patients compared to healthy control subjects during 
dynamic exercise. To our knowledge, this was the first study using NIRS to investigate 
oxygenation responses in CFS patients. However, these studies show in general, a large 
standard variability concerning VO2peak, aerobic power, peripheral blood flow and muscle 
metabolism, within the CFS population. 
3.3 Is there a connection between both diseases (MM and CFS)? 
The central problem in the MM population is a genetic defect (mtDNA and/or nDNA) causing 
mitochondrial dysfunction in skeletal muscle tissue. The severity of this dysfunction depends 
on the location of the targeted DNA sequence and on the heteroplasmy amount of the mtDNA, 
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if the mtDNA is affected (Di Mauro, 2010). This mitochondrial dysfunction has, however been 
hypothesized to be a key element of muscle abnormalities in CFS patients as well (Fulle et al., 
2000; Morris and Maes, 2013). In this context, it is interesting to recite some clinical features 
which are similar between both patient populations. Exercise intolerance and post-exertional 
malaise are some of these overlapping symptoms in MM and CFS patients. Additionally, it is 
quite remarkable that skeletal muscle is the targeted area in MM patients and a suspected 
hot spot in CFS too. General symptomatology of MM as well as the overlapping and differing 
manifestations are presented in table 1
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Table 1: Similarities and differences in the wide variety of symptoms in mitochondrial disorders and CFS 
(Morris and Maes; 2013). 
Organs Symptoms in mitochondrial disorder Symptoms in CFS 
Muscles muscle weakness yes 
 Cramps yes 
 Pain yes 
Brain mental retardation – 
 epilepsia – 
 migraine yes 
 dementia neurocognitive symptoms 
 neuro-psychiatric disorders sometimes depression 
 autistic behaviors – 
Nervous system neuropathic pain yes 
 dysautonomia yes 
Heart cardiomyopathy – 
Ears hearing loss – 
Eyes optic atrophy – 
 retinitis pigmentosa – 
 blindness – 
 ptosis – 
Endocrine system diabetes – 
Liver liver failure – 
Lungs respiratory problems – 
General sometimes fatigue key symptom 
 exercise intolerance yes 
 diminished cardiac response to exercise yes 
Course of  waxing and waning yes 
symptoms progressive course yes 
The studies on mitochondrial dysfunction in CFS patients showed inconsistent results on 
structural muscle abnormalities. Some studies found mitochondrial degeneration as well as 
fusion and branching of the mitochondrial cristae in CFS patients (Behan et al., 1991, 1993; 
Behan, 1992). Also, there is moderate evidence for an increased amount of ROS in skeletal 
muscle tissue as a possible representation of mitochondrial dysfunction (Fulle et al., 2000; 
Morris and Maes, 2013). The latter studies of Fulle et al. (2000) and Behan et al. (1991; 1993; 
1992) were performed at rest on skeletal muscle biopsy samples (m. vastus lateralis). 
Mitochondrial dysfunction can be the result and the source of the increased ROS amount as it 
is a vicious circle where deficient mitochondria produce more ROS, thereby damaging more 
mitochondria (Meeus et al., 2013). In contrast, Barnes et al. (1993) found no consistent bio-
energetic abnormalities during and after exercise in CFS patients compared to MM patients 
and healthy control subjects. In resting skeletal muscle, MM patients showed significantly 
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lower PCr/ATP and PCR/Pi ratios compared 
to CFS patients and healthy controls while no 
differences were found between CFS 
patients and healthy control subjects. This is 
an indication of an impairment of the ATP 
energy reserve phosphates in MM patients. 
Furthermore, significantly prolonged 
recovery half times for [PCr], [Pi] and [ADP] 
were found in MM patients while no general 
differences were found in the CFS 
population. Again, a large heterogeneity was 
observed in the CFS population, indicating 
that there may be subgroups suffering from 
mitochondrial dysfunction, while others do 
not. In Figure 9, free cytosolic [ADP] at the 
end of exercise in healthy control subjects, 
CFS and MM patients are presented. CFS 
patients have a very heterogeneous 
response to exercise with a wide range and 
more variability as compared to controls. This insight requires another way of thinking 
towards oxygenation responses in a CFS population. Possibly, some studies found 
mitochondrial dysfunction in CFS patients as a consequence of a small sample size rather than 
an altered physiological response to exercise. For example, Fulle et al. (2000) found significant 
differences in mitochondrial function and oxidative damage in only 6 CFS patients while 
Barnes found no consistent differences in a group of 46 CFS patients. Moreover, both studies 
were difficult to compare as Fulle et al. (2000) carried out analyses on skeletal muscle biopsy 
samples at rest while Barnes et al. (1993) investigated the bio energetic response to exercise 
of these CFS patients. Also, within this group of 46 patients, large differences were found 
between individual bioenergetics (See figure 9). It should be questioned whether it would be 
beneficial to carry out extra analyses in the individuals with abnormal bio energetic responses. 
These extra analyses are also required because it is impossible to differentiate mitochondrial 
Fig. 9: Distribution histogram of the free [ADP] 
at the end of exercise in healthy control 
subjects, MM and CFS patients. The dotted 
lines show the upper and lower limits of the 
control scores (Barnes et al., 1993). 
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dysfunction from a decreased mitochondrial content by P-MRS analysis (Smits et al., 2011). 
This is also essential to differentiate between an organic origin (i.e. mtDNA, nDNA) or a 
possible consequence of chronic inactivity (Boushel et al., 2007). In the study of Smits et al. 
(2011), it was found that mitochondrial function was intact in CFS patients as compared to 
MM patients. The mitochondrial density however, was significantly decreased in CFS patients, 
thereby indicating that skeletal muscle biopsy analysis is important to draw the right 
conclusion. Profound analysis of responses to exercise could possibly throw another light on 
the heterogeneity within the CFS cohort. Additionally, one should be aware of the frequent 
symptom similarities between both CFS, MM and physically inactive subjects (Smits et al., 
2011; Boushel et al., 2007, Taivassalo et al., 2006). There are two important exercise related 
markers that differentiate MM pathology from the other populations, i. e. a hyperdynamic 
cardiovascular response and mitochondrial dysfunction (Smits et al., 2011; Taivassalo et al., 
2001; 2006; 2012). With respect to the exercise response of CFS subjects, it is hard to 
differentiate between a primary (disease) or a secondary (chronic inactivity) cause. 
In MM, mitochondrial dysfunction during and after exercise has been clearly described and 
exercise intolerance can be clearly related to the disease severity. These problematic 
oxygenation responses to exercise are a consequence of genetic defects affecting 
mitochondrial function. However, little is known about eventual mild types and acquired types 
of MM (Morris and Maes, 2013). Notwithstanding these well described MM peripheral 
oxygenation responses, a lot of inconsistent findings are presented on eventual similar 
responses in CFS patients. Further assessment on this topic is essential, preferably with 
optimal methodological experiments to investigate peripheral oxygenation responses in CFS 
and MM patients and healthy subjects. 
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4. MEASURING PERIPHERAL OXYGENATION 
As discussed in the first part of this dissertation, according to Fick’s law,- there are two 
determinants determining the peripheral O2 consumption or peripheral oxygenation at muscle 
level, i.e. microvascular O2 extraction and skeletal muscle blood flow. To gain more insight in 
these peripheral oxygenation patterns in healthy and clinical populations, it is essential to 
obtain valid and reliable measurements of these two determinants. Also, it is important to 
emphasize that exhaustive exercise and invasive testing should be avoided to improve the 
accessibility of the measurements and exercise protocols. A critical overview of the available 
literature with respect to this subject is presented below.  
4.1 Microvascular O2 extraction 
The gold standard to monitor O2 extraction (Da-vO2) at rest or during exercise is the difference 
of O2 content in arterial (PaO2) and venous blood gasses (PvO2). During exercise at moderate 
or maximal intensity however, it is complicated to quantify PaO2 to the investigated muscle. 
In this case, venous effluent PvO2 will decrease because more O2 will be extracted to the 
exercising muscle (Pirnay et al., 1972; Costes et al., 1996). As such, the difference between 
this post exercise PvO2 and the PvO2 at rest was used multiple times to present a 
representative value of the extracted O2 to the muscle. This “Seldinger technique” (Seldinger 
et al., 1953) consists of the placement of a catheter which was percutaneously inserted in the 
investigated vein. A major disadvantage, in particular when performing exercise, is the 
invasive character of this technique. Therefore, some other techniques have been proposed 
to investigate muscle peripheral oxygenation. Since the introduction of the 31P-MRS to 
measure muscle oxidative metabolism in 1981, it has become the non-invasive gold standard 
to measure peripheral O2 extraction. Post exercise phosphocreatine (PCr) resynthesis rate 
measured by 31P-MRS has been recognized as one of the most reliable and non-invasive 
parameters for quantification of muscle oxidative function (Chance et al., 1985; Kemp et al., 
1993; Lodi et al., 1997; McCully et al., 1993). The major disadvantage when using this latter 
technique is the fact that it is very difficult and expensive to use when performing exercise. 
Also, it is impossible to differentiate a decreased mitochondrial density from a disturbed 
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mitochondrial functioning when using this technique in patient populations (Smits et al., 
2011). 
Near infrared spectroscopy (NIRS) is a frequently used method to evaluate skeletal muscle 
oxygenation in vivo at rest and during exercise (Ferrari et al., 1992; Hamaoka et al., 1996; 
2003; McCully et al., 1991) which is an indication of the balance between O2 delivered to and 
consumed within tissues (Esaki et al., 2005). This non-invasive optical technique is based on 
the penetration of NIR light throughout biological tissue such as skin, adipose tissue and 
muscle where it is absorbed by iron or copper centres of haemoglobin, myoglobin and 
mitochondrial cytochrome-c oxidase (Piantadosi and Duhaylongsod, 1994). Consequently, the 
concentration of oxygenated and deoxygenated haemo- and myoglobin (oxy[Hb+Mb] and 
deoxy[Hb+Mb]) can be determined by NIRS. Furthermore, total haemoglobin (tHb) and O2 
saturation (SmO2) can be calculated. In Figure 10, the functioning of NIRS is schematically 
presented.  
Fig. 10: Schematic presentation of the working NIRS mechanism (Beilman et al., 2009). The emitted 
light will be absorbed by oxy[Hb+Mb] and deoxy[Hb+Mb] (at different wavelengths).  
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The validity of this technique has been established in some studies (Mancini et al., 1994; 
Wilson et al., 1989; Esaki et al., 2005; Hamaoka et al., 2000), but questioned in others (Costes 
et al., 1996; MacDonald et al., 1999) comparing muscle deoxygenation with venous PO2 (de-
)saturation measurements or 31P-MRS (Sako et al., 2001). The reason for this discrepancy 
when validating NIRS, could be a consequence whether or not these values were 
physiologically calibrated by applying cuffs on the studied limb (Esaki et al., 2005). This 
“physiological calibration” consists of an occlusion of the artery at the studied limb. 
Consequently, NIRS oxy[Hb+Mb] and SmO2 will decrease and deoxy[Hb+Mb] will increase until 
steady state minimal and maximal values are reached. As such, values are physiologically 
calibrated and can be expressed relatively towards these minimal or maximal values. Another 
important issue which can be addressed when using NIRS, is what values are reliable to use 
when estimating O2 extraction. Deoxy[Hb+Mb] has been frequently used as the most 
important NIRS marker to quantify microvascular O2 extraction (Mancini et al., 1994; Grassi et 
al., 2007). 
As elucidated previously, exhaustive exercise should be avoided in MM and CFS patients, due 
to the possible comorbidity of cardiomyopathy in MM patients and the fact that disuse of leg 
muscles is an important issue in MM and CFS patients. Also, complaints of upper limb muscle 
pain and exercise intolerance are a common feature in CFS patients (Ickmans et al., 2014). 
Therefore, it would be very interesting to apply NIRS technology on upper limb muscles during 
exercise in these patient populations. Despite its major advantages (e.g. the non-invasive 
nature and low cost) when using NIRS, there are still some methodological issues that need 
serious consideration. A first problem affecting NIRS in skeletal muscle tissue is subcutaneous 
Adipose Tissue Thickness (ATT) (See figure 11). As such, some studies have demonstrated that 
NIR light measurements were attenuated with increasing ATT values (Van Beekvelt et al., 
2001; Cooper et al., 2010; Messere et al., 2013; Grieger et al., 2013). Ferrari et al. (2011) even 
stated that NIRS can only be used in lean subjects which strongly limits the clinical application 
of this tool. This statement was written supposing that a lot of patient populations have a 
larger subcutaneous ATT layer. It has been shown however, that the possible influence of 
subcutaneous ATT on NIRS signalling at rest is significantly reduced in forearm muscles 
compared to other skeletal muscles (Grieger et al., 2013). Moreover, some correction 
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algorithms have been developed to reduce this influence (Niwiyama et al., 2000; Bowen et al., 
2013). Notwithstanding these corrections, it remains crucial to keep focusing on these 
methodological issues as this device offers major advantages to measure peripheral O2 
extraction non-invasively in clinical populations at a low cost.  
Fig. 11: Schematical presentation of the possible influence of subcutaneous ATT on NIRS of skeletal 
muscle tissue (Van Beekvelt et al., 2002).  
 
A second issue, although on a different level, is the possible influence of O2 delivery on NIRS 
parameters (Ferrari et al., 2011). This issue has been poorly defined in the past and is of major 
importance when using this device in patient populations. Of course there are some indirect 
cardiovascular markers which could have a major impact on this O2 delivery at muscle level. 
Blood pressure is such a marker which is associated with the vasomotor response at the start 
of exercise. Such a “normal” response is a sympathetic mediated general vasoconstriction and 
vasodilation to the active muscle. The fact that blood pressure owns the ability to influence 
tissue oxygenation was shown in Georger et al. (2010), where norepinephrine intake induced 
a higher blood pressure resulting in a higher tissue oxygenation. Furthermore, some blood 
properties such as haematocrit may have a major impact on NIRS derived oxygenation 
parameters as well. Hence, it has been shown that transfusion of red blood cells led to an 
increased tissue oxygenation (Yuruk et al., 2011; Torella et al., 2003).  
Nothwithstanding the ongoing debate between groups preferring to use deoxy[Hb+Mb] 
values (Delorey et al., 2004; Koga et al., 2011) to estimate microvascular O2 extraction whereas 
other groups are using SmO2 values, stating that deoxy[Hb+Mb] is sensitive to changes in 
blood volume (Hamaoka et al., 2011), deoxy[Hb+Mb] is considered the most reliable value to 
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measure microvascular O2 extraction. This was also shown in other studies (Ryan et al., 2012; 
Binzoni et al., 2010; Van Beekvelt et al., 2001), where VO2m was calculated from the 
oxy[Hb+Mb] and deoxy[Hb+Mb] time constants during arterial occlusion. In the study of Ryan 
et al. (2012), a correction was implemented for changes in blood volume in order to exclude 
possible influences of this variable. Hence, it is important that totHb values are constant (by a 
synchronous increase in deoxy[Hb+Mb] and decrease in oxy[Hb+Mb]) when using this 
method. Moreover, Ryan et al. (2012) showed a significant association between absolute VO2m 
values and the previously mentioned subcutaneous ATT influence. However, when using 
relative values (%) towards the ischemic calibration, it was possible to exclude subcutaneous 
ATT influences (Ryan et al., 2012). In Figure 12, you can find a SWOT analysis about the use of 
NIRS to estimate peripheral oxygenation of skeletal muscle. 
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Fig 12: SWOT analysis of the NIRS device to estimate peripheral oxygenation in skeletal 
muscles. 
 
4.2 Skeletal muscle blood flow  
In contrast to the measurement of O2 extraction, there is no gold standard non-invasive 
method to measure skeletal muscle perfusion. As such, it remains problematic to investigate 
validity of new measurement methods as there is no ideal assessment of skeletal muscle blood 
flow (Casey et al., 2008). In general, three techniques have been developed to asses arterial 
inflow to, venous outflow from or local muscle blood flow. (i) The indicator methods (Jorfeldt 
and Wahren, 1971; Anderson and Saltin, 1985; Ganz and Swan., 1974) where a dye or a cold 
saline solution is infused in the blood, assuming that indicator concentration or temperature 
deflection is proportional to the flow rate of the blood. (ii) Venous occlusion plethysmography 
(Bygdeman and Pernow, 1978), where venous occlusion is applied to the studied limb while 
arterial inflow is not limited. The subsequent increase of the limb cross sectional area is a 
reliable measure for arterial inflow of the studied limb. (iii) Doppler Ultrasound measurements 
which are based on assessing the erythrocyte reflection to transmitted sound waves of a 
Strengths
- Valid methodology (with 
physiological calibration!)
- Non-invasive tool
- Peripheral (isolated) muscle 
oxygenation measurements
Weaknesses
- No exact O2 extraction and O2 
delivery measurement
- Influence of subcutaneous ATT
- Influence of passage Red Blood Cells 
(RBC's) (O2 delivery)
Opportunities
- To use in populations with a 
subcutaneous ATT < 6mm
- Combine with muscle blood flow 
measurements
- To use as an assessment (Pre-Post) 
in pharmaceutical and training 
studies
Threats
- Many different used methodologies 
for analysis NIRS parameters
- Applicability in patient populations 
with high ATT (useful and non invasive 
tool)
- Possible differences lower versus 
upper limb muscles 
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specific frequency (Gill, 1979; 1985). This assessment is obtained from the intraluminal space 
of the artery, which can be determined visually on the Doppler Ultrasound apparatus. As such, 
blood flow to the limb can be calculated by multiplying the cross sectional area of the artery 
by the blood velocity under the probe (Radegran, 1997). This latter technique has been 
mentioned as the most sensitive and accurate technique in two reviews assessing blood flow 
measurement methodologies (Radegran, 1999; Casey et al., 2008). The unique feature when 
using this device is a high temporal resolution of limb perfusion, allowing to accurately 
measure changes in limb blood flow when performing exercise. Moreover, this technique has 
its non-invasive character as a major advantage compared to the other techniques. It is 
however, very important to carry out these measurements in a fixed position of the limb to 
avoid changes due to movement (Radegran, 1999). When respecting all these methodological 
issues, this technique has a strong reliability (Shoemaker et al., 1996). In Figure 13, Doppler 
Ultrasound measurements are presented. 
Fig. 13: Doppler Ultrasound image of the brachial artery during forearm exercise. The waveforms 
underneath the image represent the mean blood velocity in the artery (Casey et el., 2011). 
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In general, two non-invasive methods were presented which enable us to assess microvascular 
O2 extraction and skeletal muscle blood flow. The non-invasive character combined with the 
feasibility of these techniques should be optimal to use in patient populations. Surprisingly, 
both techniques (i.e. NIRS and Doppler Ultrasound) have not been combined frequently in 
previous investigations.  
5. GAPS IN THE CURRENT LITERATURE 
In the first section of this dissertation, a short introduction of peripheral oxygenation 
mechanisms was presented, thereby demonstrating that the “classical view” on these issues 
is changing. Of course, this has a major impact on the way how certain diseases with 
microvascular or muscular complications should be analysed. Therefore, an overview was 
presented of two diseases in particular, where peripheral oxygenation abnormalities are 
suspected, i.e. MM and CFS.  
In the second section, various investigations were presented showing clear peripheral 
oxygenation abnormalities in the MM population as a consequence of mitochondrial 
malfunctioning. In general, two major problems could be raised when considering peripheral 
oxygenation responses in MM, based on this literature. (i) There is a need for combining non-
invasive and non-intensive screening tools to reliably measure peripheral oxygenation. 
Previous exercise protocols were in most of the cases whole body exercises, thereby imposing 
a high cardiopulmonary load. Especially for follow up and interventional studies of MM 
patients, this would be of great interest in future studies. (ii) Reliable testing protocols with 
sufficient specificity and sensitivity are of great interest as a lot of previous work showed a 
large heterogeneity in the MM cohort. In this context, it is important to highlight the problem 
of MM patients with a moderate heteroplasmy amount in skeletal muscle tissue. Unlike this 
MM population, there is a lot of controversy about muscle and peripheral oxygenation 
abnormalities in CFS patients. An overall conclusion that can be found in almost all studies 
investigating exercise responses in the CFS cohort, is the fact that there is a compelling 
heterogeneity within this population concerning muscle and peripheral oxygenation 
abnormalities. Again, two crucial issues can be raised towards this research area, where future 
work is essential. (i) Non-invasive and non-intensive exercise should be preferred to exclude 
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possible deconditioning bias in these patients. (ii) It should be suitable to analyze individual 
results of every patient and not only the mean values of the heterogeneous CFS cohort. As 
such, this heterogeneity could be investigated more profoundly. The reason for comparing 
these MM and CFS patient populations is that they have some possible commonalities and 
differences in exercise intolerance symptomatology and peripheral oxygenation responses to 
aerobic exercise. A clear decrease in O2 extraction due to mitochondrial dysfunction is one of 
the key mechanisms in the MM pathology. Although there have been some contradictory 
reports, this can be a common feature with a subgroup of CFS patients, probably due to a 
decreased mitochondrial density. Smits et al. (2011) stated that the major difference between 
MM and CFS patients is a mitochondrial dysfunction and a decreased mitochondrial density. 
According to the scientific literature, blood flow during exercise should be a major difference 
between both populations with a hyperdynamic cardiovascular response in MM patients and 
a decreased muscle blood flow in CFS patients, probably due to autonomic dysregulation, a 
decreased capillary density or a different muscle fibre type composition.  
In the third part of this dissertation, some techniques were presented to estimate peripheral 
O2 extraction and skeletal muscle blood flow. However, there are still some methodological 
issues that can be addressed towards the NIRS technique. (i) The influence of subcutaneous 
ATT is still a major issue influencing the NIR signal, especially when testing pathological 
populations. (ii) The reliability of this technique should be investigated on every new skeletal 
muscle and protocol where it is used to measure peripheral O2 extraction. (iii) It has not been 
clearly defined which parameters are influenced by O2 delivery and to what extent. Doppler 
ultrasound has been shown as the most sensitive technique to non-invasively measure 
skeletal muscle blood flow at rest and during exercise.  
6. RESEARCH OBJECTIVES AND GENERAL OUTLINE OF THE DISSERTATION 
Based on these problems, the aim of this research was to develop a reliable, non-invasive and 
non-exhaustive exercise screening tool for people suffering from malfunctioning peripheral 
oxygenation. In this context, the focus of this research was not only to study these parameters 
in MM patients suffering from clear mitochondrial dysfunction, but in CFS patients as well. 
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Therefore, an Incremental Cyclic Contraction Protocol (ICCP) was developed, performing 
handgrip exercise, with NIRS and Doppler Ultrasound measurements on forearm muscles. This 
protocol was based on dynamic rhythmic contractions as it is well known that this type of 
exercise predominantly activates oxidative metabolism (Poole et al., 2010). 
AIM 1: Investigate the reliability of physiologically calibrated NIRS parameters during ICCP. 
As indicated previously, various or no results have been found concerning validity and 
reliability of the NIRS technique when applied on small muscle groups. In this ICCP, relative 
deoxy[Hb+Mb] values during dynamic exercise were analyzed relative to their arterial 
occlusion maximal values. The reliability of these measurements on forearm muscles during 
ICCP was investigated in healthy subjects in study 1. We hypothesized that these relative 
deoxy[Hb+Mb] values would be reliable measurements to estimate O2 extraction. 
AIM 2: To investigate possible influence of subcutaneous ATT and blood flow on NIRS 
measurements. 
When using the previously described NIRS technique (Aim 1), one should be aware of the 
methodological issues that remain to be problematic in the analysis of these measurements. 
In this context, the aim of this study was to investigate the relation between absolute and 
physiologically calibrated NIRS values on the one hand, and subcutaneous ATT and blood flow 
on the other hand. Hence, we hypothesized in study 2 that the relative values of 
deoxy[Hb+Mb] would not be influenced by subcutaneous ATT and blood flow, and would 
therefore, be a reliable measure to use in pathological populations. 
AIM 3: To investigate post-occlusive and relative deoxy[Hb+Mb] in forearm muscles during 
ICCP in MM patients. 
As an attempt to develop a non-invasive and non-exhaustive exercise protocol, it was 
hypothesized that MM patients would have a different deoxy[Hb+Mb] pattern during this 
ICCP, due to mitochondrial dysfunction. Also, because  post-occlusive NIRS responses have 
already been studied extensively, we wanted to compare these deoxy[Hb+Mb] responses 
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during and after the arterial occlusion in an MM population and a healthy control group in 
study 3. Moreover, the relative deoxy[Hb+Mb] values during ICCP were studied in study 4. In 
both studies, we hypothesized a different pattern in the MM cohort compared to healthy 
matched control subjects. 
AIM 4: To use this ICCP deoxy[Hb+Mb] and FBF measurements as a screening tool for 
mitochondrial dysfunction in CFS patients. 
As a last part in this research, this study aimed to detect peripheral oxygenation abnormalities 
in individuals suffering from CFS. In study 5, Doppler US measurements were added to the 
ICCP to obtain insight in skeletal muscle blood flow during exercise. Distinctively from other 
scientific reports, the aim was to analyze all individual results more profoundly. Hence, CFS 
patients with a disturbed peripheral oxygenation pattern were further investigated by taking 
blood, muscle and skin biopsy samples. The aims of this dissertation are summarized in Figure 
14. 
In general, the aim of this research was to create a framework for CFS and MM patients 
complaining about exercise intolerance, muscle pain or weakness and post-exertional malaise. 
The foundation of this framework was the development of an accessible exercise test that 
didn’t evoke anxiety to participate or severe exhaustion. Moreover, to counteract eventual 
deconditioning effects, due to the disease, handgrip exercise was used in this protocol. This 
was in particular because disuse of leg muscles is an important issue in MM and CFS patients. 
Also, complaints of upper limb muscle pain and exercise intolerance are a common feature in 
CFS patients (Ickmans et al., 2014). The first step was to deal with methodological barriers 
when using these non-invasive techniques. The second step was to investigate whether 
patients with a clearly demonstrated mitochondrial dysfunction could be identified using this 
protocol. Last but certainly not least, it was the purpose to investigate peripheral oxygenation 
interference in a CFS population where these complaints occur frequently. The discussion part 
offers a critical review on this framework and postulates whether it could be used in future 
experiments. 
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Fig. 14: Overview of the studied population, used techniques and experimental aims in the different 
scientific reports (Healthy Subjects= HS; Mitochondrial Myopathy patients= MM; Chronic Fatigue 
Syndrome patients= CFS; Deoxyhaemoglobin and –myoglobin= deoxy[Hb+Mb]; Incremental Cyclic 
Contraction Protocol= ICCP; Adipose Tissue Thickness= ATT; Near Infrared Spectroscopy= NIRS). 
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ABSTRACT
The purpose of this study was to test the reliability of a new handgrip exercise protocol 
measuring forearm oxygenation in twenty healthy subjects on two occasions. The retest took 
place 48h later and at the same time of day. The incremental exercise consisted of 2-min steps 
of cyclic handgrip contraction (1/2Hz) separated by 1 min of recovery. The exercise started at 
20%MVC, was increased with 10%MVC each step and was performed until exhaustion (69,5% 
MVC and 73%MVC). Near Infrared spectroscopy (NIRS) was used to measure deoxygenation 
(deoxy[Hb+Mb]) and oxygen saturation (SmO2) in the forearm muscles. Prior to the exercise 
protocol an arterial occlusion of the forearm was performed until deoxy[Hb+Mb] did no longer 
increase. Maximal increase in deoxy[Hb+Mb] during 10s of each exercise bout was expressed 
relative to the occlusion amplitude. ICC was used to examine the test-retest reliability. 
Significant ICC’s were reported at 50% (r= 0.466; p=0.017) and 60% MVC (r=0.553; 
p=0.005).The group mean of the maximum increase in oxygen extraction was 45.6 ±16.7% and 
at the retest 44.9 ±17.0% with an ICC of r=0.867 (p<0.001) which could be classified (Landis 
and Koch 1979) as almost perfect. The absolute SmO2-values showed reliable ICC’s for every 
submaximal intensity except at 60%MVC. An ICC of r=0.774 (p<0.001) was found at maximal 
intensity. The results of the present study show that deoxy[Hb+Mb] and SmO2 responses 
during this protocol are highly reliable and indicate that this protocol could be used to get 
insight into deoxygenation and oxygen saturation in a population with low exercise tolerance. 
INTRODUCTION 
Near infrared spectroscopy (NIRS) is a well established technique to measure tissue 
oxygenation. In biological tissues like bone, muscle and skin, the NIRS-signal can be affected 
by absorbing and scattering of the NIR-light at a particular wavelength. Three molecules 
account for most of the NIRS light absorption: oxygenated and deoxygenated haemoglobin 
(Hb), myoglobin (Mb) and cytochrome oxidase c (Boushel et al., 2000). The concentration of 
cytochrome oxidase can be neglected. No distinction can be made between haemoglobin (Hb) 
and myoglobin (Mb) because there is an overlap of the NIR spectrum. In the past decade this 
technique has frequently been used to measure blood perfusion and oxygenation index of 
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several tissues. The validity of NIRS as an appropriate technique to measure oxygenation 
status at the level of microcirculation has been demonstrated in the past, both in the brain 
and in muscle tissue (Huppert et al., 2006; Mancini et al., 1994; Mehangoul-Schipper et al., 
2002). Beside validation of NIRS other studies have shown that NIRS provides a reliable 
technique for measurement of the oxygenation status of active muscles during exercise (Kell 
et al., 2004; Pereira et al., 2005). Significant test-retest intraclass correlations (ICCs) (r=0.69-
0.84) were found for total blood volume and oxygenation index of the erector spinae muscle 
during a static endurance protocol (Kell et al., 2004). Limb oxygenation measurements in the 
vastus lateralis during knee extensions at slow (r=0.73-0.76) and fast (r=0.85-0.97) velocities 
were shown to be reliable (Pereira et al., 2005). Considering the muscle oxygen saturation 
(SmO2) measurements with NIRS, reliable results were found in a recent study (Tew et al., 
2010). Blood volume and SmO2 in the vastus lateralis at rest were affected by changes in skin 
blood flow. However SmO2 during exercise was not influenced. Significant test-retest ICCs 
(r=0.93 and r=0.96) for the rest and end-exercise periods respectively, were reported for 
muscle oxygen saturation (SmO2) (Tew et al., 2010). This means that SmO2 is relevant and 
reliable to observe in an exercise protocol. 
These previous studies all focused on perfusion and oxygenation in large muscle groups. 
However little is known about the reliability of NIRS measurements in small muscles. Muthalib 
et al. (2010) tested the reliability of NIRS measuring the M. biceps brachii oxygenation. They 
concluded that the level of reliability is acceptable. Their protocol consisted of sustained 
isometric contractions at 30% and 100% of the maximal voluntary contraction (MVC) for 10 
seconds and of repeated isometric contractions (1s contraction, 1s relaxation). A second study 
of Van Beekvelt et al. (2002) established the reliability of measuring local muscle oxygen 
consumption (mVO2) in the forearm muscles. In this study however our interest is not the 
mVO2, but rather the oxygenation measurements in the forearm muscles. Also the arterial 
occlusion in Van Beekvelt et al. (2002) was used to calculate the mVO2 and was performed on 
the subjects directly after the handgrip exercise. In the present study we wanted to test the 
reliability of deoxygenation measurements on the forearm muscles during an incremental 
handgrip protocol, without calculating the mVO2. We focused on the deoxy[Hb+Mb] because 
it is often considered as an accurate indication for oxygen extraction into the muscle (Grassi 
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et al., 2006). Our study was different to Van Beekvelt et al. (2002) both in that the arterial 
occlusion occurred prior to the exercise and also in our interest in deoxy[Hb+Mb] as an 
indication for arterio-venous O2 difference in the local muscle, which is only one parameter of 
Fick’s law. Further research to establish the NIRS reliability on small muscles is necessary as it 
could be used to study muscle oxygenation without inducing a high cardiac stress in several 
populations. The purpose of this study is to test the reliability of the NIRS on forearm muscles 
in a newly developed incremental exercise protocol 
METHODS 
Subjects 
Twenty healthy subjects (8♂, 12♀) participated in this study, and their mean (±SD) age, height, 
and body mass were 24.4 ± 7.9 yr, 172.6 ± 8.2 cm and 66.5 ± 9.5 kg, respectively. Skinfold 
thickness at the forearm was measured at the location under the NIRS probe using a skinfold 
caliper (Holtain Ltd, Crymmych, UK). The mean skinfold thickness was 6.0 ± 2.2 mm at the 
proximal section of the forearm. All subjects reported no health problems or upper extremity 
injuries. Subjects were asked not to perform strenuous exercise 48h prior to and during the 
test-retest experimental period. The study conformed to the recommendations of the local 
Human Research Ethics Committee in accordance with the declaration of Helsinki. A written 
informed consent was signed by each subject. 
Near Infrared Spectroscopy (NIRS) 
During the exercise test, muscle tissue oxygenation was measured with a near infrared 
spectroscopy (NIRS) system (Oxiplex TS, ISS, Champaign, Illinois, USA). This system is based on 
an infrared light absorption method, where the infrared light is emitted at different 
wavelengths. The NIRS-probe consisted of eight light-emitting diodes operating at 
wavelengths 750 and 830 nm and one detector fibre bundle (source-detector distance = 2.0-
3.5cm). The deoxy[Hb+Mb] was stored at a frequency of 25 Hz and afterwards digitally 
averaged into 1s-values. The probe was positioned longitudinally on the M. flexor carpi radialis 
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and ulnaris and on the M. flexor digitorum superficialis and secured with Velcro straps around 
the upper arm. Pen marks were made over the skin to detect movement of the probe during 
the exercise and in order to ensure that the probe could be positioned in exactly the same 
location during the retest. This retest took place 48h after the first test at the same time of 
day. 
Study design and protocol 
Preceding the test the maximal voluntary contraction (MVC) force was determined on the 
hydraulic handgrip dynamometer (Saehan corporation, Masan, Korea) for all subjects ( best of 
three attempts). Each attempt was terminated when the force showed a clear stagnation or a 
decrease. Between every attempt there was a five minute rest period. The NIRS probe was 
placed on the M. flexor carpi radialis and ulnaris and a pneumatic cuff on the upper arm. The 
subjects performed the complete exercise protocol in supine position. The protocol started 
with an arterial occlusion of the forearm. There was no specific timeframe for this occlusion 
period as it was executed until a steady state in deoxy[Hb+Mb] was reached. This occlusion 
was carried out with a cuff inflated at about 260mmHg on the upper arm. After the occlusion 
there was a 5 minute rest period before the exercise task started. This task consisted of 2 
minute periods of an incremental cyclic contractions protocol (ICCP) at ½ Hz (1 second 
contraction, 1 second relaxation) at different intensities of maximal voluntary contraction (% 
MVC). These contraction periods were separated by a 60-s rest period. The work intensity was 
increased by 10% MVC each step. This protocol was executed until exhaustion was reached 
and the subjects were not able to produce the required force. The cyclic contractions for all 
subjects used the same (dominant) hand in each period and in each of the two sessions, which 
were separated by 48 hours.  
Data analysis 
When muscle tissue is exposed to an arterial occlusion, acute local hypoxia is induced. 
Following Fick’s law muscular oxygen consumption (VO2m) is the resultant of the product of 
muscle blood perfusion (Qm) and oxygen extraction (∆ a-v O2). To determine the mean values 
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within this protocol a smoothing procedure was performed in which the 30-s and 10-s mean 
values were determined by means of a moving average (Boone et al., 2010). The amplitude of 
the deoxy[Hb+Mb] response (i.e. the difference between the highest 30-s average of 
deoxy[Hb+Mb] during the occlusion and the 30-s average of deoxy[Hb+Mb] preceding the 
occlusion) was used as an index for maximal O2-extraction and was set to 100%. The changes 
in deoxy[Hb+Mb] during each work step ( i.e., the mean of the maximum 10-s) were expressed 
relative to this amplitude. 
The muscle oxygen saturation (SmO2) is a calculation of oxy[Hb+Mb]/(oxy[Hb+Mb]+ 
deoxy[Hb+Mb]). Because the NIRS instrument provides absolute measurements of these 
parameters and the oxy[Hb+Mb] is set relative to the tot[Hb+Mb], values can be reported 
without the need for a physiological calibration using arterial occlusion. At every intensity 
(%MVC) interval the 10-s mean minimum values of the SmO2 were subtracted from the 30-s 
baseline value before the exercise protocol started.  
Statistical analysis 
To measure significant differences in the MVC and amplitude of the occlusion steady state a 
paired samples T-test was used. The same analysis was used to compare the increase (in %) in 
deoxy[Hb+Mb] as a function of the amplitude in deoxy[Hb+Mb] and the decrease in SmO2 
between the test and the retest for each work step. In addition single measure intraclass 
correlation coefficients (ICCs) and the kappa test for agreement were used to examine the 
test–retest reliability of this new protocol. The ICCs were interpreted following Landis and 
Koch's (1977) benchmarks of 0.00–0.20 slight, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 
substantial, 0.81–1.0 almost perfect. Significance was set at P<0.05. Statistical computations 
were performed using SPSS® software (version 18; SPSS Lead Technologies Inc., Chicago, IL, 
USA). All data are presented as mean ± SD. 
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RESULTS 
No significant differences (p=0.188) were found between the MVC at the test ( x=492 ±125 N 
10.72) and at the retest (x=475 ± 127 N). The mean final step when the exercise was finished 
was at 69 % MVC for the first test and 73 % MVC for the retest. Typical deoxy[Hb+Mb] outputs 
as a response on the arterial occlusion and the incremental cyclic contractions protocol (ICCP) 
are shown in figure 1. The mean amplitude of the maximal deoxy [Hb+Mb] during the arterial 
occlusion between the test (x=44.05 ± 5.22µM) and the retest (x=47.16 ± 4.65 µM) showed no 
significant difference (p=0.156). For the amplitude of the arterial occlusion an ICC of r=0.952 
(p<0.001) was found. 
Fig.1: Typical changes in the values of deoxygenated haemoglobin and myoglobin (Deoxy[Hb+Mb])) of 
one subject during arterial occlusion and the incremental cyclic contractions protocol (ICCP) until 
exhaustion.  
 
The submaximal and maximal deoxy[Hb+Mb] values (in %) at the test and the retest are 
presented in figure 2 and figure 3. No significant differences were found for the mean values 
of the submaximal increase (in %) in deoxy[Hb+Mb] for 20% (p=0.419), 30% (p=0.331), 40% 
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(p=0.947), 50% (p=0.12) and 60% MVC (p=0.894). The ICC and p-values are presented in table 
1 for all submaximal and maximal increases relative to the occlusion value. In addition no 
significant differences were found (p=0.907) for the increase in deoxy[Hb+Mb] (in %) during 
the final bout (i.e. 69.5%-73%) between the test (n=45.6 ± 16.7%) and the retest (n=44.9 ± 
17%). For the maximal increase in oxygen extraction during the incremental cyclic contractions 
protocol (ICCP) an ICC of r=0.873 (p<0.001) was found between the test and the retest values 
(see figure 4). The pattern (in %) at these intensities at the test and the retest is given in figure 
2. Following Landis and Koch’s (1977) benchmarks the reliability for the submaximal 
intensities is slight for an intensity of 30%, fair for the intensities of 20% and 40% MVC and 
moderate for the intensities of 50% and 60%. For the maximal O2-extraction (in %) the 
reliability of the measurements is almost perfect (Landis and Koch 1977). 
 
Table 1: ICC and p-values for the deoxy[Hb+Mb]-values relative to the maximum value (during arterial 
occlusion) at the submaximal and maximal intensities. 
 20%MVC  30%MVC  40%MVC  50%MVC  60%MVC  69.5%-73%  
ICC  0,321 0,025 0,334 0,466 0,553 0,873 
P-value  0,078 0,457 0,069 0,017 0,005 <0,001 
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Fig. 2: Mean submaximal percentual deoxy[Hb+Mb] values at different intensities (% MVC) at the test 
and the retest for all 20 subjects. Trends of significant ICC’s ($≤0.1) and ICC’s at the significance levels 
of *p≤0.05, **p≤0.01and ***p≤0.001 are presented between the test and retest. 
 
 
Fig. 3: Mean maximal percentual deoxy[Hb+Mb] values at the maximal intensity at the test and retest 
for all 20 subjects. ICC at the significance level ***p≤0.001 is presented between the test and the retest. 
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Fig. 4: The ICC between the maximal deoxy[Hb+Mb] increase (in %) between the test and the 
retest. 
 
The submaximal and maximal SmO2-values (Subtracted from baseline) at the test and the 
retest are presented in figure 5. No significant differences were found for the SmO2-values 
between the test and the retest. The ICC and p-values are presented in table 2 for all 
submaximal and maximal decreases in SmO2. Following Landis and Koch’s (1977) benchmarks 
the reliability for the submaximal intensities is fair for the intensities of 30%, 50% and 60% 
MVC, moderate for the intensity of 40% and substantial for 20%MVC. For the maximal SmO2 
the reliability of the measurements is substantial (Landis and Koch 1977). 
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Table 2: ICC and p-values for the SmO2 (differences between the lowest 10-s mean values and 30-s 
baseline values) at the submaximal and maximal intensities. 
 20%MVC  30%MVC  40%MVC  50%MVC  60%MVC  69.5%-73%  
ICC  0,602 0,39 0,579 0,345 0,22 0,774 
P-value  0,002 0,04 0,003 0,063 0,171 <0,001 
 
Fig. 5: Mean submaximal and maximal absolute SmO2-values (subtracted from baseline values) (St) at 
different intensities (% MVC) at the test and the retest for all 20 subjects. Trends of significant ICC’s 
($≤0.1) and ICC’s at the significance levels of *p≤0.05, **p≤0.01and ***p≤0.001 are presented between 
the test and retest. 
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DISCUSSION 
To our knowledge, this is the first study reporting a significant test-retest ICC for the 
deoxy[Hb+Mb] and SmO2 response in forearm muscles with near infrared spectroscopy (NIRS). 
Other researchers have concluded that NIRS is a reliable tool for measuring haemodynamics, 
but specific to large muscles (limb) or brain (Kell et al., 2004; Pereira et al., 2005). The main 
finding of our study was that according to our protocol NIRS is a reliable tool for measuring 
deoxygenation in small muscles. The deoxy[Hb+Mb] was studied, to gain a better insight into 
peripheral extraction mechanisms. The only calculation in this study was to compare the 
increases of deoxy[Hb+Mb] relative to the maximal deoxygenation. It is important to mention 
that this arterial occlusion was very important in our protocol as a maximal deoxygenation 
value. The difference between our protocol and other studies is that the occlusion was 
maintained until a steady state of the deoxy[Hb+Mb] was reached. Our underlying rationale 
for the use of this protocol is that because it is expressed relatively, it can be used for 
comparison between individuals. This is because other factors (i.e. adipose tissue) can 
influence the absolute value. In our opinion an arterial occlusion standardized in time is not 
effective because the time to reach a steady state differs greatly between individuals. When 
an arterial occlusion is induced, muscle blood perfusion (Qm) of the forearm is stopped. As a 
consequence local available oxygen is consumed to respond to the metabolic demands of the 
forearm muscles at that moment. The increased O2-extraction from the blood into the muscle 
can be observed in our deoxy[Hb+Mb]- output because more oxygen is released from the 
haemoglobin molecules. The maximal increase (in %) in the protocol was the most important 
output from this test: a high value represents in fact a high extraction rate of oxygen from the 
blood into the muscle. 
In the research of Van Beekvelt et al. (2002) the occlusion was imposed for 45-s and the 
muscular VO2 (mVO2) was calculated. The protocol and the outcome that was examined were 
very different in this study compared to the study of Van Beekvelt et al. (2002). In this research 
our interest was not to calculate the mVO2, but to determine the oxygen extraction in the 
forearm muscles. Van Beekvelt et al. (2002) used the 45-s arterial occlusion to calculate the 
mVO2. In our study, as mentioned previously, the occlusion had a different purpose: as a 
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maximal deoxy[Hb+Mb]-value to analyze the other data relative to, and not as a calculation 
parameter. Despite the fact that both studies investigated the reliability of NIRS on forearm 
muscles, both outcome and methods were very different. 
Grassi et al. (2006) were the only researchers that used a similar protocol and outcome to 
compare the oxygen extraction between a mitochondrial myopathy and a control population. 
The fact that this protocol was executed on a cycle ergometer was a major difference 
compared to our study. The deoxy[Hb+Mb] increases in the incremental cycloergometric test 
were also examined relative to the maximal steady state deoxy[Hb+Mb]. Grassi et al. (2006) 
concluded that the NIRS showed an impaired oxygen extraction in a mitochondrial myopathy 
and a McArdle population. Our method is very easy to execute and could be useful to study 
oxygen extraction reliably in a population with a high exercise intolerance as well as in a 
healthy population. 
The fact that substantial reliability was found considering the oxygen saturation supports the 
fact that reliable results were found with the deoxy[Hb+Mb]-values. The SmO2 is a calculation 
of oxy[Hb+Mb]/ Tot[Hb+Mb] or oxy[Hb+Mb]/ (oxy[Hb+Mb]+deoxy[Hb+Mb]). Although the 
Deoxy[Hb+Mb] output is the most important as a measure for microvascular oxygen 
extraction, it is useful to compare the SmO2 as well. Physiological calibration using arterial 
occlusion is not necessary. The relation between the SmO2 and the deoxy[Hb+Mb] values are 
inverse. When the deoxy[Hb+Mb] values are increasing, the SmO2-values decrease. The fact 
that the decrease of SmO2 shows similar reliability with the deoxy[Hb+Mb] values supports 
the fact that the measurements of forearm oxygenation during this protocol are reliable. 
To our knowledge Van Beekvelt et al. (2002) is the only study that addressed the reliability of 
NIRS on the forearm muscles, using a different protocol and outcome. Using this protocol, this 
is the first study that finds a highly reliable outcome for measuring the deoxy[Hb+Mb] 
relatively and the SmO2. In conclusion we propose that this protocol can be used to compare 
muscle deoxygenation and oxygen saturation between different subjects. 
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ABSTRACT 
Objectives: The influence of subcutaneous adipose tissue (ATT) and oxygen (O2) delivery has 
been poorly defined in frequency domain (FD) near infrared spectroscopy (NIRS). Therefore, 
the aim of this study was to investigate the possible influence of these variables on all FD NIRS 
responses using a reliable protocol. Moreover, these influences were also investigated when 
using relative oxy- and deoxyhaemoglobin and –myoglobin (oxy[Hb+Mb] and deoxy[Hb+Mb]) 
values (in %). 
Methodology: In part 1 of this study, a regression analysis was carried out for ATT and 
maximal/minimum oxy[Hb+Mb], deoxy[Hb+Mb], oxygen saturation (SmO2) and total 
haemoglobin (totHb) amplitudes during an incremental cyclic contraction protocol (ICCP) in a 
group of 45 subjects. Moreover, the same analysis was carried out between subcutaneous ATT 
and the relative oxy- and deoxy[Hb+Mb] values (in percentage). In part 2 of this study, a 
regression analysis was performed for peak forearm blood flow (FBF) during ICCP and the 
absolute and relative NIRS values in a group of 37 subjects. 
Results:  
Part 1: Significant exponential correlation coefficients were found between ATT and 
deoxy[Hb+Mb] (r=0.53; p<0.001), oxy[Hb+Mb] (r=0.57; p<0.001) and SmO2 amplitudes 
(r=0.57; p<0.001). No significant relations were found between ATT and relative oxy[Hb+Mb] 
(r=0.37; p=0.07) and deoxy[Hb+Mb] (r=0.09; p=0.82). 
Part 2: Significant positive correlation coefficients were found between force at exhaustion 
and maximal FBF (r=0.66; p<0.001), maximal differences in deoxy[Hb+Mb] (r=0.353; p=0.032) 
and totHb (r=0.512; p=0.002) while no significant correlation coefficients were found between 
these maximal force values and maximal differences in oxy[Hb+Mb] (r=-0.267; p=0.111) and 
SmO2 (r=-0.267; p=0.111). Significant linear correlation coefficients were found between FBF 
and deoxy[Hb+Mb] (r=0.51; p=0.001), oxy[Hb+Mb] (r=-0.50; p=0.001), SmO2 (r=-0.54; 
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p=0.001) and totHb amplitude (r=0.61; p<0.001). No significant correlations were found when 
using relative oxy[Hb+Mb] (r=-0.01; p=0.957) and deoxy[Hb+Mb] (r=-0.02; p=0.895). 
Conclusion: Based on these findings, caution is advised when using NIRS values, as 
subcutaneous ATT and O2 delivery significantly influence NIRS measurements. To eliminate 
these influences, use of relative deoxy[Hb+Mb] is advised, especially in clinical settings and/or 
in people with a higher subcutaneous ATT layer.  
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INTRODUCTION 
Near infrared spectroscopy (NIRS) is a frequently used method to evaluate muscle oxidative 
metabolism and haemodynamics in vivo at rest and during exercise (Ferrari et al., 2011; 
Hamaoka et al., 2011). This noninvasive optical technique is based on the penetration of NIR 
light throughout biological tissue such as skin, adipose tissue and muscle where it is absorbed 
by iron or copper centers of haemoglobin, myoglobin and mitochondrial cytochrome-c 
oxidase (Piantadosi and Duhaylongsod, 1994). In this way, the concentration of oxygenated 
and deoxygenated haemo- and myoglobin (oxy[Hb+Mb] and deoxy[Hb+Mb]) can be 
determined with NIRS. In general, there are three types of NIRS, i.e. continuous wave (CW), 
frequency domain (FD) and time domain (TD) NIRS. The difference between CW spectroscopy, 
which is the most widely used oximetry approach, and FD spectroscopy, is the technical 
complexity. Moreover, only the FD technique offers the absolute characterization of the tissue 
optical properties from which it is possible to obtain absolute concentration values of 
oxy[Hb+Mb] and deoxy[Hb+Mb] (Ferrari et al., 2011). The validity of this technique has been 
established in some studies (Mancini et al., 1994; Hamaoka et al., 2000; Wilson et al., 1989; 
Esaki et al., 2005) but questioned in other studies (Costes et al., 1996; MacDonald et al., 1999) 
comparing muscle deoxygenation with venous blood oxygen (de-)saturation measurements 
or phosphorous magnetic resonance spectroscopy (P-MRS) (Sako et al., 2001).  
In general, two major issues need consideration when using NIRS, i.e. subcutaneous adipose 
tissue thickness (ATT) and changes in blood volume (Hamaoka et al., 2011). Because the 
majority of earlier studies investigating this matter, used the CW NIRS technique, these issues 
are poorly/less well defined when using FD spectroscopy. The possible influence of 
subcutaneous ATT is an important factor determining the NIRS signal (Van Beekvelt et al., 
2001; Messere and Roatta, 2013; Grieger et al., 2013; Cooper et al., 2010). Ferrari et al. (2011) 
stated that the NIRS technique is therefore constrained to lean subjects, strongly limiting the 
clinical application of this tool. Although some correction algorithms have been developed 
(Bowen et al., 2013; Niwiyama et al., 2000) to measure muscle oxygenation independent from 
ATT, limited data are available regarding varying interventions such as arterial occlusion to 
counteract these influences (Hamaoka et al., 2011). A second point that merits consideration 
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is the influence of O2 supply on NIRS values as little is known about this issue. When focusing 
on microvascular O2 extraction, some investigators prefer to report deoxy[Hb+Mb] as it seems 
be the best indicator of O2 extraction when total haemoglobin (totHb) remains stable (Delorey 
et al., 2004; Koga et al., 2011). Other investigators however, prefer to use O2 saturation (SmO2) 
as deoxy[Hb+Mb] is sensitive to blood volume changes during exercise (Hamaoka et al., 2011). 
All these previous studies did, however, investigate this matter using CW modalities. The 
possible influence of ATT and changes in blood volume on these FD measurements are, to our 
knowledge, not known.  
Due to the fact that possible influence of subcutaneous ATT and changes in blood volume are 
poorly defined, especially on FD NIRS, the purpose of this study was twofold. The first aim was 
to investigate the influence of subcutaneous ATT on all FD NIRS responses. Given the fact that 
we carried out limb ischemia as a physiological calibration in our protocol (Celie et al., 2012), 
we also investigated the influence of ATT on the relative oxy[Hb+Mb]- and deoxy[Hb+Mb] 
values (i.e. maximal responses during exercise towards the arterial occlusion (AO) maximal 
value). The second aim was to explore the relation between limb O2 delivery and FD NIRS 
values to gain more insight about the influence of limb blood flow on all NIRS responses during 
exercise. According to earlier studies, investigating the relation between ATT and CW NIRS, 
we hypothesized that absolute FD NIRS responses would decrease with increasing 
subcutaneous ATT. Also, we hypothesized that increasing limb O2 delivery would influence the 
FD NIRS responses during exercise. However, when using relative oxy[Hb+Mb] and 
deoxy[Hb+Mb] values, we hypothesized that these influences could be eliminated. 
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METHODS 
Subjects 
In part 1 of this study, the relation between subcutaneous ATT and the NIRS responses was 
studied in healthy subjects (21♀, 24♂). The mean age, body weight and height was 
respectively 28 ± 11 years; 73.5 ± 13.9 kg and 1.76 ± 0.1 m (mean values ± SD).  
In part 2 of this study, the relation between forearm blood flow (FBF) and the NIRS responses 
was studied in healthy subjects (14♀, 23♂). The mean age, body weight and height was 
respectively 26 ± 6 years; 67.7 ± 11.4 kg and 1.76 ± 0.09 m. The subjects were fully informed 
of the study protocol and of any risk associated with the experiments before giving their 
written consent for participation. The study was approved by the ethical committee at the 
Ghent University Hospital. Procedures were in accordance with the recommendations of the 
Helsinki Declaration. 
Study design and protocol 
In part 1 of the study, before the start of the incremental cyclic contraction protocol (ICCP)20 
maximal voluntary contraction (MVC) force (expressed in Newton (N)) in the dominant arm 
was determined using a hydraulic handgrip dynamometer (Saehan corporation, Masan, 
South-Korea) for all subjects (best of three attempts). Determination of the MVC force was 
performed without warming up and they had to sustain their maximum force for at least 2 
sec. Between every attempt a 5 minute resting period was included. Then the NIRS probe was 
placed on the M. flexor carpi ulnaris and the M. flexor digitorum superficialis, where 
subcutaneous ATT was measured using a skinfold caliper (Holtain Ltd., Crymmych, U.K.). After 
the placement of the NIRS probe on the muscles, a pneumatic cuff was placed around the 
ipsilateral upper arm. All subjects performed the complete exercise protocol in supine 
position. This protocol started with a forearm arterial occlusion by inflating the cuff to 
260mmHg. The duration of the occlusion was not specified as it was executed until a steady 
state in deoxy[Hb+Mb] was reached. However, the mean duration of the arterial occlusion in 
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this study was 420 ± 112 sec. After the occlusion, there was a resting period before baseline 
conditions were restored and then the ICCP started. The ICCP consisted of 2 minute periods 
during which incremental cyclic contractions were performed at ½Hz (1 second contraction, 1 
second relaxation), at different intensities of maximal voluntary contraction (% MVC). The 
contraction periods were separated by a 60-s rest period. The work intensity started at 20% 
MVC and increased by 10% MVC each step. This protocol was executed until exhaustion was 
reached and the subjects were no longer able to produce the required force. A typical NIRS 
output of one subject during this ICCP is presented in fig. 1. The duration of this test procedure 
was about 1h and the reliability of this protocol has been established in a previous study (Celie 
et al., 2012).  
Additional to the experimental procedure of part 1 of the study, brachial artery Doppler US 
measurements (on the forearm muscles) were executed in part 2 of the study to determine 
FBF. As such, baseline FBF values were recorded for all subjects preceding the exercise test 
and during the ICCP. 
Measurements 
Near Infrared Spectroscopy (NIRS) 
Skeletal muscle tissue oxygenation was measured with a FD near infrared spectroscopy (NIRS) 
system (Oxiplex TS, ISS, Champaign, Illinois, USA). This system is based on an infrared light 
absorption method, where near-infrared light is emitted at different wavelengths. The NIRS-
probe consisted of eight light-emitting diodes operating at two wavelengths, 690 and 830nm, 
and one detector fibre bundle (source-detector distance = 2.0 - 3.5cm). The deoxy[Hb+Mb] 
data were stored at a frequency of 25Hz and afterwards digitally averaged into 1s-values. The 
probe was positioned longitudinally on the M. flexor carpi ulnaris and M. flexor digitorum 
superficialis of the dominant arm and secured with Velcro straps. Pen marks were made on 
the skin to detect probe displacement during the exercise. 
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Doppler Ultrasound 
In part 2 of the study, the ultrasound Doppler system (Vivid 7, GE Vingmed Ultrasound , 
Horten, Norway) was used to measure FBF which is the preferred method during exercise 
compared to plethysmography (Casey et al., 2008). A M12L linear probe was used to image 
the brachial artery. The brachial artery was insonated approximately midway between the 
antecubital and axillary regions, medial to the biceps brachii. Brachial arterial diameter (BAD) 
was measured during peak systolic momentum at a perpendicular angle along the central axis 
of the scanned area (2D longitudinal view) to optimize spatial resolution. Velocity 
measurements were obtained from angle-corrected longitudinal spectral Doppler images. The 
angle between the direction of blood flow and the direction of the ultrasound beam was kept 
at ≤60 degrees. Also, a velocity-time integral was used to average 10 cardiac cycles for blood 
flow velocity measurements. Blood flow was calculated using BAD (cm) and mean blood 
velocity (vmean cm/sec):  
Blood flow (ml min-1) = vmean(cm s-1) {π ( vessel diameter (cm)/ 2}2 * 60 (s min-1) 
Data analysis 
In part 1 and 2 of the study, we analyzed the mean values of oxy[Hb+Mb], deoxy[Hb+Mb], 
SmO2 and totHb using a smoothing procedure in which the 10-s mean values were determined 
by means of a moving average. At every work bout during the ICCP, the amplitude of the NIRS-
response was calculated by subtracting the baseline value (i.e., the mean 30s value prior to 
the start of the ICCP) from the steady state values during the exercise bout (i.e., the highest 
10s average). For the statistical analysis we only included the maximal amplitudes of the 
responses obtained during the completed work bout with the highest intensity. Because 
oxy[Hb+Mb] and SmO2 are decreasing during exercise towards baseline resting values, these 
are negative values. In Figure 1, typical oxy[Hb+Mb], deoxy[Hb+Mb], SmO2 and totHb values 
are presented during arterial occlusion and ICCP. In addition to the amplitude of these values 
, the relative responses of oxy[Hb+Mb] and deoxy[Hb+Mb] were calculated by expressing the 
Part II – Study 2 
 
70 
maximal absolute amplitude during ICCP relative to the amplitude from the arterial occlusion 
(i.e. difference between baseline values and highest 30 s mean values during AO). As such, we 
used these values in percentage for statistical analysis with subcutaneous ATT (Celie et al., 
2012).  
In part 2 of the study, FBF (expressed in ml min-1) was measured preceding ICCP and after 
every incremental step (% MVC) in the protocol. ICCP had FBF baseline values subtracted so 
as to calculate the response to exercise compared to resting conditions. The maximal 
difference during ICCP (peak FBF- baseline FBF) were used for statistical analysis with the 
oxy[Hb+Mb], deoxy[Hb+Mb], totHb and SmO2 amplitudes and the relative oxy[Hb+Mb] and 
deoxy[Hb+Mb] values, as described previously. In Figure 1, an individual pattern is presented 
whereas a schematic summary is given of all measurements. 
Fig. 1 Example of a typical deoxy[Hb+Mb], oxy[Hb+Mb], totHb and SmO2 output of one subject during 
the incremental cyclic contractions protocol (ICCP). All measurements (e.g. forearm blood flow (FBF) in 
study 2) are presented schematically. In study 2, FBF measurements were always combined with 
brachial artery diameter (BAD) measurements.  
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Statistical analysis 
In part 1 of the study, a regression analysis was performed for ATT and maximal/minimal 
oxy[Hb+Mb], deoxy[Hb+Mb], SmO2 and totHb amplitudes calculating Pearson’s R square. 
Also, a regression analysis was used to investigate the relationship between ATT and the 
relative maximal/minimal oxy[Hb+Mb] and deoxy[Hb+Mb] values (in %). When statistical 
significance was observed, a best fit analysis was performed. This was executed using 
Sigmaplot 10 with SigmasStat 3.5 software (Systat Software Inc., San José, USA) to find the 
best fit (between) model, a linear or an exponential/logarithmic model. 
In part 2 of the study, the same statistical analysis was executed to study the relationship 
between the force at the maximal reached intensity during ICCP (%MVC), FBF (O2 delivery) 
and the NIRS responses. Significance was set at P<0.05. Statistical computations were 
performed using SPSS® software (version 18; SPSS Lead Technologies Inc., Chicago, IL, USA). 
All data are presented as mean ± SD. 
RESULTS 
1. Subcutaneous ATT  
The best fit between subcutaneous ATT and all significant NIRS responses was an 
exponential/logarithmic fit (Y = Y0 + a (1-e-(X-X0)/b)). All results of this best fit model analysis are 
presented in table 1. A significant exponential/logarithmic correlation coefficient was found 
between subcutaneous ATT (µ=6.5 ± 3.4 mm) and maximal amplitude in absolute 
deoxy[Hb+Mb] (µ=36.1 ± 17.7 µM) (r=0.53; p<0.001), oxy[Hb+Mb] (µ=-20.2 ± 22.5 µM) 
(r=0.57; p<0.001) and SmO2 (µ=-18.2 ± 13.7 %) (r=0.57; p<0.001). No significant relation was 
found between ATT and maximal difference in totHb (µ=33.2 ± 22.4 µM) (r=-0.34; p=0.3). All 
correlations relating these NIRS responses to subcutaneous ATT are presented in Figure 2. 
When using relative oxy[Hb+Mb] (µ=-33.5 ± 30.1 %) (r=0.37, p=0.07) or deoxy[Hb+Mb] (µ=55.3 
± 20.3 %) (r=0.10; p=0.82) values (in %) towards the arterial occlusion maximal values, no 
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significant relation was found with subcutaneous ATT. These correlation coefficients are 
added in Figure 3. 
Table 1: Results of the ‘best fit model’ for a linear and an exponential/logarithmic model (SEE= Standard 
Error of estimate; RSS= Residual Sum of Squares): 
  R-Square SEE RSS F-value p-value 
Deoxy[Hb+Mb] Linear 0.22 33.1 48205 12.2 0.01 
 Exponential 0.28 31.8 44509 16.9 0.0002 
Oxy[Hb+Mb] Linear 0.22 20.1 16613 11.7 0.0014 
 Logarithmic 0.28 19.3 15304 16.2 0.0002 
SmO2 Linear 0.25 10.7 4807 14.4 0.0005 
 Logarithmic 0.30 10.2 4509 18.6 <0.0001 
 
Fig. 2: Correlation coefficients between subcutaneous ATT and maximal oxy[Hb+Mb], deoxy[Hb+Mb], 
totHb and SmO2 responses. Pearson’s R and p- values are included as well as the intercept values where 
significant. 
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Fig. 3: Correlation between subcutaneous ATT and maximal relative deoxy[Hb+Mb] and 
oxy[Hb+Mb]. Pearson’s correlation coefficients and p- values are included.  
 
2. Maximal voluntary contraction (MVC) force and forearm blood flow (FBF) 
The mean maximal force output at exhaustion for the entire population was respectively 326 
± 107N, which was at a mean intensity (± SD) of 65 ± 10 %MVC. Significant positive correlation 
coefficients were found between the force, reached at the maximal intensity and maximal FBF 
(µ=419.8 ± 245 ml/min) (r=0.66; p<0.001), maximal differences in deoxy[Hb+Mb] (µ=82 ± 73.8 
µM) (r=0.353; p=0.032) and maximal differences in totHb (µ=296.4 ± 199 µM) (r=0.512; 
p=0.002) while no significant correlation coefficients were found between this maximal force 
and maximal differences in oxy[Hb+Mb] (µ=-58.6 ± 53.9 µM) (r=-0.267; p=0.111) and SmO2 
(µ=-29.7 ± 18.8 %) (r=-0.267; p=0.111). Also, no significant relation between maximal force at 
exhaustion and the relative values (towards arterial occlusion maximum values) of 
deoxy[Hb+Mb] (µ=51.8 ± 25.1 %) (r= -0.20; p=0.231) and oxy[Hb+Mb] (µ=-35.9 ± 20.9 %) (r=-
0.154; p=0.369) were found. 
Significant positive correlation coefficients were found between maximal FBF and maximal 
amplitudes in deoxy[Hb+Mb] (r=0.511; p=0.001) and totHb (r=0.609; p<0.001) while 
significant negative correlation coefficients were found between maximal FBF and maximal 
amplitudes in oxy[Hb+Mb] (r=-0.503; p=0.001) and SmO2 (r=-0.537; p=0.001). All correlations 
relating NIRS amplitudes to FBF are presented in Figure 4. When using relative deoxy[Hb+Mb], 
no significant relation was found with FBF (r=-0.022; p=0.895). This same result was found for 
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relative oxy[Hb+Mb] values (r=-0.009, p=0.957). These correlation coefficients are shown in 
Figure 5. 
Fig. 4: Correlation between maximal FBF and maximal/minimal oxy[Hb+Mb], deoxy[Hb+Mb], totHb 
and SmO2 responses during ICCP. Pearson’s correlation coefficients and p- values are included as well 
as intercept values. 
 
Fig. 5: Correlation between maximal FBF and relative maximal oxy[Hb+Mb] and deoxy[Hb+Mb]. 
Pearson’s correlation coefficients and p- values are included. 
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DISCUSSION 
In the present study, the influence of ATT on the responses of a frequency domain (FD) NIRS 
was investigated. It was observed that the maximal oxy[Hb+Mb], deoxy[Hb+Mb] and SmO2 
responses to an incremental handgrip test were related to the thickness of the skinfold at the 
location of the probe, indicating that ATT might blunt the NIRS responses to exercise. 
However, when the oxy[Hb+Mb] and deoxy[Hb+Mb] responses were expressed relative to the 
amplitude values obtained during arterial occlusion, the impact of ATT was no longer present. 
Additionally, to obtain insight into the interpretation of the absolute and relative NIRS 
responses, the relationship with FBF and MVC was studied. It was observed that MVC as well 
as FBF correlated significantly with the amplitude of the NIRS responses. Similar to the 
subcutaneous ATT influence on the NIRS signal, this relationship disappeared when using 
relative oxy[Hb+Mb] and deoxy[Hb+Mb]. 
1. Subcutaneous ATT 
In part 1 of the study, a significant negative correlation coefficient was found between 
subcutaneous ATT layer and deoxy[Hb+Mb] which is an indication that maximal 
deoxy[Hb+Mb] amplitudes were attenuated with higher subcutaneous ATT. Additionally, 
significant positive correlation coefficients were found between ATT and oxy[Hb+Mb] and 
SmO2 amplitudes in forearm muscles during ICCP. Hence, this positive relation means that 
both variables were also influenced by subcutaneous ATT during exercise. On the contrary, no 
significant relation was found with totHb which is, however, in contradiction with other 
studies showing a significant negative relation between totHb measurements and ATT (Van 
Beekvelt et al., 2001; Grieger et al., 2013; Bowen et al., 2013). This could be due to the fact 
that a different NIRS technology was used in these studies, whereas CW spatially resolved 
spectroscopy obtains a scaled absolute value of tHb (Ferrari et al., 2011). In this study FD NIRS 
was used, where tHb values are derived from the absolute concentration values of 
oxy[Hb+Mb] and deoxy[Hb+Mb] (Ferrari et al., 2011). Another plausible explanation for these 
divergent findings could be the fact that the correlation between ATT and totHb is significantly 
Part II – Study 2 
 
76 
weaker in forearm muscles compared to leg muscles, probably due to a smaller muscle tissue 
thickness (Grieger et al., 2013). In contrast to the study of Grieger et al. (2013), we found a 
significant correlation coefficient between SmO2 and ATT in forearm muscles. These opposite 
results could be clarified by the fact that we measured minimal saturation values during 
exercise, whereas Grieger et al. (2013) used resting baseline values. Considering the significant 
correlation coefficients for all NIRS responses except totHb, it can be stated that a higher 
subcutaneous ATT layer resulted in an attenuated absolute oxy[Hb+Mb], deoxy[Hb+Mb] and 
SmO2 signal. Taking into account these results, the statement of Ferrari et al. (2011) saying 
that the NIRS technique is strongly constrained to lean subjects, could be confirmed. A 
possible explanation for the blunting influence of ATT on NIRS responses is the reduced 
absorption and/or scattering in muscle tissue (Wolf et al., 2003). This latter investigation has 
shown that, whereas ATT was between 6 and 14 mm, the NIRS absorption coefficient (µa) 
quickly decreased while the NIRS scattering coefficient (µs) remained constant (Wolf et al., 
2003). In this study however, mean subcutaneous ATT (±SD) for all subjects was 6.5 ± 3.4 mm. 
Based on the conclusions drawn in Wolf et al. (2003), this indicates that the NIRS absorption 
coefficient (µa) was decreased in this study. This of course limits the clinical application of this 
tool in diverse patient populations. Therefore, it is interesting that the relative values of 
oxy[Hb+Mb] and deoxy[Hb+Mb] did not correlate significantly with ATT values. As such, when 
using relative oxy[hb+Mb] and deoxy[Hb+Mb] values, subcutaneous ATT does not influence 
the outcome and so, these relative values could be used in clinical populations with a higher 
subcutaneous ATT. In this context, it is important to highlight the role of arterial occlusion as 
a physiological calibration. When validating the NIRS technique for measuring microvascular 
O2 extraction, in some studies (Mancini et al., 1994; Hamaoka et al., 2000; Wilson et al., 1989; 
Esaki et al., 2005) an arterial occlusion was performed in the studied limb as a physiological 
calibration. In the other studies where NIRS validation was not confirmed to measure 
microvascular O2 extraction (Costes et al., 1996; MacDonald et al., 1999), no physiological 
calibration was carried out. Consequently, the use of absolute NIRS values, without arterial 
occlusion to measure O2 extraction, seems not valid. When using FD NIRS in clinical 
populations, it is strongly advised to use the relative values using a physiological calibration. 
As such, relative deoxy[Hb+Mb] values (in percentage) could be an interesting parameter of 
microvascular O2 extraction rate in different populations. 
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2. Forearm blood flow (FBF) 
Another issue concerning FD NIRS use is the possible influence of exercise intensity (MVC) and 
limb blood flow (O2 delivery) on all responses. In part 2 of this study, it has been shown that 
MVC correlated significantly with FBF and all absolute NIRS responses. Moreover, forearm 
blood flow (FBF) correlated significantly with the amplitude of the NIRS responses. To discuss 
this issue it is important to emphasize that O2 delivery should differentially influence the 
different NIRS responses. Only one preceding study focused on the relation between O2 
delivery and NIRS values during exercise (Fadel et al., 2004). In accordance with the study of 
Fadel et al. (2004), totHb correlated significantly positive with FBF during rhythmic handgrip 
exercise. TotHb has frequently been used in earlier studies as an indicator of blood 
volume/flow changes (Ferrari et al., 2011; Cettolo et al., 2007). The results of this study 
confirms the appropriate use of totHb as a marker for changes in muscle blood volume/flow. 
Furthermore, for the interpretation of our results, it is important to emphasize that the 
individual intensity during this ICCP depends on the MVC. When individual MVC values are 
higher, O2 demand at muscle level during ICCP will be proportionally increased as well. 
According to Fick’s law, skeletal muscle blood flow (Qm) and microvascular O2 extraction (∆a-
v O2) will be higher during ICCP in subjects with a higher MVC in order to meet the increased 
O2 demand. In our opinion it is obvious that higher MVC values can be associated closely with 
higher maximal FBF values. The linear increase in limb blood flow to match O2 supply to O2 
demand has been demonstrated in leg muscles (Calbet et al., 2007; Mortensen et al., 2007; 
Richardson et al., 1995) and in forearm muscles (Green et al., 2005). 
The rationale for this methodological paper concerning NIRS, is its possible application in 
clinical populations. In this context, the relationship between NIRS responses on the one hand 
and maximal FBF and MVC on the other hand is rather complicated. The absolute maximal 
values correlated significantly with maximal force at exhaustion and maximal FBF, whereas 
the relative oxy[Hb+Mb] and deoxy[Hb+Mb] did not. A higher force at exhaustion implicates 
an improved functional capacity of the muscle to contract at a higher load. The higher maximal 
FBF value is an indication of the improved functional capacity at muscle level, probably due to 
an increased capillary density and modifications in dilator function related to endothelial 
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change (Delp and Laughlin, 1997; Sinoway et al., 1986; Smolander, 1994; Snell et al., 1987). 
Whereas a maximal force at exhaustion during ICCP is higher, FBF values will be increased too 
in these individuals, probably to have an expanded passage of O2, free fatty acids and glucose 
during sustained dynamic contractions. It could be possible that individuals with a higher MVC 
may have a higher amount of capillaries that influences the NIR penetration at muscle level. 
In these individuals, capillary blood flow will be increased at the site where deoxy[Hb+Mb] is 
measured. This higher amount of capillary O2 supply at the site of the NIRS probe means that 
haemoglobin flux will be increased. As such, larger deoxy[Hb+Mb] increases will be possible 
during exercise compared to subjects with a lower haemoglobin flux at the measurement site. 
Consistent with this explanation, absolute deoxy[Hb+Mb] measurements will depend on 
intensity and capillary haemoglobin flux. It is however questionable, whether it is favorable to 
measure this improved functional capacity rather than clinical related peripheral problems in 
some pathologic populations. Therefore, it is interesting that the relationship between 
intensity (MVC) and O2 delivery on the one hand and NIRS responses on the other hand 
disappears by using relative values. In our opinion, the use of absolute or relative oxy[Hb+Mb] 
and deoxy[Hb+Mb] depends on the experimental purpose of the study. When searching for 
functional adaptations in certain sports or other populations with a very low subcutaneous 
ATT, one could use absolute NIRS values. However, when testing clinical populations to detect 
certain muscle abnormalities, one should definitely use relative values because it excludes 
eventual differences in muscle oxygenation due to an improved functional capacity of the 
muscle.  
In conclusion we can state that NIRS remains a very interesting and useful tool to study 
haemodynamics. However, it is very important to be aware of some practical and 
methodological issues when using this device. Subcutaneous ATT has a significant influence 
on all FD NIRS responses except totHb and FBF influences all FD NIRS responses. It appears 
that these influences are not different as described in other studies using CW spectroscopy. 
Moreover, based on these findings, caution could be advised to use NIRS values. To eliminate 
these influences, use of relative deoxy[Hb+Mb] could be strongly advised, especially in clinical 
settings and/or in people with a higher subcutaneous ATT layer. 
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ABSTRACT 
The aim was to study whether mitochondrial myopathy induces different oxygenation 
(deoxy[Hb+Mb] and oxy[Hb+Mb]) responses during and following arterial occlusion. In 10 
mitochondrial myopathy patients (MMpatients) (age: 29 ± 7 years; body mass: 59.9 ± 15.7 kg; 
heigth: 166.2 ± 11.4 cm) and age- and gender-matched healthy subjects (age: 28 ± 9 years; 
body mass: 72.7 ± 16.9 kg; height: 174.4 ± 8.7 cm) arterial occlusion was performed by inflating 
a cuff to 240mmHg. Deoxy[Hb+Mb] and oxy[Hb+Mb] were registered during (AOoxy and 
AOdeoxy) and following (POdeoxy and POoxy) arterial occlusion. Amplitude of AOdeoxy did 
not differ (p=0.47) between MMpatients (44.9±28.0µM) and healthy subjects (38.6±22.8µM), 
The time constant of the exponential model was greater in MMpatients (263.4±49.1s vs. 
200.3±73.7s, p=0.03). Following cuff release, in both populations a transient increase in 
total[Hb+Mb] was observed induced by different kinetics of POoxy and POdeoxy. The increase 
in POoxy (TD=6.6±2.2s and 11.9±3.5s; τ=3.8±1.4s and 6.4±2.9s for MMpatients and healthy 
subjects, respectively) was faster (p<0.001 for TD and τ) compared to the decrease in POdeoxy 
(TD=13.2±3.6s and 26.5±4.6s; τ=-6.2±2.2s and -9.6±2.4s for MMpatients and healthy subjects, 
respectively). POoxy and POdeoxy showed faster kinetics (p<0.001 and p<0.01 for TD and τ, 
respectively) in MMpatients compared to healthy subjects. MMpatients display altered 
oxygenation responses during and following arterial occlusion reflecting pathology related 
changes in the relationship between muscle blood flow and oxygen uptake.  
KEYWORDS: oxygenation, arterial occlusion, O2 supply, O2 extraction, mitochondrial 
myopathy 
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INTRODUCTION 
The relationship between muscle blood flow (Qm) and oxygen uptake (VO2m) is an important 
determinant of exercise tolerance in healthy and patient populations. A thorough 
understanding of this relationship provides insight into cardiovascular and muscular 
adjustments to changes in metabolic demand. In healthy subjects a tight coupling between O2 
supply and O2 demand has been observed, while in patient populations this relationship is 
often disturbed inherent to the pathologic condition either affecting the central (i.e., 
cardiovascular and pulmonary) and/or peripheral (i.e., muscle) response (Poole et al., 2011). 
In patients suffering from mitochondrial myopathy (MMpatients) one or more genetic defects 
impair the oxidative phosphorylation system (OXPHOS), resulting in a reduced capacity to 
increase muscle O2 extraction during exercise and in this way disturbing the functioning of the 
aerobic metabolism. Furthermore, a hyperdynamic cardiovascular response has been shown 
as a compensation for the limited O2 extraction exercise (Dandurand et al., 1995; Taivassalo 
et al., 2002).  
Evaluation of the capacity to increase muscle O2 extraction in patients suffering from MM can 
be performed directly by the invasive measurement of the arterio-venous O2 difference (C(a-
v)O2) across the exercising muscles (Linderholm et al., 1969; Taivassalo et al., 2002), or 
indirectly based on the Fick-principle with measurements of whole-body VO2 and blood flow 
(Q) (Taivassalo et al., 2003). Since the validity of the non-invasive determination of Q during 
maximal exercise has been questioned (Warburton et al., 1999) and considering practical 
issues when using invasive methods, the need has emerged to develop new techniques to 
estimate the functional capacity for muscle O2 extraction in MM patients. Near-infrared 
spectroscopy (NIRS) is a non-invasive technique that measures the concentration of 
oxygenated and deoxygenated haemoglobin and myoglobin (deoxy[Hb+Mb] and 
oxy[Hb+Mb]), thus providing information on the oxygenation at the muscle level. Especially 
deoxy[Hb+Mb] seems to be useful for functional evaluation in MMpatients since it has been 
shown that deoxy[Hb+Mb] can be considered as a reflection of microvascular O2 extraction 
(Delorey et al., 2003; Grassi et al., 2003; Ferreira et al., 2005). 
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The hyperemic response following brachial artery occlusion at rest is often used to evaluate 
the relative health of the vasculature (Rossi et al., 2008; Suzuki et al., 2008; Takase et al., 2008; 
Schechter et al., 2009). Bopp et al. (2011) suggested that using NIRS during and following 
brachial occlusion might have significant (clinical) implications. This non-invasive technique 
can provide insight into the dynamic relationship between convective delivery of O2 to the 
microvasculature and diffusion of O2 from capillary to myocyte (i.e., the relationship between 
Qm and VO2m). Previously, this relationship has proven insightful for understanding the 
determinants of exercise tolerance in both healthy and patient populations, such as 
MMpatients (Poole et al., 2011).  
Therefore, the purpose of the present study was to test if muscle oxygenation responses, 
measured with NIRS, during and following arterial occlusion at rest would differ between 
MMpatients and age- and gender-matched healthy subjects. We hypothesized that 1) 
MMpatients would display slower deoxygenation kinetics during arterial occlusion compared 
to healthy subject, reflecting an impaired aerobic capacity, and 2) the reoxygenation kinetics 
(oxy[Hb+Mb]) following arterial occlusion would be faster in Mmpatients, mimicking the 
hyperdynamic cardiovascular response to exercise seen in these patients (Dandurand et al., 
1995; Taivassalo et al., 2002).  
METHODS 
Subjects 
We studied two groups of subjects. The first group consisted of ten patients suffering from 
mitochondrial myopathy (MMpatients), based on biochemically findings. The second group 
consisted of ten age- and gender-matched untrained healthy subjects. The present study was 
approved by the ethics committee of the Ghent University Hospital. Prior to the start of the 
experiments, the subjects were fully informed of any risk associated with the experiments 
before giving their written consent for participation and all experiments were in accordance 
with the recommendations of the Helsinki Declaration. All patients were diagnosed as having 
MM based on the results of biochemical analysis in a skeletal muscle biopsy, using 
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spectrophotometrical assays (De Vriese et al., 2006), which remains the gold standard for 
diagnosis of mitochondrial diseases and by Blue Native Polyacrylamide Gel Electrophoresis 
(Van Coster et al., 2001).  
Experimental protocol 
On arrival at the laboratory the subjects had some time to adjust to the laboratory conditions. 
First the anthropometric characteristics (body weight and height) and the skinfold thickness 
at the location of the probe were registered. Afterwards the subjects were asked to lie down 
on a bed and they remained in supine position throughout the entire protocol. The NIRS-probe 
was positioned longitudinally on the M. flexor carpi and ulnaris and on the M. flexor digitorum 
superficialis of the right arm. Pen marks were made over the skin to detect movement of the 
probe during the experimental procedures. The NIRS-probe was secured with Velcro straps 
and a black blanket was placed over the probe to ensure that the ambient light could not 
penetrate the tissue and disturb the measurement. An inflatable cuff was placed on the upper 
right arm to induce the arterial occlusion. The subjects remained in this resting position for a 
few minutes until a stable baseline value at rest was obtained for the NIRS-parameters 
(deoxy[Hb+Mb] and oxy[Hb+Mb]). Then the cuff was quickly (within 3s) inflated to 240 mmHg 
in order to induce an arterial occlusion of the brachial artery obstructing the blood flow to the 
muscles of the lower arm (under the NIRS-probe). The arterial occlusion was maintained until 
deoxy[Hb+Mb] and oxy[Hb+Mb] reached a clear steady state without a specific pre-set time 
frame. The cuff was then released and deoxy[Hb+Mb] and oxy[Hb+Mb] was recorded for three 
minutes to follow the reoxygenation kinetics. All subjects were tested in an air-conditioned 
laboratory at 21° C.  
Measurements 
Throughout the arterial occlusion, muscle tissue oxygenation was measured with a near 
infrared spectroscopy (NIRS) system (Oxiplex TS, ISS, Champaign, USA). This system is based 
on an infrared light absorption method, where infrared light is emitted at different 
wavelengths. The NIRS-probe consisted of eight light-emitting diodes operating at 
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wavelengths 750 and 830 nm and one detector fibre bundle (source-detector distance = 2.0-
3.5 cm). The deoxy[Hb+Mb] was stored at a frequency of 25 Hz and afterwards digitally 
averaged into 1s-values. 
Data analysis 
The 1 s-values of deoxy[Hb+Mb] and oxy[Hb+Mb] were plotted as a function of time. An 
exponential model (1) was fit to the deoxy[Hb+Mb] and oxy[Hb+Mb] response to the arterial 
occlusion (AOdeoxy and AOoxy). 
Y(t) = Y0 + A (1-e-(t-TD)/τ) 
in which Y0 is the baseline value (i.e., prior to the start of the arterial occlusion), A is the 
amplitude of the deoxy[Hb+Mb] and oxy[Hb+Mb] response, TD is the time delay and τ is the 
time constant.  
Since Bopp et al. (2011) showed that the deoxy[Hb+Mb] and oxy[Hb+Mb] response 
immediately following arterial occlusion follow a sigmoid pattern, these response were also 
fit by means of a Gompertz sigmoid function. 
Y(t) = Y0 + Ae-e
-(t-TD)/τ 
in which Y0 represents the baseline value (i.e., the steady state level of deoxy[Hb+Mb] and 
oxy[Hb+Mb] to the arterial occlusion), A is the amplitude of the response, TD is the time delay 
and τ represents a time constant. Curve fitting was performed in Sigmaplot 10 with SigmaStat 
3.5 software (Systat Software Inc., San José, USA). Additionally, the parameter estimates were 
plotted against the thickness of the skinfold at the location of the NIRS-probe and Pearson 
product correlation was performed. If this correlation was significant, the slope of the 
correlation line was used to correct the parameters affected by skinfold thickness (i.e., Y0 and 
A)(Koga et al., 2011). 
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Statistical analysis 
Descriptive statistics were calculated (mean ± SD) for Y0, A, TD and τ of the exponential (AOoxy 
and AOdeoxy) and Gompertz (POoxy and POdeoxy) models. The parameter estimates for 
AOoxy, AOdeoxy, POoxy and POdeoxy were compared between the two groups and two NIRS-
signals (oxy[Hb+Mb] vs. deoxy[Hb+Mb]) by means of Repeated Measures ANOVA (2x2) in SPSS 
14.0. Post hoc analysis was performed by means of Tukey tests. Statistical significance was set 
at P<0.05. 
RESULTS 
The patients’ (3 women, 7 men) age, height and body weight were respectively 29 ± 7 years, 
166.2 ± 11.4 cm and 59.9 ± 15.7 kg. The healthy subjects’ age, height and body weight were 
respectively 28 ± 9 years, 174.4 ± 8.7 cm and 72.7 ± 16.9 kg. Dominant forearm skinfold 
thickness under the NIRS probe was respectively 8.2 ± 4 mm and 12.3 ± 8.5 mm for 
MMpatients and healthy subjects.  
1. Arterial occlusion 
The arterial occlusion lasted on average 504 ± 129s in the MM patients and 476 ± 102s in 
the healthy subjects (P=0.42). In Figure 1 the deoxy[Hb+Mb] response of a representative 
patient and healthy subjects is displayed. The exponential model provided a good fit to 
both AOoxy and AOdeoxy (R²=0.98 ± 0.01 and 0.99 ± 0.01 in MMpatients and healthy 
subjects, respectively). The amplitude (A) and baseline (Y0), but not the kinetic 
parameters (TD and τ) of both AOoxy (R=-0.47, P=0.034 and R=-0.55, P=0.040 for Y0 and 
A, respectively) and AOdeoxy (R=-0.45, P=0.043 and R=-0.56, P=0.029 for Y0 and A, 
respectively) were significantly correlated with the skinfold thickness at the location of 
the probe. Table 1 gives the mean parameter estimates, where necessary corrected for 
skinfold thickness, for the exponential model for the MMpatients and healthy subjects.  
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The baseline Y0 and amplitude A of AOoxy and AOdeoxy did not differ significantly 
between Mmpatients and healthy subjects (P=0.64 and P=0.71, respectively). For TD 
there was no significant difference between the groups (P=0.41), nor the signals 
(oxy[Hb+Mb] vs. deoxy[Hb+Mb] (P=0.72). However, for τ there was a significant main 
effect of group (P=0.03), indicating that τ was significantly longer in patients compared to 
healthy subjects. 
Fig. 1: The pattern of deoxy[Hb+Mb] during arterial occlusion in a representative patient (grey dots) 
and healthy subject (black dots). The cuff was inflated to 240mmHg at time 0s. 
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Table 1 (Exponential parameters to AOoxy and AOdeoxy): Mean parameter estimates for the 
exponential model fitted to AOoxy and AOdeoxy in patients and controls. * indicate significantly 
different from the healthy subjects (P<0.05). Y0’ and a’ represent Y0 and a corrected for skinfold 
thickness. 
 AOoxy AOdeoxy 
 
Patients Healthy 
subjects 
Patients 
Healthy 
subjects 
Y0 (µM) 82.4 ± 15.2 81.4 ± 13.7 26.8 ± 14.8 23.7 ± 11.8 
Y0’ (µM) 93.4 ± 13.8 89.5 ± 12.4 33.9 ± 12.1 27.8 ± 10.0 
a (µM) 43.7 ± 29.7 37.9 ± 21.4 44.9 ± 28.0 38.6 ± 22.8 
a’ (µM) 52.9 ± 22.4 49.4 ± 19.1 53.1 ± 20.4 49.9 ± 19.3 
 TD (s) 6.2 ± 2.3 4.7 ± 1.7 5.5 ± 1.7 3.8 ± 1.0 
 τ (s)  258.4 ± 52.3 * 199.7 ± 69.8 263.4 ± 49.1 * 200.3 ± 73.7 
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2.  Post-occlusion 
The responses of oxy[Hb+Mb] (POoxy), deoxy[Hb+Mb] (POdeoxy) and total[Hb+Mb] 
(tot[Hb+Mb]) for a representative healthy subject and a patient are shown in Figure 2. 
Because tot[Hb+Mb] for both healthy subjects and patients was not constant through the 
early post-occlusion response, this implied that the amplitude and/or kinetics of the 
responses of POoxy and POdeoxy differed (Bopp et al., 2011).  
Fig. 2 (POoxy and POdeoxy): The pattern of deoxy[Hb+Mb], oxy[Hb+Mb] and tot[Hb+Mb] immediately 
following arterial occlusion (time 0 represents the release of the cuff) for patient and healthy subject 
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The Gompertz function provided a good fit to both POoxy and POdeoxy (R²=0.95 ± 0.02 
and 0.98 ± 0.02, respectively). The amplitude (A) for POoxy (R=-0.56, P=0.024) and 
baseline (Y0) and A for POdeoxy (R=-0.35, P=0.041 and R=-0.48, P=0.029, respectively) 
were significantly correlated with skinfold thickness at the location of the probe.  
For both POoxy and POdeoxy response (Table 2), Y0 (and Y0’) did not differ between the 
two test groups (P=0.81) but Y0 was higher in POoxy compared to POdeoxy (P<0.01). For 
the amplitude of the response (A [and A’]) there was no significant main effect of signal 
(P=0.44) nor of group (P=0.65), pointing out that the amplitude of POoxy did not differ 
from POdeoxy and that there was no difference between MMpatients and the healthy 
subjects. However, the kinetic parameters differed between signals (POoxy vs. POdeoxy) 
and groups (patients vs. healthy subjects). For TD, there was a main effect of both signal 
(P<0.001) and group (P<0.001). Post hoc analysis showed that TD was significantly higher 
in POdeoxy compared to POoxy and that TD was significantly higher in the healthy 
subjects compared to the patients. Similar results were obtained for the time constant 
(τ), i.e., there was a significant main effect of signal (P<0.001) and of group (P<0.01). The 
post hoc analysis revealed that b τ was higher (i.e ., slower response) in POdeoxy 
compared to POoxy and that b τ was higher (i.e., slower) in the healthy subjects compared 
to MMpatients. 
  
OXYGENATION DURING AND AFTER OCCLUSION 
 
95 
Table 2 (Gompertz parameters to POoxy and POdeoxy) 
 
 POoxy POdeoxy 
 Patients 
Healthy 
subjects 
Patients 
Healthy 
subjects 
Y0 39.5 ± 20.7 # 45.8 ± 18.9 # 25.8 ± 10.6 22.5 ± 6.5 
Y0’   25.3 ± 9.4 29.6 ± 6.5 
a 38.9 ± 17.1 34.1 ± 17.4 40.4 ± 22.8 37.7 ± 20.8 
a’ 43.2 ± 11.1 51.3 ± 16.0 47.4 ± 16.0 53.5 ± 21.3 
 TD (s) 6.6 ± 2.2 *,# 11.9 ± 3.5 # 13.2 ± 3.6 * 26.5 ± 4.6 
 τ (s) 3.8 ± 1.4 *,# 6.4 ± 2.9 # -6.2 ± 2.2 * -9.6 ± 2.4 
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Mean parameter estimates for the Gompertz model fitted to the oxy[Hb+Mb] (POoxy) and 
deoxy[Hb+Mb] response (POdeoxy) following the arterial occlusion in patients and healthy controls. 
The Y0’ and a’ represent the Y0 and a corrected for skinfold thickness. * indicates significantly different 
from the healthy subjects; # indicates significantly different from POdeoxy (P<0.05). 
Even though the kinetic parameters (TD and τ) were significantly different  between POoxy 
and POdeoxy (resulting in the non-constant tot[Hb+Mb]), they were significantly 
correlated when the entire study population (both patients and healthy subjects) was 
considered (Figure 3), Thus, subjects who had faster responses in one variable tended to 
have faster responses in the other as well. 
Fig. 3 (Correlations of kinetic parameter of POoxy and POdeoxy): Correlations between the kinetic 
parameters (b and X0) from the Gompertz model fit to the oxy[Hb+Mb] and deoxy[Hb+Mb] response 
immediately following arterial occlusion in the entire study population. * indicates significant 
correlations (P<0.05)  
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DISCUSSION 
The aim of the present study was to test if the relationship between O2 supply and O2 demand 
during and following brachial artery occlusion differed between healthy controls and patients 
suffering from mitochondrial myopathies, using NIRS. This technique has been used to 
describe the relationship between convective and diffusive O2 flux and the oxygenation within 
skeletal muscle non-invasively during exercise and thus might provide important clinical 
information. In the present study the kinetics of deoxy[Hb+Mb] and oxy[Hb+Mb] during and 
post arterial occlusion were described in a patient group suffering from mitochondrial 
myopathy (MM) and in healthy sedentary individuals. It was observed that, although the 
amplitude of the deoxy[Hb+Mb] response during arterial occlusion (AOdeoxy) was unaffected, 
MM patients had a slower increase in deoxy[Hb+Mb] following the onset of the occlusion, 
consistent with our first hypothesis. Post-occlusion, in the entire study population the kinetics 
of oxy[Hb+Mb] (POoxy) were faster compared to those of deoxy[Hb+Mb] (POdeoxy), 
reflecting a transient increase in tot[Hb+Mb] response, suggestive of a hyperemic response in 
the microvasculature. Furthermore, the kinetics of both POoxy and POdeoxy were faster in 
MMpatients compared to healthy subjects, consistent with hypothesis 2. 
Arterial occlusion 
Arterial occlusion has been used to obtain the maximal deoxygenation (i.e., highest 
deoxy[Hb+Mb]) of skeletal muscle (Grassi et al., 2007; Celie et al., 2011). Since deoxy[Hb+Mb] 
can be considered as an expression of microvascular oxygen extraction (Delorey et al., 2003; 
Grassi et al., 2003; Ferreira et al., 2005), this technique has also been used to obtain 
representative values of maximal capacity for O2 extraction, so that deoxy[Hb+Mb] values 
during exercise can be referenced to these maximal values (Grassi et al., 2007; Celie et al., 
2011). In this way, near-infrared spectroscopy can provide insight into the capillary-to-
myocyte O2 exchange and on the relationship between convective and diffusive capacity at 
the level of the myocyte (Poole et al., 2011). In the present study it was observed that 
deoxy[Hb+Mb] during arterial occlusion at rest follows an exponential increase to a steady 
state level which required on average 6-8 minutes. It should be noted that this caused some 
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discomfort in some subjects but they were all able to maintain the occlusion until there was a 
clear leveling off in deoxy[Hb+Mb]. The present study showed non-invasively slower 
deoxy[Hb+Mb] kinetics in MMpatients compared to healthy controls. Given that there is no 
blood flow in this condition (i.e., Qm is zero), and that the amount of O2 in the tissues was 
similar between groups (as reflected by a similar tot[Hb+Mb] Y0 and A values), these slower 
deoxygenation kinetics can be related to genetic defects impairing the mitochondrial 
subcomplexes and/or enzymes (i.e., the oxidative phosphorylation system (OXPHOS)), 
resulting in a slower VO2m and thus a reduced rate of O2 extraction. Surprisingly the amplitude 
of deoxygenation response did not differ between MMpatients and healthy subjects. 
However, due to the heteroplasmic nature of this mitochondrial disorder there is a mixture of 
wild type and mutant mtDNA in the muscle tissue of these patients which means that not all 
mitochondria at the muscle level are defective (Taivassalo et al., 2003; Durham et al., 2007; 
DiMauro, 2010). Some wild type mitochondria are able to take up and consume oxygen. Our 
hypothesis is that in these circumstances some of the patients’ mitochondria are able to utilize 
oxygen, but since the density of functioning mitochondria is lower in the patient population, 
the rate of oxygen utilization (indicating resting metabolic rate) will be slower compared to 
healthy subjects. Interestingly, the final amplitude of change in deoxy[Hb+Mb] in the two 
groups was the same, suggesting that the total content of Hb and Mb in the tissue during the 
occlusion was similar in both groups. 
Post-occlusion 
In line with the studies of Bopp et al. (2011) and Kragelj et al. (2001) a transient increase in 
tot[Hb+Mb] was observed in body study populations, reflecting an increase in microvascular 
[Hb] and hematocrit, since presumably muscle [Mb] remained constant throughout the 
protocol (Davis and Barstow, 2013). The increase in hematocrit (as tot[Hb+Mb]) is likely 
associated with the transient increase in blood flow (Klitzman and Duling, 1979) although the 
precise temporal relationship may be variable (Kindig et al., 2002; Ferreira et al., 2006). 
Further, we observed a delay in rise in tot[Hb+Mb] during reactive hyperemia following cuff 
release in the present study. This delay is similar to that reported by Kindig et al. (2003) who 
showed a delayed increase in capillary hematocrit of 10-15 s following the onset of muscle 
OXYGENATION DURING AND AFTER OCCLUSION 
 
99 
contractions. This delay reflected a faster rise in the velocity of red blood cells in the capillaries 
compared to the slower rise in red blood cell flux following the onset of contractions. For both 
groups in the present study, the deoxy[Hb+Mb] response was slower relative to that of 
oxy[Hb+Mb] following cuff release, similar to that reported by Bopp et al. (2011). The transient 
increase in tot[Hb+Mb] (and the different recovery kinetics of oxy[Hb+Mb] and 
deoxy[Hb+Mb]) upon cuff release are likely related to convective and diffusive characteristics 
at the level of the myocyte (Poole et al., 2011). Upon cuff release, blood flow into the forearm 
muscle increases rapidly (Burton and Johnson, 1972) due to the increased conductance 
occurring during the arterial occlusion from the release of vasodilators (Engelke et al., 1996; 
Gonzalez-Alonso, 2012), resulting in a fast recovery of microvascular O2 pressure and increase 
in oxy[Hb+Mb], assuming a constant VO2m. In contrast, the more sluggish decrease in 
deoxy[Hb+Mb] compared to that of oxy[Hb+Mb] in all subjects likely reflects a sustained O2 
extraction in this early transient phase.  
On average, the patients’ POoxy and POdeoxy responses, and thus also tot[Hb+Mb], were 
faster than those of the healthy controls. This would suggest that the initial rise in blood flow 
and oxygen delivery following cuff release was faster than the rate of utilization of oxygen by 
the tissue (higher Qm/VO2m in the transition) (Delorey et al., 2003; Grassi et al., 2003; Boone 
et al., 2009). This faster rate of change in oxy[Hb+Mb], deoxy[Hb+Mb] and tot[Hb+Mb] in 
MMpatients compared to healthy controls likely reflects a hyperdynamic cardiovascular 
response that has been observed during exercise in patients with mtDNA mutations (Jeppesen 
et al., 2012). In contrast to chronic heart failure patients (Copp et al., 2010), in which O2 
delivery is impaired relative to VO2m, resulting in impaired recovery of microvascular PO2 
following exercise, this hyperemic response in Mmpatients results in the opposite effect, i.e., 
a higher velocity of blood flow and faster recovery of microvascular O2 pressure compared to 
healthy subjects. In addition, the higher blood flow, in concert with the impaired VO2m in 
Mmpatients, results in faster deoxy[Hb+Mb] kinetics following the ischemic challenge. The 
slower rate of reoxygenation in the healthy controls (as expressed by a slower decrease in 
deoxy[Hb+Mb]) is consistent with the observation of Kime et al. (2003), who found that 
muscles with a higher oxidative capacity displayed a slower reoxygenation following 10s of 
maximal isometric contraction. Thus, the slower decrease in deoxy[Hb+Mb]  post-occlusion in 
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the healthy subjects reflects a healthier muscle recovery. This is however, in contrast to the 
study of Bravo et al. (2012), in which slower deoxy[Hb+Mb] kinetics were observed in 
MMpatients compared to healthy subjects following high-intensity exercise. It should be 
noted however, that the test methodology is difficult to compare to our study, since it 
consisted of cycle exercise at 70% of the peak power (i.e., large muscle mass and 
cardiopulmonary effort). 
It should be noted that the deoxy[Hb+Mb] responses measured with NIRS provide insight into 
the relative relationship between Qm and VO2m without being able to address either the 
convective or diffusive capacity separately. This implies that changes in the NIRS signals in 
response to challenges such as ischemia or exercise can either reflect changes in muscle blood 
flow and/or microvascular O2 extraction. Thus, the ability of the NIRS technique, by itself, to 
identify the mechanisms which underlie the responses of these challenges is limited. It is 
recommended to combine NIRS with other measurements, such as the non-invasive 
measurement of Qm with Doppler Ultrasound, to gain greater quantitative insight.  
The results of the present study might have important clinical implications. First, it is shown 
that NIRS can potentially be used for non-invasive screening and functional evaluation of 
Mmpatients, in place of traditionally more invasive techniques. Second, this study furthers the 
understanding of the relationship of Qm to VO2m in healthy subjects and Mmpatients. This 
relationship has been considered as an important determinant of exercise tolerance since it 
provides information on the capacity of the cardiovascular and muscle systems to adjust to 
changes in metabolic demand. While we did not measure exercise responses or tolerance in 
the current study, the insights gained regarding the balance of Qm to VO2m following an 
ischemic challenge at rest may provide insight into the relative impairment of this relationship 
during exercise in patient populations such as Mmpatients. Testing of this hypothesis must 
await further experimentation. 
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Conclusion 
In the present study it was found that the kinetic responses of muscle oxygenation 
(deoxy[Hb+Mb], oxy[Hb+Mb] and tot[Hb+Mb]) differs between patients suffering from 
mitochondrial myopathy and healthy subjects. MMpatients showed a more rapid and 
pronounced increase in O2 supply upon cuff-release, in combination with impaired VO2m, 
compared to healthy controls. These different kinetics of oxy[Hb+Mb] and deoxy[Hb+Mb] 
reflect the pathology (impaired VO2m) and adaptation (enhanced Qm). These results indicate 
that NIRS can provide important insight into muscle oxygenation and the relationship between 
Qm and VO2m in response to brachial artery occlusion in healthy and disease. 
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ABSTRACT 
Objectives: The purpose of the present study was to test whether peripheral oxygenation 
responses measured with near infrared spectroscopy (NIRS) would differ between patients 
suffering from mitochondrial myopathy (MM) and healthy controls during an incremental 
handgrip exercise test.  
Methodology: Two groups of subjects were studied: 11 patients with MM and 11 age- and 
gender-matched untrained healthy controls. A handgrip exercise protocol until exhaustion 
was used consisting of 2-min periods of work (½ Hz) at different intensities, separated by a 60-
s rest period. The changes in deoxy[Hb+Mb] during each work step were expressed in percent 
to the maximum deoxy[Hb+Mb]-value measured during arterial occlusion in forearm muscles. 
A Repeated Measures ANOVA was used to compare the increase in deoxy[Hb+Mb] between 
MM patients and controls with increasing intensity.  
Results: Statistical analysis revealed a significant difference between both populations 
(p<0.001) indicating that the increase in deoxy[Hb+Mb] showed a significantly different 
pattern in the two populations. In the post hoc analysis significant lower deoxy[Hb+Mb] -
values were found for MM patients at every intensity. 
 Conclusion: The results of the present study showed significant different skeletal muscle 
oxygenation responses, measured with an optical method as NIRS, between MM patients and 
age- and gender-matched healthy subjects at submaximal and maximal level during an 
incremental handgrip exercise. This optical method is thus a valuable tool to assess differences 
in peripheral oxygenation. Moreover, this method could be used as an evaluation tool for 
follow up in interventional pharmacological studies and/or rehabilitation programs.  
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INTRODUCTION 
The relationship between skeletal muscle blood flow (Qm) and oxygen uptake (VO2m) is an 
important determinant of exercise tolerance in healthy and patient populations. A thorough 
understanding of this relationship provides insight into cardiovascular and muscular 
adjustments to changes in metabolic demand. In healthy subjects a tight coupling between O2 
supply and O2 demand has been observed, while this relationship is often disturbed in patient 
populations inherent to the pathologic condition either affecting the central (i.e., 
cardiovascular and pulmonary) and/or peripheral (i.e., skeletal muscle) response (Poole et al., 
2011). Since the validity of non-invasive determination of blood flow (Qm) and arterio-venous 
O2 difference (C(a-v)O2) during exercise has been questioned (Warburton et al., 1999) and 
because of practical issues when using invasive methods, near infrared spectroscopy (NIRS) 
might be a useful and non-invasive optical technique. More specific to provide more 
information on the oxygenation at muscle level and to gain more insight into the capillary-to-
myocyte O2 exchange and the relationship between convective and diffusive capacity at the 
level of the myocyte (Poole et al., 2011). The reliability and validity of NIRS as an appropriate 
technique to measure non-invasively peripheral tissue oxygenation has been established in 
erector spinae (Kell et al., 2004) and limb skeletal muscles (Mancini et al., 1994) as well as in 
brain tissue (Mehangoul-Schipper et al., 2002) at rest and during cycle ergometric exercise 
(Pereira et al., 2007). Also, the reliability has been established in forearm skeletal muscles 
using an incremental handgrip protocol (Celie et al., 2012). NIRS evaluates the concentration 
of deoxy[Hb+Mb] and oxy[Hb+Mb] at the level of the microcirculation in exercising skeletal 
muscle and could be used as an expression of microvascular O2 extraction (Abe et al., 1997; 
Chance and Banks, 1995). 
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Mitochondrial myopathies (MM) are multisystem disorders, clinically characterized by a large 
variety of signs and symptoms predominantly affecting skeletal muscle tissue (Di Mauro, 
2011). These MM patients present one or more genetic defects responsible for an impaired 
oxidative capacity of the skeletal muscle tissue resulting in a reduced capacity to increase 
skeletal muscle O2 extraction. Differences in VO2 (Dandurand et al., 1995; Dysgaard Jeppesen 
et al., 2003; Grassi et al., 2009; Siciliano et al., 1999) and VO2-kinetics (Taivassalo et al., 2003) 
and blood flow have already been found in MM patients during cycle ergometry protocols in 
different studies. Also, lower deoxy[Hb+Mb]-values as a marker for reduced O2 extraction 
have been reported in MM patients during a cycle ergometer protocol (Grassi et al., 2007). 
However for some patients cycle ergometric testing is potentially life-threatening as these 
patients can suffer from cardiomyopathy and might be at risk for arrhythmia during the test. 
Therefore, handgrip exercise protocols were introduced for measuring O2 desaturation using 
venous blood samples. These O2 desaturation values were significantly lower in MM patients 
during exercise, presuming a reduced O2 extraction due to a decreased oxidative capacity in 
skeletal muscle (Hanisch et al., 2006; Jensen et al., 2002; Taivassalo et al., 2002). To our 
knowledge there was only one study (Van Beekvelt et al., 2001) that combined optical non-
invasive NIRS measurements with a non exhaustive handgrip protocol. These authors found 
significant lower muscular VO2 values in MM patients during handgrip exercise measured with 
NIRS. However some concerns can be raised with the interpretation of the absolute 
deoxy[Hb+Mb] values and the influence of subcutaneous adipose tissue in this study (Van 
Beekvelt et al., 2001). 
The purpose of the present study was to test whether skeletal muscle oxygenation responses, 
measured with an optical method as NIRS, would differ between MM patients and age- and 
gender-matched healthy subjects at submaximal and maximal level during an incremental 
handgrip exercise. The reliability of the handgrip exercise protocol using this technique was 
established in a previous study (Celie et al., 2012). It was hypothesized that the increase in 
deoxy[Hb+Mb] in response to exercise would be lower in MM patients as compared to healthy 
controls, as a reflection of a limited capacity to increase microvascular O2 extraction and thus 
an altered Qm/VO2m-relationship. 
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METHODS 
Subjects 
We studied two groups of subjects. A first group consisted of 11 patients suffering from a 
mitochondrial myopathy (MM). The second group consisted of 11 age- and gender-matched 
untrained healthy controls. It was not possible to find matched control subjects for body 
weight or height as weight loss is a predominant symptom for MM patients. Moreover, short 
stature is one of the prevalent symptoms in the MELAS genotype (MM) (De Vriese et al., 2006). 
The patients were recruited from the Neuromuscular Reference Center at the Ghent 
University Hospital, Belgium. The subjects were fully informed of any risk associated with the 
experiments before giving their written consent for participation. The study was approved by 
the ethics committee at the Ghent University Hospital. Procedures were in accordance with 
the recommendations of the Helsinki Declaration. The patients’ (4 women, 7 men) age, height 
and body weight were respectively 29 ± 12 years, 166.5 ± 11.7 cm and 60.7 ± 16 kg (mean 
values ± SD). Control subjects’ age, height and body weight were respectively 29 ± 12 years, 
177.4 ± 10 cm and 77.2 ± 16.8 kg (mean values ± SD). All patients were diagnosed as having 
MM based on clinical presentation and on the results of the biochemical analysis in a skeletal 
muscle biopsy, which remains the gold standard for diagnosis of mitochondrial diseases. This 
was done by evaluation of OXPHOS function in skeletal muscle from selected patients by 
spectrophotometry using standard enzyme assays (Van Coster et al., 2001) and by Blue Native 
Polyacrylamide Gel Electrophoresis (BN-PAGE) (Smet et al., 2009). The z score was calculated 
as the activity ratio for the patient sample minus the mean activity ratio for the control 
samples divided by the SD for the control samples. When the z-score was lower than -1.96 or 
higher than +1.96, the result for the patient sample was considered as significantly different 
(p< 0.05) from the result in the control samples (Van Coster et al., 2001). Results with z scores 
of less than -1.96, indicative of significantly decreased OXPHOS activity in the patient tissue 
sample, are presented in bold. All diagnostic information of the MM patients is presented in 
table 1. Patients presenting complex V subcomplexes at BN-PAGE analysis are known to 
present intramitochondrial translation defects in the analysed tissue (Van Biervliet et al., 
2009).  
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Table 1: Diagnostic data of all Mitochondrial Myopathy (MM) patients 
Gender 
(M/F) 
Age 
(years) 
Clinical description 
OXPHOS analyses 
Tissue 
Spectrophotometric 
investigations (z scores*) 
Blue Native PAGE 
+ activity staining 
I II II+III III IV 
F/17 
Exercise intolerance, 
fatigability 
-3.25 0.69 0.08 2.08 1.54 Normal 
Skeletal 
muscle 
M/1326 
Mitochondrial 
encephalomyopathy 
lactic acidosis and 
stroke-like episodes 
(MELAS)  
-10.86 1.18 1.38 1.73 -0.98 
 Complex I   
 Complex IV  
 Complex V 
subcomplexes25  
Skeletal 
muscle 
M/45 
Visual failure, ptosis, 
external 
ophthalmoplegia, 
neurosensorial 
hearing loss, exercise 
intolerance, muscle 
weakness, ataxia  
-3.95 -1.08 -1.02 ND -0.42 
Complex I  
 Complex IV   
Complex V 
subcomplexes25 
Skeletal 
muscle 
F/5427 
Maternally inherited 
diabetes and deafness 
(MIDD) -0.56 -0.23 0.61 -0.12 0.21 
Normal, except for 
Complex V 
subcomplexes25 
Skeletal 
muscle  
M/28 Exercise intolerance  -8.25 0.84 2.78 1.32 0.21 Complex I  
Skeletal 
muscle 
F/25 Exercise intolerance  -10.17 ND 0.41 0.01 0.26 ND 
Skeletal 
muscle 
M/19 
 Mental retardation, 
dystonia, pyramidal 
signs in lower limbs  
(Leigh syndrome) 
-5.23 -1.82 -0.94 ND -0.91 ND 
Skeletal 
muscle 
F/21 
Exercise intolerance, 
hypertrophic 
cardiomyopathy, mild 
mental retardation 
-7.59 0.32 0.15 ND -0.33 Complex I  
Skeletal 
muscle 
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Measurements 
During the incremental exercise test, skeletal muscle tissue oxygenation was measured with 
a near infrared spectroscopy (NIRS) system (Oxiplex TS, ISS, Champaign, Illinois, USA). This 
system is based on an infrared light absorption method, where the infrared light is emitted at 
different wavelengths. The NIRS-probe consisted of eight light-emitting diodes operating at 
wavelengths 750 and 830nm and one detector fibre bundle (source-detector distance = 2.0-
3.5cm). The deoxy[Hb+Mb] data were stored at a frequency of 25Hz and afterwards digitally 
averaged into 1s-values. The probe was positioned longitudinally on the M. flexor carpi ulnaris 
and M. flexor digitorum superficialis and secured with Velcro straps around the dominant 
upper arm. Pen marks were made on the skin to detect probe displacement during the 
exercise. 
M/24 
Exercise intolerance, 
hypertrophic 
cardiomyopathy 
-8.26 0.99 0.54 ND -0.33 Complex I  
Skeletal 
muscle 
M/36 Exercise intolerance -7.29 -0.77 0.16 ND -1.15 Complex I   
Skeletal 
muscle 
M/32 Exercise intolerance -3.31 -1.18 -0.44 ND -1.38 Complex I   
Skeletal 
muscle 
M: Male; F: Female 
: moderately reduced, : severely reduced 
* z score: To control for mitochondrial mass, the ratio of the logarithm of each OXPHOS complex to the 
logarithm of the citrate synthase activity is calculated. Subtracting the mean activity ratio for the control 
samples from the activity ratio of the patient samples, divided by the SD for the control samples gives the z 
score. When the z score was lower than -1.96 or higher than +1.96, the result for the patient sample was 
considered as significantly different (p< 0.05) from the result in the control samples22. Results with z scores 
of less than -1.96, indicative of significantly decreased OXPHOS activity in the patient tissue sample, are 
presented in bold.  
26 Published in Acta Gastroenterol Belg. 2009 Jul-Sep;72(3):365-8, Van Biervliet et al. 
27 Published in Ophthalmic Genet. 2010 Dec;31(4):240-3, Robberecht et al. 
25 Published in Electrophoresis. 2009 Oct;30(20):3565-72, Smet et al. 
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Study design and protocol 
Preceding the test, the maximal voluntary contraction (MVC) (expressed in Newton (N)) force 
was determined in the dominant arm using a hydraulic handgrip dynamometer (Saehan 
corporation, Masan, South-Korea) for all subjects (best of three attempts). Between every 
attempt, a 5 minute resting period was included. After the placement of the NIRS probe on 
muscles, a pneumatic cuff was placed around the ipsilateral upper arm . The subjects 
performed the complete exercise protocol in supine position. The protocol started with a 
forearm arterial occlusion by inflating the cuff at 260mmHg. In the protocol, the duration of 
the occlusion was not specified as it was executed until a steady state in deoxy[Hb+Mb] was 
reached. After the occlusion, there was a minimum 5 minute rest period before baseline 
conditions were reached again and then the incremental cyclic contraction protocol (ICCP) 
started. The time interval between the end of the arterial occlusion and the beginning of the 
exercise task, before baseline values were reached, varied among all subjects. This task 
consisted of 2 minute periods during which incremental cyclic contractions were performed 
at ½Hz (1 second contraction, 1 second relaxation), at different intensities of maximal 
voluntary contraction (% MVC). The contraction periods were separated by a 60-s rest period. 
The work intensity started at 20% MVC and increased by 10% MVC at each step. This protocol 
was executed until exhaustion was reached and the subjects were no longer able to produce 
the required force. The duration of this test procedure was about 1h. The reliability of this 
protocol has been established in a previous study (Celie et al., 2012) 
Data analysis 
To determine the mean values within this protocol, a smoothing procedure was performed in 
which the 10-s mean values were determined by means of a moving average (Boone et al., 
2010). When skeletal muscle tissue is exposed to an arterial occlusion, acute local hypoxia is 
induced. The amplitude of the deoxy[Hb+Mb] response during arterial occlusion (i.e. the 
difference between the highest 30-s average of deoxy[Hb+Mb] during occlusion and the 30-s 
average of deoxy[Hb+Mb] preceding the occlusion) was used as index for maximal O2 
extraction and was set at 100%. The changes in deoxy[Hb+Mb] during each work step (i.e. the 
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mean of the highest 10-s value) were expressed relative to this amplitude (Celie et al., 2012) . 
These calculations were made to reduce possible influence of forearm adipose tissue 
thickness as values are relatively presented towards their individual maximum value. 
Statistical analysis 
Statistical analysis for MVC and amplitude of the occlusion steady state was performed using 
an independent samples t-test. A Repeated Measures ANOVA was used to compare the 
increase in deoxy[Hb+Mb] (in %) during ICCP between the MM population and the controls. 
When a significant main effect was found, post-hoc analysis was performed by means of an 
independent samples t-test. The level of significance was set at p<0.05. Statistical 
computations were performed using SPSS® software (version 18; SPSS Lead Technologies Inc., 
Chicago, IL, USA). All data are presented as mean ± standard deviation (SD). 
RESULTS 
MM patients had a significantly lower MVC (p<0.001) as compared to control subjects 
(x=255.1 ± 127.5N vs. x=529.7 ± 137.3N). Typical deoxy[Hb+Mb] outputs measured during 
arterial occlusion and the ICCP in one healthy and one diseased subject are shown in Figure 1 
(a+b). No significant difference was found (p= 0.899) between both populations for the arterial 
occlusion deoxy[Hb+Mb] amplitude. All patients tolerated the test well as no pain was 
perceived after the test protocol. 
Mean submaximal and maximal deoxy[Hb+Mb] values (expressed as a percentage) during 
ICCP for MM patients and controls are presented in Figure 2. Statistical analysis revealed that 
there was a significant main effect for groups with an F=36,263 (p<0.001) indicating that the 
increase in deoxy[Hb+Mb] showed a significantly different pattern in the two populations. 
Although deoxy[Hb+Mb] increased significantly during the ICCP in both populations, the 
increase in deoxy[Hb+Mb] was significantly higher in healthy controls. Post hoc analysis 
revealed significant percentual deoxy[Hb+Mb] differences between MM patients and healthy 
controls at all intensities (% MVC). All p- and t-values are included in Figure 2. 
DEOXY[HB+MB] DURING ICCP IN MM PATIENTS 
 
115 
Fig. 1a-b.: Typical deoxy[Hb+Mb] outputs as a response to the arterial occlusion and the ICCP in one 
healthy subject (a) and one diseased(MM) subject (b). (BL 1= Baseline 1; BL 2= Baseline 2; AO max= 
Arterial Occlusion deoxy[Hb+Mb] maximum value). 
Fig. 2. Mean submaximal and maximal deoxy[Hb+Mb]-values (expressed as a percentage) during ICCP 
for patients and controls. 
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DISCUSSION 
In the present study the peripheral oxygenation during an incremental dynamic handgrip 
exercise was studied in patients suffering from mitochondrial myopathy and in healthy 
subjects. The MM patients showed significantly altered deoxy[Hb+Mb] responses in 
comparison to matched controls. Whereas in healthy controls the NIRS-derived O2 extraction 
gradually increased with incremental intensity, only a small increase was observed in MM 
patients. The results of the present study are in line with earlier studies using more invasive 
techniques during handgrip exercise (Hanisch et al., 2006; Jensen et al., 2002; Taivassalo et 
al., 2002) and/or cycle ergometry tests(Dandurand et al., 1995; Dysgaard Jeppesen et al., 
2003; Grassi et al., 2009; Siciliano et al., 1999; Taivassalo et al., 2003). At every intensity during 
ICCP, patients showed a significantly lower rate of microvascular O2 extraction in comparison 
to the healthy matched controls. Deoxy[Hb+Mb] in healthy subjects increased with increasing 
contraction intensity (%MVC). This suggests that there is a growing imbalance between O2 
supply and O2 demand, resulting in a progressive increase in microvascular O2 extraction. This 
deoxy[Hb+Mb] response as a function of work rate has already been observed during 
incremental cycle exercise (Grassi et al., 2006, 2007; Ferreira et al., 2005). This pattern has 
been related to either the Bohr-effect, indicating that a local metabolic acidosis induces a 
rightward shift of the O2Hb-dissociation curve or either to differential muscle fiber 
recruitment, with a progressive recruitment of fast-twitch fibers with a different C(a-v)O2 
pattern in response to exercise (Boone et al., 2014).  
The healthy subjects were able to functionally increase the microvascular O2 extraction during 
exercise to 72.8 % of the maximal ‘forced’ O2 extraction. In the MM patients on the other 
hand, the increase in deoxy[Hb+Mb] was significantly lower both at submaximal and maximal 
intensities indicating that O2 extraction does not increase progressively as observed in healthy 
control subjects. A possible explanation for this divergent response is the limited ability to 
produce energy aerobically in the mitochondria. We hypothesize that, because some 
mitochondria are malfunctioning, myoglobin remains saturated and the intracellular PO2 will 
not decrease sufficiently. Consequently, O2 diffusion will be limited because the PO2 gradient 
is not increasing significantly. This limited O2 diffusion from capillary to myocyte which is 
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inherent to genetically determined OXPHOS deficiencies leads to a limited capacity to increase 
microvascular O2 extraction (Taivassalo et al., 2003). The small increase in deoxy[Hb+Mb] 
throughout the exercise test should be an expression of this mechanism. It should be noted 
that the deoxy[Hb+Mb] response in the MM patients was homogeneous as can be estimated 
from the relatively small standard deviation and thus the small response range (i.e., 17.2- 34.4 
% at maximal exercise intensity). To detect MM patients using this method a sensitivity of 91% 
and a specificity of 91% was found which could be considered as good values. According to 
these data and compared to other forearm tests where venous blood samples were taken 
(Taivassalo et al., 2003; Hanisch et al., 2006; Jensen et al., 2002), the NIRS measurements are 
equally sensitive and specific but less/non-invasive. Since deoxy[Hb+Mb] only increased 
slightly, it can be suggested that the MM patients compensated the limited O2 extraction by a 
hyperdynamic cardiovascular response and thus an emphasized convective O2 delivery, as 
observed by Grassi et al. (2006). Therefore, additional use of Doppler ultrasound as a second 
non-invasive tool to assess muscle blood flow, could be recommended to obtain a more 
integrative view on the Qm/VO2m relationship during exercise. Grassi et al. (2009) also 
observed a less pronounced increase in deoxy[Hb+Mb] (measured with NIRS) during 
incremental cycle exercise. However, cycle exercise is not recommended in MM patients as 
these patients can suffer from cardiomyopathy and might be at risk for arrhythmia during the 
test. To our knowledge, only one study used NIRS during handgrip exercise in MM patients 
(Van Beekvelt et al., 1999). They found lower VO2m-values, calculated from the changes in 
deoxy[Hb+Mb] and oxy[Hb+Mb] in response to a 45s arterial occlusion. It should be noted, 
however, that the authors did not account for possible differences in skinfold thickness at the 
site of the probe (Van Beekvelt et al., 2001) which might impact the oxygenation responses. 
Moreover, the arterial occlusion was used to calculate VO2m and was only maintained for 45s 
(Van Beekvelt et al., 1999). However, arterial occlusion has been used to obtain representative 
values of maximal capacity for O2 extraction, so that deoxy[Hb+Mb] values during exercise can 
be referenced to these maximal values (Celie et al., 2012; Grassi et al., 2007). In this context, 
it was recently observed that there are temporal differences in the deoxy[Hb+Mb] response 
to arterial occlusion ,i.e. a slower increase in MM patients, but no differences in amplitude in 
response to arterial occlusion (Boone et al., 2014). Therefore, in the present study, the 
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occlusion was performed until deoxy[Hb+Mb] showed a clear leveling-off, and was used as 
reference value for maximal change in deoxy[Hb+Mb].  
 In summary, it was shown that MM patients had significantly lower deoxy[Hb+Mb] values 
during this dynamic handgrip test compared to healthy control subjects, indicating that the 
peripheral oxygenation is altered in this pathological population. The results of the present 
study suggest that the incremental handgrip test, in combination with non-invasive 
registration of peripheral oxygenation respectively, could be used as an evaluation tool for 
detection and/or follow up in interventional pharmacological studies and/or rehabilitation 
programs. 
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ABSTRACT 
Introduction: Chronic fatigue syndrome (CFS) is characterized by chronic fatigue persisting for 
at least six months in the absence of any sufficiently explanatory medical condition and in the 
presence of additional minor criteria, including myalgia and post-exertional malaise. 
Mitochondrial dysfunction and oxidative damage may underlie the typically experienced 
exercise intolerance, myalgia and weakness. Previous work showed that Near Infrared 
Spectroscopy (NIRS) distinguishes patients with mitochondrial myopathy and documented 
mitochondrial dysfunction from healthy controls by reliably measuring deoxyhaemoglobin 
and –myoglobin in forearm muscles during an Incremental Cyclic Contractions Protocol (ICCP). 
This study aimed to screen for mitochondrial dysfunction in CFS.  
Methods: Twelve CFS patients and 12 matched healthy controls underwent the ICCP 
consisting of rhythmic handgrip contractions with increasing intensity. Muscle peripheral 
oxygenation was measured with NIRS and blood flow with Doppler Ultrasound. Patients with 
an abnormal profile on NIRS and/or ultrasound were invited for skeletal muscle biopsy, the 
gold standard for diagnosis of mitochondrial abnormalities.  
Results: A significant difference was found in deoxy[Hb+Mb] during ICCP at 50 % and at 
maximal handgrip force between the patient and control group. This was due to a subset of 
four CFS patients with limited to absent increases in deoxy[Hb+Mb], similar to the profile 
observed in documented mitochondrial myopathy. Of these subset, three patients underwent 
muscle and skin biopsy with cultured fibroblast analyses, indicating patterns of mitochondrial 
dysfunction. 
Conclusions: A subset of 4 out of 12 CFS patients showed significantly altered peripheral 
oxygen extraction during ICCP. In this subgroup mitochondrial dysfunction was confirmed by 
skeletal muscle biopsy and cultured fibroblast analysis. 
 
PART II – STUDY 5 
 
126 
INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterized by abnormal fatigue for a duration of at least 
six months resulting in significant reductions of professional and social activities and 
associated with a number of minor criteria, without an obvious medical or psychiatric 
explanation (Fukuda et al., 1994). Hence, the diagnosis of CFS requires careful exclusion of any 
other explanatory condition. Post-exertional malaise and myalgia are prominent features of 
CFS and hence have been included into the syndromal definition of CFS (Committee on the 
Diagnostic Criteria (CDC)).  
Previous studies have investigated a potential role of mitochondrial oxidative dysfunction in 
CFS (Arnold et al., 1984; Barnes et al., 1993; Gibson et al., 1993) but an anatomical or 
pathophysiological muscular substrate for CFS remains controversial (Fulle et al., 2000). 
Barnes et al. (1993) already focused on skeletal muscle bioenergetics in CFS using 
Phosphorous Magnetic Resonance Spectroscopy (31P-MRS), but failed to find consistent 
muscle abnormalities possibly due to heterogeneity in the CFS cohort.  
Exercise intolerance, myalgia and muscular weakness are key symptoms in the recognized 
entity of mitochondrial myopathies (MM). Near infrared spectroscopy (NIRS) has been 
validated as a tool to assess microvascular O2 extraction in skeletal muscle through 
measurement of muscle deoxyhaemoglobin and –myoglobin (deoxy[Hb+Mb]) in forearm 
muscles during an Incremental Cyclic Contractions Protocol (ICCP) (Celie et al., 2012). By using 
these non-invasive ICCP NIRS measurements, an unequivocal distinction could be made 
between healthy control subjects and MM patients suffering from a distinct mitochondrial 
defect (Celie et al., 2015). One recent study using NIRS in CFS patients demonstrated 
significantly reduced deoxy[Hb+Mb] increases upon exercise (Miller et al., 2015). 
The aim of this study was to screen for mitochondrial dysfunction in a selected group of CFS 
patients, to compare their results with those obtained in healthy controls and to further 
investigate through muscle and skin biopsy in order to document histologic and biochemical 
correlates of noninvasively obtained indications of mitochondrial dysfunction. 
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METHODS 
Subjects 
Two samples were compared. A first group consisted of 12 patients diagnosed with chronic 
fatigue syndrome (CFS). The second group consisted of 12 age and gender-matched untrained 
healthy controls. CFS patients were recruited from the department of general internal 
medicine at the Ghent University Hospital, Belgium. All subjects gave written informed 
consent and the study was approved by the ethics committee at the Ghent University Hospital. 
Procedures were in accordance with the recommendations of the Helsinki Declaration. The 
patients’ (11 female, 1 male) age, height and body weight were respectively 45 ± 8 years, 165 
± 6 cm and 71 ± 17 kg (mean values ± SD). Control subjects’ age, height and body weight were 
respectively 46 ± 8 years, 168 ± 7 cm and 70 ± 15 kg (mean values ± SD). 
Diagnostic decision making process CFS 
For the assessment of hitherto unexplained and longstanding chronic fatigue we followed a 
holistic approach based on the biopsychosocial model by Wessely et al. (1999). The integrated 
diagnostic pathway involved internal medicine assessment, psychodiagnostic screening, 
rehabilitation assessment and polysomnography combined with a multiple sleep latency test 
as previously described (Mariman et al., 2013). The internal medicine assessment consisted of 
comprehensive history taking, also considering any previous medical diagnoses or 
investigations, and a physical examination, with additional investigations upon indication. A 
rehabilitation physician evaluated for the presence of any musculoskeletal comorbidity 
suitable for physiotherapy. Psychodiagnostic screening performed by a clinical psychologist 
included history taking, the administration of validated questionnaires and psychological 
tests. Psychiatric consultation was scheduled when the history was suggestive of former or 
current psychiatric disorder, and whenever hints for the presence of a psychiatric disorder 
emerged from the psychodiagnostic evaluation or from the multidisciplinary discussion. The 
outcome of the multidisciplinary discussion was a diagnostic categorization into (i) 
unequivocal CFS, (ii) CFS with comorbidity, or (iii) a condition that excludes CFS. In the 
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unequivocal CFS patients that were included in this study, no coexisting sleep or psychiatric 
disorders could be documented. 
Measurements and data analysis 
Near Infrared Spectroscopy (NIRS) 
During the incremental exercise test, skeletal muscle tissue oxygenation was measured with 
a near infrared spectroscopy (NIRS) system (Oxiplex TS, ISS, Champaign, Illinois, USA). This 
system is based on an infrared light absorption method, where infrared light is emitted at 
different wavelengths. The NIRS-probe consisted of eight light-emitting diodes operating at 
wavelengths 690 and 830nm and one detector fibre bundle (source-detector distance = 2.0-
3.5cm). The changes in deoxy[Hb+Mb] during each work step (i.e. the mean of the highest 10-
s value) were expressed relative to the arterial occlusion amplitude (Celie et al., 2012; 2015). 
These calculations were made to reduce possible influence of forearm adipose tissue 
thickness as relative values are presented in relation to their individual maximum value. 
Doppler US  
Ultrasound Doppler (Vivid 7, GE Vingmed Ultrasound , Horten, Norway) was used to measure 
forearm blood flow (FBF) which is a method preferred to plethysmography during exercise 
(Radegran, 1999). FBF was measured preceding ICCP and after every incremental step (% 
MVC) in the protocol. Also, for normalization, all FBF values (expressed in ml min-1) during 
ICCP were expressed as increments above baseline values.  
ICCP 
The ICCP consisted of rhythmic handgrip contractions with increasing intensity, as described 
in previous studies (Celie et al., 2012; 2015). This test was performed in supine position using 
a hydraulic handgrip dynamometer (Saehan corporation, Masan, South-Korea). The NIRS 
probe was placed on the M. flexor carpi ulnaris and the M. flexor digitorum superficialis to 
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measure microvascular O2 extraction. This protocol started with a forearm arterial occlusion 
by inflating the cuff to 260mmHg, of unpredetermined duration until a steady state in 
deoxy[Hb+Mb] was reached. The ICCP was executed until exhaustion was reached. A typical 
NIRS output of a healthy subject during ICCP is presented in figure 1. In order to confirm the 
results of the first test in the CFS population, a NIRS retest was performed in all CFS subjects 
three months later, in combination with brachial artery Doppler US measurements of FBF. 
Fig. 1: Example of a typical deoxy[Hb+Mb] output of one healthy subject during ICCP with a schematic 
presentation of all measurement points (FBF and MVC). (ICCP= Incremental Cyclic Contraction Protocol; 
BL= Baseline; AO= Arterial Occlusion; MVC= Maximal Voluntary Contraction; FBF= Forearm Blood 
Flow). 
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Oxidative Phosphorylation (OXPHOS) investigations  
Patients with abnormal deoxy[Hb+Mb] values (in %) during ICCP or a hyperkinetic limb blood 
flow (Taivassalo et al., 2003), were invited to undergo a skeletal muscle biopsy in order to 
histochemically document mitochondrial dysfunction. The biopsy samples were analyzed by 
light microscopic (LM) and electron microscopic (EM) examination and by biochemical 
analysis. Skeletal muscle specimen was analysed using standard histological, histochemical, 
histoenzymatic and immunohistochemical techniques for light microscopy (Raducu et al., 
2015) and was further analysed by EM after fixation in 4% glutaraldehyde. After postfixation 
in 2% osmium tetroxide, blocks were embedded in araldite for conventional electron 
microscopy. Ultrathin sections contrasted with uranyl acetate and lead citrate were examined 
using a CM10 transmission electron microscope (FEI Europe, Eindhoven, The Netherlands) at 
60 kV. Spectrophotometric analysis was used for measurement of the catalytic activities of 
the OXPHOS complexes (complexes I, II, II+III, III and IV) and of citrate synthase. Analyses were 
performed according to previously described methods (Ajit-Bolar et al., 2013). The OXPHOS 
function in skeletal muscle was also evaluated by Blue Native Polyacrylamide Gel-
Electrophoresis (BN-PAGE) (Ajit-Bolar et al., 2013). The latter was used to separate and 
visualise the OXPHOS complexes in mitochondria isolated from skeletal muscle. Solubilisation 
of the complexes, BN-PAGE, and staining of the catalytic activities in the gel were performed 
as reported earlier (Van Coster et al., 2001). Patient and control samples were loaded in 
duplicate using equal amounts of mitochondrial protein (50 µg). The Z-score was calculated 
as the activity ratio for the patient sample minus the mean activity ratio for the control 
samples divided by the SD for the control samples. When the Z-score was lower than -1·96 or 
higher than +1·96, the result for the patient sample was considered as significantly different 
(p< 0·05) from the control sample. 
Immuno- and fluorescent staining in cultured skin fibroblasts  
The mitochondrial membrane potential was evaluated by measuring the red over green 
fluorescence ratio of the cationic dye 5,5’, 6,6’-tetraethylbenzimidazolyl-carbocyanine iodide 
(JC-1, Invitrogen), with or without 30 ng/ml of the complex I inhibitor rotenone, following a 
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published procedure (De Paepe et al., 2012). To visualize mitochondria, the fluorescent 
Mitotracker Red CMXRos dye (Invitrogen) was used according to the manufacturer’s 
instructions. With monoclonal antibodies, the oxidative phosphorylation complexes I (subunit 
NDUFA9), II (subunit IP), and IV (subunit I) (Abcam, Cambridge, MA) were immunostained and 
visualized using the labeled streptavidin biotin system (Dako, Glostrup, Denmark). 
Statistical analysis 
Statistical analysis for MVC and baseline FBF values was performed using an independent 
samples t-test. A Repeated Measures ANOVA was used to compare the increase in 
deoxy[Hb+Mb] and FBF (in %) during ICCP between the CFS population and the controls. 
Because test retest deoxy[Hb+Mb] results were obtained for all CFS subjects, this Repeated 
Measures ANOVA was first performed by using the test deoxy[Hb+Mb] values and secondly 
by using retest deoxy[Hb+Mb] values for comparison with healthy control subjects. When a 
significant main effect was found, post-hoc analysis was performed by means of an 
independent samples t-test. The level of significance was set at p<0·05. Statistical 
computations were performed using SPSS® software (version 18; SPSS Lead Technologies Inc., 
Chicago, IL, USA). All data are presented as mean ± standard deviation (SD). 
RESULTS 
General results 
No significant difference in MVC was found between CFS patients (µ= 318 ± 89N) and healthy 
control subjects (µ= 365 ± 67N) (p=0·174). Also, baseline FBF values did not differ significantly 
between both groups (p=0·841). All patients tolerated the test well. 
Mean submaximal and maximal deoxy[Hb+Mb] values (expressed as %) during test-retest ICCP 
for CFS patients and controls are presented in Figure 2a. A significant difference in 
deoxy[Hb+Mb] was found between CFS patients and healthy control subjects during ICCP at 
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both the first test (p=0·008) and retest (p=0·042). Post hoc analysis results are presented in 
Figure 2a. 
Mean submaximal and maximal FBF values (expressed as increments to baseline in ml/min) 
during ICCP for CFS patients and controls are presented in Figure 2b. Statistical analysis 
revealed no significant interaction effect (p=0·304) or main effect for groups (p=0·7) indicating 
that the increase in FBF was not significantly different between both groups. 
Fig. 2a&b. Mean submaximal and maximal deoxy[Hb+Mb]- test and retest values (expressed as %) ( a) 
and FBF values ( b) during ICCP for patients and control subjects. (* p ≤ 0•05, ** p ≤ 0•01). 
 
  
SCREENING FOR MITOCHONDRIAL DYSFUNCTION 
 
133 
Individual results 
As the CFS population consisted of a small number of patients, the mean deoxy[Hb+Mb] 
values were significantly influenced by four CFS patients without significant increases in 
deoxy[Hb+Mb] at the test-retest. Moreover, after statistical analysis, one of these CFS patients 
had extremely high FBF values during every step of the ICCP. These FBF values were higher 
than mean FBF+ 2SD at every intensity. Individual maximal deoxy[Hb+Mb] and FBF values for 
all subjects are presented in Figure 3a and b. These findings were similar to previous 
observations in mitochondrial myopathy patients (Celie et al., 2015; Taivassalo et al., 2003). 
Three out of the four patients agreed to undergo skeletal muscle and skin biopsy for 
microscopic and biochemical analyses. 
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Fig. 3a&b. Individual maximal deoxy[Hb+Mb] (Fig 3a) and FBF (Fig 3b) values during ICCP for all CFS 
patients and their age- and gender matched healthy control subjects. Additionally, the individual 
maximal deoxy[Hb+Mb] values from MM patients8 in a previous study are presented. The subgroup 
with lower deoxy[Hb+Mb] rates is marked. (Patient 1, 2, 3 and 4 are respectively marked with 1, 2, 3 
and 4) 
 
  
SCREENING FOR MITOCHONDRIAL DYSFUNCTION 
 
135 
OXPHOS and immuno- and fluorescent staining in cultured skin fibroblasts analyses 
The three patients in whom a biopsy was performed, showed abnormalities in either skeletal 
muscle tissue or cultured skin fibroblasts. The type of anomaly however, differed between 
patients. In patient 1, numerous lipid droplets were observed in skeletal muscle on LM and on 
EM examination (Figure 4). Moreover, cultured skin fibroblasts from this patient, showed a 
mosaic staining pattern after addition of JC1 (plus rotenone), which is aberrant from control 
samples. Cells containing mitochondria with a low mitochondrial membrane potential (only 
green color) were detected among other cells enclosing a mixture of mitochondria with high 
and low mitochondrial membrane potential (red and green color) (See Figure 5). While the 
overall activities of the respiratory chain complexes were normal when analyzing skin 
fibroblast homogenate, this mosaic staining pattern was confirmed by immunostaining of 
cultured skin fibroblasts with an antibody against a subunit in complex IV. Biochemical analysis 
in a skeletal muscle homogenate revealed a slight decrease of the activity of complex IV, but 
only when expressed as ratio over the activity of complex II (see Table 1). Compared to patient 
1, only a slight increase of small lipid droplets was seen in patient 2. Notwithstanding, in 
cultured skin fibroblasts, a mosaic staining pattern was seen after addition of JC1 (plus 
rotenone). The amount of cells that contained only mitochondria with low mitochondrial 
membrane potential was, however, less than in patient 1. Catalytic activities of the respiratory 
chain complexes were normal in the homogenates of skeletal muscle and cultured skin 
fibroblasts. While microscopic examination did not reveal any abnormality in skeletal muscle 
tissue from patient 3, biochemical analysis revealed a significant decrease of complex I and 
complex II+III activity. In contrast to both previous patients, no mosaic staining pattern in 
cultured skin fibroblasts was observed after staining with JC1 (plus rotenone). However, 
immunostaining with an antibody against a subunit of complex I, and with an antibody against 
a subunit of complex IV demonstrated significantly lower Cross Reacting Material (CRM) than 
control samples. Complex IV activity was significantly decreased in a cultured skin fibroblast 
homogenate (complex I was not measured). 
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Fig. 4:LM and EM investigation of skeletal muscle tissue in the three CFS patients with abnormal ICCP 
deoxy (Hb+Mb) profile. 
 
 
 
- Pt 1: Parallel arranged intermyofibrillar rows of multiple lipid droplets are illustrated in a 
longitudinal cut muscle fibre 
-  Pt 2: A transversely oriented muscle fibre shows a relative abundance of lipid droplets with 
variable sizes under the sarcolemma and between the myofibrils. 
- Pt 3: normal amounts of smaller lipid droplets appear in the biopsy such as seen in a 
longitudinal muscle fibre 
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Fig 5: Immuno- and fluorescent staining in cultured skin fibroblasts with JC1 (plus rotenone) in the three 
CFS patients (P1-3) with abnormal ICCP deoxy (Hb+Mb) profile as compared to control (C). 
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- JC-1 fluorescent staining after rotenone treatment shows equal distribution of active (red) and 
inactive (green) mitochondria in C and P3; P1 and P2 display a mosaic staining pattern with a 
subset of cells containing only inactive (green) mitochondria. 
- Immunocytochemical staining (ICC) for oxidative phosphorylation (OXPHOS) complex I subunit 
39kd and complex IV subunit I (DAB, brown), nuclei counterstained with hematoxylin (blue), 
shows reduced staining for complex IV in P1, and complex I and complex IV in P3. 
- Immunofluorescent staining (IF) for complex IV subunit I and complex II subunit IP 
(AlexaFluor488, green), nuclei counterstained with dapi (blue), shows a mosaic staining pattern 
for complex IV in P1. 
- Normal MitoTracker CMXRos staining (red) is present in all cell lines, nuclei counterstained with 
dapi (blue) 
 
Table 1: Spectrophotometric analysis of the activities of the OXPHOS complexes in skeletal muscle and 
cultured fibroblast tissue homogenate for the three CFS patients. Abnormalities are presented in bold. 
(* Results expressed as the logarithm of OXPHOS activity divided by the logarithm of citrate synthase 
(CS) activity. Control sample ratios are given as mean ± SD. Deficient activities are considered when the 
Z-score is <±1.96.) 
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DISCUSSION 
This study is the first to determine biochemical and histological correlates of mitochondrial 
abnormalities in relation to NIRS and Doppler US non-invasive assessment of muscle oxidative 
metabolism in CFS patients. A subgroup of CFS patients was identified with significantly 
decreased oxygen extraction using an ICCP standardized exercise protocol. The deoxy[Hb+Mb] 
pattern of these patients was similar to the NIRS pattern observed in patients with 
documented mitochondrial myopathy (Celie et al., 2015). The results of the present study are 
in line with the study of Miller et al. (2015), who were the first to demonstrate a significantly 
altered oxygenation pattern in CFS patients, although without blood flow measurements. In 
contrast to the study of Miller et al. (2015), mitochondrial dysfunction was determined in a 
subgroup of three CFS patients, with blood flow measurement and histologic and biochemical 
correlates. In the present study mitochondrial dysfunction was documented in the subgroup 
with decreased oxygen extraction in skeletal muscle and cultured skin fibroblasts. In patient 
1, a clear increase of the amount of fat droplets was observed in skeletal muscle whereas in 
cultured skin fibroblasts, a mosaic pattern was seen following staining of the mitochondria 
with JC1 (plus rotenone). The increased amount of fat droplets, observed in skeletal muscle 
tissue and the mosaic pattern, observed in cultured skin fibroblasts, were however less 
pronounced in patient 2. Notwithstanding the divergent degree of anomalies, an equal 
pattern could be recognized in these two patients. A mosaic staining pattern is usually 
observed in patients suffering from mitochondrial DNA abnormalities (e.g. point mutation, 
deletion or depletion of the mitochondrial DNA). Hence, the results of patient 1 and 2 are 
indicative for the presence of such a mitochondrial abnormality. In patient 3 however, a 
different pattern could be recognized as no skeletal muscle microscopic abnormalities could 
be detected. On the other hand, complex I deficiency was established biochemically , and, 
more surprisingly, a deficient complex IV activity in cultured skin fibroblasts (no complex I 
measurements were performed in fibroblasts). Complex I and complex IV contain the largest 
number of mitochondrial encoded subunits. Deficiencies of either complex I, or complex IV, 
or a combined deficiency of complex I and IV, are usually caused by a disturbed 
intramitochondrial synthesis of the mitochondrial encoded subunits. The significantly 
decreased activity of complex II + III (succinate cyrochrome 3 reductase), in combination with 
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a normal activity of the individual complexes II and III, is rather suggestive for a decreased 
amount of functionally active co-enzyme Q. 
The heterogeneity in NIRS response and the possible existence of different subgroups among 
CFS patients may explain previously reported contrasting results in physiologic responses 
including reduced muscle strength (Fulcher and White, 2000; Wagemakers et al., 1988), 
maximal oxygen consumption (De Becker et al., 2000; Sargent et al., 2002), muscle 
metabolism (Fukuda et al., 1994; Arnold et al., 1984; Barnes et al., 1993; Gibson et al., 1993; 
Fulle et al., 2000) and blood flow (McCully et al., 1996; 2003; 2004; McCully and Natelson, 
1999). A typical example of these discrepancies in the existing literature are conflicting reports 
on blood flow in CFS, ranging from reduced blood flow (McCully et al., 1996; 2004; McCully et 
al., 1999), attributed to autonomic dysregulation or reduced capillary density (Lindh et al., 
1995) to normal blood flow as compared to healthy subjects (McCully et al., 2003). In the 
present study FBF was either normal or in one patient significantly higher, potentially 
indicating a compensatory hyperkinetic muscle circulation during exercise (Taivassalo et al., 
2003), as observed in MM with increased capillary areas (Taivassalo et al., 2012). CFS 
represents a mere syndromal description lacking validated pathophysiology and diagnostic 
tests. The particular experimental approach in the present study seems to allow the 
identification of a subgroup of CFS patients with mitochondrial abnormalities. 
A possible confounder may be identified in the concomitant use of metformin in 2 out of the 
three CFS patients with the observed histologic and biochemical abnormalities suggestive of 
mitochondrial dysfunction. This biguanide has been shown to inhibit complex I activity of the 
mitochondrial respiratory chain (El Mir et al., 2000; Owen et al., 2000). However, exercise 
intolerance and muscular pain preceded the initiation of metformin in these patients. Clearing 
this potential issue of adverse effects is important, in view of the widespread advocacy for 
early treatment and documented beneficial effects of metformin in type 2 diabetes mellitus 
and even in the stage of peripheral insulin resistance (Tran et al., 2015). These promising 
findings need to be confirmed in a randomised prospective assessment of a larger sample of 
CFS patients with and without metformin, prior to and during metformin treatment.  
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In conclusion, NIRS and Doppler US measurements during a non-exhaustive ICCP, can identify 
a subgroup of CFS patients with potential mitochondrial abnormalities.  
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The purpose of this research was to develop a non-invasive and non-exhaustive screening 
protocol for malfunctioning peripheral oxygenation in Chronic Fatigue Syndrome (CFS) and 
Mitochondrial Myopathy (MM) populations, complaining about muscle weakness and 
exercise intolerance. Therefore, non-invasive measurements on forearm muscles during non-
exhaustive handgrip exercise were proposed. As sustained dynamic cyclic contractions are 
preferable when aiming to challenge the oxidative metabolism, an Incremental Cyclic 
Contraction Protocol (ICCP) was developed in different steps and tested in pathological 
populations. These steps will consequently be discussed in this part to assess the applicability 
and quality of this research. 
1. METHODOLOGICAL ISSUES OF NEAR INFRARED SPECTROSCOPY (NIRS) 
As the main purpose of this research was to use an exercise protocol in clinical populations, 
we aimed to develop a non-exhaustive test with non-invasive measurements to gain more 
insight into their peripheral oxygenation mechanisms. Therefore, NIRS technology was used 
to estimate O2 extraction at muscle level during exercise. Because NIRS technique is not the 
gold standard method to measure O2 extraction, there were some methodological barriers 
requiring further investigation before using this instrument in patient populations. This is of 
particular importance because reliability and validity of NIRS measurements have not been 
shown on forearm muscles when performing handgrip exercise. Of course, handgrip exercise 
was an important item in this study as exhaustive exercise should be avoided in MM and CFS 
patients, due to the possible comorbidity of cardiomyopathy in MM patients and the fact that 
disuse of leg muscles is an important issue in MM and CFS patients. Such a chronic physical 
inactivity can be a contributing or disturbing factor of the distinctive response to whole body 
exercise in MM and CFS patients. Also, complaints of upper limb muscle pain and exercise 
intolerance are a common feature in CFS patients (Ickmans et al., 2014). Therefore, it was very 
interesting to apply NIRS technology on upper limb muscles during exercise. Moreover, it is 
important to highlight the role of using relative deoxyhaemoglobin and myoglobin 
(deoxy[Hb+Mb]) values during ICCP as reliability of these measurements have, to our 
knowledge, never been established in the past. These relative NIRS values are the result of a 
physiological calibration of the NIRS measurements which was carried out by applying a cuff, 
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inflated above the systolic blood pressure, on the upper arm. As a consequence, absolute 
oxyhaemoglobin and myoglobin (oxy[Hb+Mb]) and O2 saturation (SmO2) will decrease and 
deoxy[Hb+Mb] will increase until a steady state is reached. The NIRS response during arterial 
occlusion was calculated as the difference between maximal (deoxy[Hb+Mb])/minimal 
(oxy[Hb+Mb] and SmO2) and resting values and was set as the 100% value. Every response to 
exercise (i.e. difference between maximal /minimum and baseline value) was set relative to 
the arterial occlusion maximal/minimal values. This latter technique was already used in some 
studies (Mancini et al., 1994; Wilson et al., 1989; Esaki et al., 2005; Grassi et al., 2007) and 
could offer a possible solution to eliminate other influences like subcutaneous Adipose Tissue 
Thickness (ATT) and blood flow (O2 delivery). However, to our knowledge, this was the first 
study investigating the reliability of these relative deoxy[Hb+Mb] values on forearm muscles 
during exercise. Moreover, the impact of using these relative deoxy[Hb+Mb] values to 
eliminate the influence of subcutaneous ATT and FBF was, to our knowledge, never studied 
before. 
1.1 Reliability of NIRS parameters during this ICCP 
When aiming to study pathological populations, using NIRS as a technique to measure 
microvascular O2 extraction, it is thoroughly important to investigate reliability and possible 
disturbing influences on this NIRS signal. The reliability and validity of this technique has 
already been established in previous studies, although in most cases on brain tissue or in large 
muscle groups (Kell et al., 2004; Pereira et al., 2007). Additionally, these studies did not 
execute an arterial occlusion before the exercise protocol to physiologically calibrate NIRS 
parameters. Therefore, it was of major importance to investigate the reliability of these 
relative deoxy[Hb+Mb] values towards the arterial occlusion maximum in forearm muscles 
during the ICCP. In agreement with most of the NIRS reliability studies (Kell et al., 2004; Pereira 
et al., 2007), it was shown in study 1 that these relative deoxy[Hb+Mb] values as well as the 
SmO2 values were reliable parameters during the ICCP. However, it is important to notice that 
reliability at the lower intensities were absent or small, probably due to the heterogeneous 
deoxy[Hb+Mb] response. Moreover, the lower intensities were also used for familiarisation of 
the protocol and this could be another possible explanation for the low ICC values. At the 
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higher and maximal relative deoxy[Hb+Mb] intensities, there was a good reliability ICC value. 
Because the ICC values are not sufficiently to show agreement between the test and retest, 
Bland Altman plots for every intensity are presented in Figure 1, 2, 3, 4, 5 and 6. In general, 
some outliers can be recognized in these plots. Hence, as a first step in this research it was 
shown that these relative deoxy[Hb+Mb] values, measured during ICCP, could be reliably used 
to gain more insight into peripheral O2 extraction mechanisms. 
Fig. 1: Test-retest Bland Altman plot for 20% MVC 
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Fig. 2: Test-retest Bland Altman plot for 30% MVC 
 
Fig. 3: Test-retest Bland Altman plot for 40% MVC 
 
  Part III: General Discussion 
 
151 
Fig. 4: Test-retest Bland Altman plot for 50% MVC 
 
 
Fig. 5: Test-retest Bland Altman plot for 60% MVC 
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Fig. 6: Test-retest Bland Altman plot for maximal deoxy[Hb+Mb] 
 
1.2  Possible influence of subcutaneous ATT and blood flow on NIRS measurements 
In study 2 of this research, it was observed that all absolute NIRS parameters (in µM) except 
tHb were influenced by subcutaneous ATT indicating that ATT might blunt the NIRS responses 
to exercise. However, when using the relative deoxy[Hb+Mb] values, the impact of 
subcutaneous ATT was no longer present. Hence, the statement that it is impossible to use 
NIRS in clinical populations as a consequence of ATT influence (Ferrari et al., 2011) should be 
refined, in particular because this physiological calibration and non-exhaustive handgrip 
exercise offer an increased applicability of the NIRS technique in patients. A plausible 
explanation for this influence on absolute parameters could be the fact that, when ATT at the 
measurement site was between 6mm and 14 mm, the NIRS absorption coefficient (µa) quickly 
decreased (Wolf et al., 2003). In this study, mean subcutaneous ATT (±SD) for all subjects was 
6.5 ± 3.4 mm, indicating that µa was decreased in the studied population, thereby possibly 
blunting the NIRS signal. Of course, it is very important to be aware of the depth sensitivity of 
the NIRS device, because there are a lot of different NIR technologies. Generally taken, 
penetration depth of the infrared signal is half of the interoptode distance of the NIRS probe (Ryan 
et al., 2012). As mentioned in the methods part, our NIRS device has source detector distances 
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ranging from 2.0 – 3.5 cm, which means that depth sensitivity ranges from 1.0 – 1.75 cm. As a 
second step in this research, it was of major importance to investigate whether it was possible 
to exclude the influence of subcutaneous ATT by performing an arterial occlusion as 
physiological calibration. Otherwise, it would not have been correct to execute this ICCP in 
subjects with a large skinfold (>6mm) at the site of the NIRS probe. As was shown in this study, 
it is possible to exclude subcutaneous ATT influence by using relative oxy[Hb+Mb] or 
deoxy[Hb+Mb] values. 
It has also been shown in study 2 that FBF influences all absolute NIRS parameters, except the 
relative oxy- and deoxy[Hb+Mb] values. A significant relation was observable as well, between 
absolute deoxy[Hb+Mb] and tHb on the one hand, and the maximal force at exhaustion on 
the other hand. Moreover, these maximal force values correlated significantly positive with 
maximal FBF values. First of all, it is crucial to emphasize that the possible influence of FBF on 
NIRS parameters requires a different approach than the possible influence of subcutaneous 
ATT. It was the aim of this study to investigate the possible relationship between FBF on the 
one hand, and absolute and relative NIRS parameters on the other hand, specifically in an 
explorative way. This was in particular because the relation between these measurements 
was carried out in only one preceding study (Fadel et al., 2004). A higher maximal force at 
exhaustion implicates an improved functional capacity of the muscle to contract at a higher 
load, especially because a higher maximal force while performing cyclic contractions 
increasingly elicits the aerobic energy delivery system. The higher maximal FBF value 
represents an improved functional capacity at muscle level as well, probably due to an 
increased capillary density and modifications in dilator function related to endothelial change 
(Delp and Laughlin, 1997; Sinoway et al., 1986; Smolander, 1994; Snell et al., 1987). As this 
ICCP is based on rhythmic dynamic contractions to predominantly challenge the oxidative 
metabolism, the relation between both values (i.e. FBF and maximal force) is obvious. 
Whereas MVC -and thus incremental load- during ICCP is higher, FBF values will be increased 
too in these individuals, probably to have an expanded passage of O2, free fatty acids and 
glucose. The hypothetical question of the repercussions of these divergences in maximal force 
and FBF on NIRS parameters, remains unanswered. Possibly, individuals with a higher MVC 
and FBF may have a higher amount of capillaries that influences the NIR penetration at muscle 
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level. In these individuals, capillary blood flow will be increased at the site where 
deoxy[Hb+Mb] is measured. Moreover, it has been shown that haemoglobin flux at capillary 
level increases during exercise up to two- or threefold (Kindig et al., 2002; Copp et al., 2009). 
This abundantly higher capillary O2 supply at the site of the NIRS probe means that 
microvascular haemoglobin flux will be increased at that location. As such, larger absolute 
deoxy[Hb+Mb] increases will be possible during exercise compared to subjects with a lower 
haemoglobin flux at the measurement site. Consistent with this explanation, absolute 
deoxy[Hb+Mb] measurements will depend on intensity and capillary haemoglobin flux. It is 
however questionable, whether it is favourable to measure this higher capillary haemoglobin 
flux, due to improved functional capacity rather than clinical related peripheral problems in 
some pathologic populations. Therefore, it is interesting to observe that the relationship 
between intensity (MVC) and O2 delivery on the one hand, and NIRS parameters on the other 
hand, disappears by using relative values. In our opinion, the use of absolute or relative 
oxy[Hb+Mb] and deoxy[Hb+Mb] depends on the experimental purpose of the study.  
When aiming to test clinical populations for detection of certain muscle abnormalities, one 
should definitely use relative values as it excludes possible (de)conditioning effects in muscle 
oxygenation due to an improved or impaired functional capacity of the muscle. It is of major 
importance to investigate these issues, especially when aiming to execute these 
measurements during ICCP in patient populations, where (de)condition effects have been 
used in the past to explain possible differences as a secondary cause. Hence, to exclude these 
possible (de)conditioning effects, it could be strongly advised to use the relative 
deoxy[Hb+Mb] parameters in patient populations. 
In the first part of this research, the appropriate use of the NIRS measurements during ICCP 
were analysed. It was shown that SmO2 as well as relative deoxy[Hb+Mb] were reliable 
measurements during this protocol. However, SmO2 values during ICCP were significantly 
blunted with increasing ATT values and could therefore, not be used in further analyses of 
subjects. The relative deoxy[Hb+Mb] values during ICCP were reliable measurements to assess 
microvascular O2 extraction in diverse populations with minimal influence of ATT, 
deconditioning effects (maximal force at exhaustion) and limb blood flow. Consequently, 
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these ICCP relative deoxy[Hb+Mb] measurements could be reliably used to analyse healthy 
and clinical populations, thereby eliminating the blunting ATT effect on the NIRS signal and 
blood flow (O2 delivery) influence. 
2. RELATIVE DEOXY[HB+MB] IN MM PATIENTS 
The conclusions, drawn in this previous part, allowed us to start using ICCP relative 
deoxy[Hb+Mb] measurements in patient populations. Before using this experimental set up 
as a screening tool for mitochondrial abnormalities in cohorts complaining about muscle pain 
and weakness, post-exertional malaise and exercise intolerance, it was necessary to 
understand arterial occlusion responses of a Mitochondrial Myopathy (MM) population and 
to investigate whether severe MM could be identified using ICCP measurements.  
2.1 Response during and following arterial occlusion 
In the second part of this study, significant differences were found in the deoxy[Hb+Mb] signal 
during and after arterial occlusion, as well as during ICCP, in patients suffering from severe 
MM with clear mitochondrial dysfunction at muscle level. As such, the kinetics of MM patients 
were significantly slower compared to healthy subjects during arterial occlusion. A possible 
explanation for these divergent kinetics could be the heteroplasmic nature of this 
mitochondrial disorder, whereby a mixture of pathogenic mtDNA and wild type mtDNA is 
present at muscle level (Durham et al., 2007; DiMAuro, 2010). During brachial arterial 
occlusion, the circulation of red blood cells in forearm muscles will be interrupted. As a 
consequence of this blood pooling, O2 will be transported to the few functioning 
mitochondria, where O2 will be consumed. Hence, this process will take significantly more 
time in MM patients compared to healthy control subjects, as this clinical population has a 
reduced amount of functioning mitochondria. This may explain the slower kinetics of 
deoxy[Hb+Mb] values during arterial occlusion in MM patients. In Figure 7 and Figure 8, this 
explanation was presented schematically. 
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Fig. 7: Schematic presentation of the O2 cascade at skeletal muscle level during arterial occlusion while 
measuring NIRS in healthy subjects (PO2 =oxygen partial pressure; oxy[Hb] = oxyhaemoglobin; 
deoxy[Hb]= deoxyhaemoglobin; oxy[Mb]=oxymyoglobin; deoxy[Mb]=deoxymyoglobin; mt= 
mitochondria). 
 
 
 
 
 
 
Fig. 8: Schematic presentation of the O2 cascade at skeletal muscle level during arterial occlusion while 
measuring NIRS in MM patients (PO2 =oxygen partial pressure; oxy[Hb] = oxyhaemoglobin; deoxy[Hb]= 
deoxyhaemoglobin; oxy[Mb]=oxymyoglobin; deoxy[Mb]=deoxymyoglobin; mt= mitochondria). 
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 A second finding in study 3 were the faster post-occlusive oxy[Hb+Mb] and deoxy[Hb+Mb] 
responses in the MM population compared to healthy controls. This means that  post-
occlusion reoxygenation took place earlier in the MM cohort, thereby demonstrating a faster 
O2 delivery following cuff release. A faster reoxygenation is an indication for a decreased 
skeletal muscle oxidative capacity (Kime et al., 2003; Callewaert et al., 2012) due to 
mitochondrial dysfunction in the MM patient population. By performing an arterial occlusion 
in MM patients in study 3, two determinants could be identified as a reflection of the 
decreased muscle oxidative capacity, i.e. slower deoxy[Hb+Mb] kinetics during arterial 
occlusion and a faster reoxygenation following cuff release. 
2.2 During ICCP  
In study 4, it has been shown that MM patients had a significantly altered pattern of relative 
deoxy[Hb+Mb] during ICCP, compared to healthy control subjects. These results were in line 
with all other studies comparing exercise responses between MM patients and healthy control 
subjects during whole body (Dandurand et al., 1995; Dysgaard Jeppesen et al., 2003; Grassi et 
al., 2009; Siciliano et al., 1999; Taivassalo et al., 2003) or handgrip (Hanisch et al., 2006; Jensen 
et al., 2002; Taivassalo et al., 2002; Van Beekvelt et al., 2001) exercise. From these latter 
studies, only two of them carried out exercise tests with non-invasive NIRS measurements 
(Grassi et al., 2007,2009; Van Beekvelt et al., 1999). To our knowledge, Van Beekvelt et al. 
(1999) was the only past study carrying out a handgrip exercise test analysing NIRS 
measurements on forearm muscles. However, some methodological concerns could be raised 
when considering possible influences on the NIRS signal, i.e. ATT and O2 delivery. In a second 
study, these authors reported that they did not account for possible differences in 
subcutaneous ATT among the subjects (Van Beekvelt et al., 2001). With a sensitivity and 
specificity of both 91% in study 4, it could be stated that equal values were found using these 
measurements, compared to invasive methods for detection of decreased oxidative capacity. 
Also, relative deoxy[Hb+Mb] response was quite homogeneous in our study as the MM 
population had a relatively small response range (17.2% to 34.4%) at maximal intensity. 
Hence, in this study, a contribution was made in order to solve two major issues concerning 
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this research area, i.e. the need of non-invase and not-intensive screening tools and the need 
for reliable measurements with sufficient sensitivity and specificity. 
In an attempt to explain these divergences between both populations, it is important to refer 
to the first part of this dissertation on peripheral oxygenation. As elucidated, scientific 
evidence suggests that skeletal muscles possess the property to create an “O2 depleted 
region” during exercise, thereby improving O2 passive diffusion capacity (Gayeski and Honig, 
1985, 1987; Honig et al., 1997; Voter and Gayeski, 1995; Richardsson et al., 1995a,b, 1998). A 
crucial element in this theory is the O2 desaturation of intramuscular myoglobin to create this 
O2 depletion during exercise. Myoglobin is an important intramuscular protein to transport O2 
to the mitochondrial reticulum. This mitochondrial reticulum comprises the entity of cytosolic 
mitochondria, forming a dynamic partially interconnected reticular network which spreads 
over the whole cytosolic volume excluding the nucleus (Sukhorukov et al., 2012). During 
exercise, O2 delivery to the mitochondrial reticulum will be increased and intramuscular 
myoglobin desaturation will take place, thereby creating an “O2 depleted region”. It should be 
questioned however, how this theory of a “depleted O2 region” could be applied to a MM 
population with severe mitochondrial dysfunction. It could be hypothesized that the 
intramuscular myoglobin O2 desaturation does not completely occur in MM patients as a 
consequence of clear mitochondrial malfunctioning. Consequently, O2 passive diffusion from 
haemoglobin to the myocyte will be significantly restricted and microvascular O2 extraction 
will be reduced as well. Interestingly, this inability of passive O2 diffusion to the muscle can be 
detected when measuring relative deoxy[Hb+Mb] values during ICCP. In Figure 9 and Figure 
10, divergences in capillary-to-myocyte O2 transport are schematically presented for both 
healthy control subjects and MM patients. 
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Fig. 9: Schematic presentation of the O2 cascade at skeletal muscle level during ICCP while measuring 
NIRS in healthy subjects (PO2 =oxygen partial pressure; oxy[Hb] = oxyhaemoglobin; deoxy[Hb]= 
deoxyhaemoglobin; oxy[Mb]=oxymyoglobin; deoxy[Mb]=deoxymyoglobin; mt= mitochondria). 
 Fig. 10: Schematic presentation of the O2 cascade at skeletal muscle level during ICCP 
measuring NIRS in MM patients (PO2 =oxygen partial pressure; oxy[Hb] = oxyhaemoglobin; 
deoxy[Hb]= deoxyhaemoglobin; oxy[Mb]=oxymyoglobin; deoxy[Mb]=deoxymyoglobin; mt= 
mitochondria). Patholologic response (malfunctioning mitochondria) are presented in red. 
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In this second part, a clear distinction was shown in relative deoxy[Hb+Mb] during ICCP 
between healthy control subjects and MM patients with a severe mitochondrial dysfunction. 
It is essential to emphasize that this was a crucial step in this research to be able to make a 
clear contrast in peripheral oxygenation mechanisms between this pathologic population and 
healthy control subjects. In general, three deoxy[Hb+Mb] abnormalities could be identified as 
a marker for reduced muscle oxidative capacity in this MM population. (i) Slower 
deoxy[Hb+Mb] kinetics during arterial occlusion. (ii) A faster decrease in deoxy[Hb+Mb] after 
cuff release, indicative for an earlier reoxygenation. (iii) A significant altered relative 
deoxy[Hb+Mb] pattern during ICCP. Hence, by measuring relative deoxy[Hb+Mb], it is possible 
to accurately and reliably measure peripheral oxygenation abnormalities without possible 
influence of subcutaneous ATT and capillary (de)conditioning. 
3. RELATIVE DEOXY[HB+MB] AND FBF RESPONSES IN CFS PATIENTS  
To our knowledge, no previous studies have investigated oxidative metabolism in CFS patients 
with non-invasive assessment of microvascular O2 extraction and limb blood flow by using 
NIRS and Doppler Ultrasound. The only preceding study using NIRS to establish altered 
oxygenation responses to exercise in CFS patients, did not measure blood flow (Miller et al., 
2015). Additionally, no corrections were made for subcutaneous ATT in this latter study, 
whereby mean ATT values were higher than 6 mm (Miller et al., 2015). As was mentioned 
before, caution is advised when analysing NIRS values without ATT correction methodology. 
Moreover, Wolf et al. (2003) has shown that the NIRS absorption coefficient (µa) is 
significantly influenced when subcutaneous ATT is higher than 6mm. Based on clear 
observations of an excessive O2 delivery during and after exercise in MM patients, brachial 
artery blood flow measurements were added in this study (Jeppesen et al., 2012; Taivassalo 
et al., 2003; Taivassalo et al., 2012). Considering the relative deoxy[Hb+Mb] values, significant 
differences were found at different steps during ICCP. Notwithstanding the lack of overall, 
significant differences regarding relative deoxy[Hb+Mb]- and FBF values between CFS patients 
and their healthy matched control subjects, a subgroup of four CFS patients was identified 
with abnormal peripheral oxygenation responses. Similarities could be identified in relative 
deoxy[Hb+Mb] pattern between these four CFS patients and the MM patients of previous 
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observations. Hence, based on abnormal ICCP responses in four of these patients, skeletal 
muscle biopsy collection was proposed. Biochemical and histological analysis on these biopsy 
samples revealed mitochondrial abnormalities in 3 out of 3 of these patients (one did not 
agree for skeletal muscle biopsy collection). In general, two patterns of aberrant skeletal 
muscle biopsy and fibroblast results could be recognized. In patient 1 and two, a clear increase 
of the amount of fat droplets was seen in skeletal muscle whereas in cultured skin fibroblasts, 
a mosaic pattern was seen following staining of the mitochondria with JC1 (plus rotenone). 
The increased amount of fat droplets, observed in skeletal muscle tissue and the mosaic 
pattern, observed in cultured skin fibroblasts, were however less pronounced in patient 2. A 
mosaic staining pattern is usually observed in patients suffering from mitochondrial DNA 
abnormalities (e.g. point mutation, deletion or depletion of the mitochondrial DNA). In patient 
3 however, a different pattern could be recognized as skeletal muscle microscopic 
abnormalities could not be detected. On the other hand, complex I deficiency was 
biochemically determined, and, more surprisingly, a deficient complex IV activity in cultured 
skin fibroblasts (no complex I measurements in fibroblasts). Complex I and complex IV contain 
the largest number of mitochondrial encoded subunits. Deficiencies of either complex I, or 
complex IV, or a combined deficiency of complex I and IV, are usually caused by a disturbed 
intramitochondrial synthesis of the mitochondrial encoded subunits. The significantly 
decreased activity of complex II+III, in combination with a normal activity of the individual 
complexes II and III, is rather suggestive for a decreased amount of functionally active co-
enzyme Q.  
The heterogeneity in NIRS response within this CFS population is in agreement with multiple 
previous mentioned studies, investigating physiological responses to exercise in this CFS 
population (Fulcher and White, 2000; Wagemakers et al., 1988; De Becker et al., 2000; Sargent 
et al., 2002; Fukuda et al., 1994; Arnold et al., 1984; Barnes et al., 1993; Gibson et al., 1993; 
Fulle et al., 2000). Additionally, discrepancies in CFS patients’ blood flow response were in 
agreement with existing literature (McCully et al., 1996; McCully et al., 1999; McCully et al., 
2003; McCully et al., 2004). In this study, blood flow was either normal, but in one patient 
significantly higher during ICCP. As indicated previously, increased limb blood flow values have 
been shown in MM patients as a representation of the compensatory hyperkinetic muscle 
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perfusion (Taivassalo et al., 2003). In contrast to these findings in MM patients, it has been 
accepted that CFS patients have a reduced blood flow, probably due to autonomic 
dysregulation or reduced capillary density (Lindh et al., 1995). The results of the present study 
show the possible existence of subgroups within the CFS population as one patient showed 
an abundantly higher muscle perfusion while the other patients showed no divergent FBF 
responses compared to healthy control subjects. 
The novelty of this research, in our opinion, is the approach towards CFS patients complaining 
about exercise intolerance, post-exertional malaise, muscle pain and weakness. These CFS 
patients were included in study 5, as these complaints are primordial features in the 
syndromal description of the disease. While a lot of preceding studies considered CFS patients 
as one group, often with heterogeneous responses to exercise, it was the purpose of this study 
to detect an eventual subgroup with abnormal peripheral oxygenation responses during ICCP. 
Hence, these measurements during ICCP were developed exactly for this purpose, i.e. reliable 
detection for disturbed oxidative metabolism by analysing non-invasively peripheral 
oxygenation mechanisms. It is of major importance to emphasize the word “screening” as it is 
impossible to establish a clear diagnosis based on these measurements. On the other hand is 
it almost impossible and cost ineffective to carry out skeletal muscle biopsy in every patient 
complaining about exercise intolerance, post-exertional malaise and muscle weakness. In our 
opinion, this ICCP measurements could offer an optimum balance between invasive skeletal 
muscle biopsy analysis on the one hand and cost effectiveness and applicability on large 
samples on the other hand. Of course, when patients should be declared “positive” after this 
screening, skeletal muscle biopsy analysis remains crucial for diagnosis.  
Besides these “peripheral” muscle complaints in CFS patients, “central” problems are reported 
as well in the literature. As mentioned in the introduction, these problems are mainly related 
to autonomic dysfunction or central sensitisation (exaggerated pain perception). The 
relationship between both central and peripheral problems, in particular in combination with 
mitochondrial dysfunction, remains however questionable. Recently, Meeus et al. (2013) 
related these variables to each other, stating that mitochondrial dysfunction in muscle and/or 
central nervous system (CNS) cells could have an important influence on the central 
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sensitisation related problems in these patients. A possible mechanism could be the fact that 
mitochondrial dysfunction is associated with an increased oxidative and nitrosative stress 
(ROS and NOS). Consequently, there will be an increased amount of tissue injury as well as an 
increased inflammatory response. Another contribution could be made by ATP depletion (as 
a consequence of reduced aerobic energy delivery) in the CNS cells, thereby inducing 
hypersensitivity of the N-Methyl-D-Aspartic acid (NMDA)- receptors. An increased sensitivity 
of these nociceptive receptors is responsible for an elevated pain perception (Park et al., 
2000). According to this hypothesis, it is clear that mitochondrial dysfunction could have a 
major impact on the centrally located symptomatology of these CFS patients as well. As was 
stated before, however, there is only moderate evidence for histochemically determined 
mitochondrial dysfunction in CFS patients. 
A possible explanation for mitochondrial dysfunction in CFS patients is the type of medication 
intake. All patients with histologic abnormalities of mitochondrial dysfunction, were taking 
metformin when ICCP took place. Previous work revealed however, that this biguanide inhibits 
complex I activity of the respiratory chain in the mitochondria (El-Mir et al, 2000; Owen et al., 
2000).  
Based on this research, we propose a screening framework for CFS and MM patients suffering 
from exercise intolerance, post-exertional malaise and muscle weakness or pain to detect 
eventual peripheral oxygenation abnormalities (See figure 11). Hence, Doppler Ultrasound 
and relative NIRS measurements during ICCP can be properly used as a first line screening tool 
in large cohorts to detect eventual microvascular or muscle abnormalities. Despite the fact 
that significant differences were found in deoxy[Hb+Mb] kinetics during and after arterial 
occlusion between MM patients and healthy control subjects, it is important to study relative 
deoxy[Hb+Mb] during exercise. This is due to the fact that there is a large overlap between 
both MM and control populations when only using the arterial occlusion set up. Patients with 
abnormal muscle perfusion (Qm) and/or microvascular O2 extraction, should be further 
investigated by performing skeletal muscle biopsy analysis, which is still the gold standard to 
establish muscle oxidative dysfunction.  
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Fig. 11: Framework proposition for CFS patients complaining about exercise intolerance, muscle pain 
or weakness and post-exertional malaise 
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4. LIMITATIONS AND FUTURE DIRECTIONS 
In this dissertation, a very broad area of scientific research was covered, ranging from 
profound fundamental research on peripheral oxygenation and muscle diseases, to the 
implementation of applicable tests with non-invasive measurements. Of course, there are 
some limitations connected to this research, requiring further and more profound research in 
this area. A first limitation of this research is the fact that the validity of NIRS measurements 
relative to venous PO2 measurements during ICCP has not been investigated. This is of course 
important matter as conflicting validity results have been reported in the past when using this 
technique. In general, one should be extremely careful when using this technique as there is 
still a lot of scientific controversy about NIRS measurements. Therefore, it would be 
appropriate to perform a validation study where the relation between relative deoxy[Hb+Mb] 
values and venous PO2 measurements during cyclic dynamic exercise is investigated. 
Notwithstanding the lack of validation studies concerning NIRS, we were aware of certain 
problems when using this technique and an attempt to avoid possible disturbing influences 
was made in this dissertation (study 2). Our main interest of course, was the fact that the 
blunting effect of subcutaneous ATT in overweighed subjects was neutralized when using 
relative NIRS values. Also, the possible influence of blood flow was investigated whereas 
relative values are uninfluenced by O2 delivery. A major issue, which was not treated in this 
research, was the question whether these measurements during ICCP are reliable to carry out 
in patient populations. Also, the reliability study solely focused on the reliability of the relative 
deoxy[Hb+Mb] values but not on FBF measurements during ICCP. Consequently, despite the 
practical difficulties to test these patient populations, reliability of FBF and relative 
deoxy[Hb+Mb] measurements during ICCP should be investigated in these patient 
populations.  
A second limitation requiring future research was the lack of a larger MM and CFS patient 
sample size in study 3, 4 and 5. Considering the MM population, this was due to a limited 
prevalence of patients suffering from a severe mitochondrial myopathy in Belgium. 
Consequently, there was no ability to include more patients in the investigation of the 
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deoxy[Hb+Mb] pattern during arterial occlusion and ICCP. To accentuate the importance of 
this framework and eliminate possible influences of medication, this ICCP should be carried 
out in much larger cohorts of CFS patients and other patients complaining about muscle 
weakness and pain, post-exertional malaise and exercise intolerance. Consequently, it could 
be analysed whether aberrant FBF and relative deoxy[Hb+Mb] results of these patients 
represent indeed muscle oxidative dysfunction, as was found in study 5. 
A third limitation towards the use of NIRS and FBF measurements, especially in a CFS 
population, was the fact that there was no registration of haematocrit and blood pressure 
before and during the ICCP. This was in particular because hypotension, probably due to 
autonomic and vasomotor dysregulation, is a common feature in CFS patients. Therefore, 
blood pressure should be included in future studies on larger CFS cohorts as it possibly 
influences peripheral oxygenation and in particular limb blood flow. In the introduction, we 
have listed some studies stating that blood pressure and haematocrit (amount of RBC) may 
have an important influence on peripheral oxygenation. Therefore, despite the fact that no 
variances are supposed in these patient populations it is a limitation in this research that these 
parameters were not included to assess their possible influence on the relative deoxy[Hb+Mb] 
values during ICCP. 
A fourth limitation is the fact that these “peripheral” issues (e.g. mitochondrial dysfunction) 
in CFS patients were never related to eventual “central” problems ranging from autonomic 
dysregulation to hypersensitivity of peripheral stimuli (central sensitisation). In the discussion 
part, a hypothetical explanation was provided about the possible mechanisms of 
mitochondrial dysfunction influencing these central issues. It could be interesting to 
investigate the possible relationship between CFS patients’ peripheral oxygenation and 
mitochondrial functioning results with pain perception on the one hand. On the other hand it 
would be interesting to look for eventual associations between histochemically determined 
mitochondrial abnormalities and oxidative damage (ROS) as this could be a possible mediator 
in this process. 
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If the aim of future studies would be to use this tool in larger sample sizes, it could be very 
useful to reduce the length of this procedure by performing an arterial occlusion and a 
subsequent single bout of high intensity dynamic handgrip exercise. As such, eventual 
conveniences and differences between ICCP and a short part of the ICCP NIRS and FBF 
responses should be further elaborated. This is in particular because the higher intensities 
possess higher reliability coefficients and relative deoxy[Hb+Mb] differences between 
patients and healthy control subjects were more pronounced in these higher intensities. Also, 
when future studies on large sample sizes would be able to establish the reliability and quality 
of this screening tool, a possibility would be to use it as an assessment in intervention studies. 
Consequently, this tool could be used to detect eventual improvements or deteriorations in 
peripheral O2 extraction and/or limb blood flow after certain pharmacological, nutritional or 
training interventions in patients suffering from abnormal peripheral oxygenation and 
reporting significant improvement in validated health questionnaires, such as MOS-SF36. Of 
course, there are other patient populations with reported microvascular and mitochondrial 
problems that could be investigated using this tool.  
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5. CONCLUSIONS 
In this dissertation we aimed to present an overall image of scientific evolution in a very broad 
area of peripheral oxygenation at muscle level and pathological conditions limiting these 
oxygenation mechanisms. In the last century, the ‘classical view’ of Auguste Krogh concerning 
peripheral oxygenation has been challenged by investigations using modern technologies. 
Moreover, in the late 1980’s, a whole new research area started to unfold the pathogenesis 
of Mitochondrial Myopathies (MM). Notwithstanding the significant evolutions that have 
been made in this area of severe MM diseases, there is a lack of information on patients 
suffering from moderate types of this illness. Contrary to MM diseases, Chronic Fatigue 
Syndrome (CFS) doesn’t own a clear aetiology and is based on the exclusion of any other 
disease. The similarities between both diseases are the unique symptomatology of exercise 
intolerance, post-exertional malaise, muscle pain and weakness. Despite the heterogeneity in 
scientific reports about CFS patients, commonalities have been identified between both 
populations when focussing on oxidative metabolism and muscle abnormalities. In this 
research we have developed an exercise protocol (ICCP) with reliable and relative 
deoxy[Hb+Mb] measurements. Hence, it has been shown that it is possible to overcome 
methodological issues influencing the NIRS signal when performing this ICCP with relative 
deoxy[Hb+Mb] values. A clear distinction could be made when assessing relative 
deoxy[Hb+Mb] values between healthy control subjects and a MM population with severe 
mitochondrial malfunctioning. Although larger sample sizes are needed to assess the 
applicability of this research, 4 out of 12 CFS patients showed peripheral oxygenation 
abnormalities when performing this ICCP. Further investigation revealed mild mitochondrial 
abnormalities in skeletal muscle biopsy and cultured fibroblast samples in 3 out of 3 patients. 
To further elaborate the screening quality of this research, larger cohorts should be tested. 
The preliminary data of this research applied to patients complaining about exercise 
intolerance, post-exertional malaise, muscle pain and weakness, are however, promising. 
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Background 
In one century of scientific evolution, the classical view of Auguste Krogh and Adolphe Eugene 
Fick concerning peripheral oxygenation has progressed. These evolutions influence of course 
the point of view of certain diseases suffering from muscle or microvascular abnormalities. 
Two diseases where such abnormalities have already been shown are Mitochondrial 
Myopathy (MM) and Chronic Fatigue Syndrome (CFS). The aetiology of MM is a mutation or 
deletion in critical mitochondrial or nuclear DNA regions, responsible for the construction of 
mitochondrial (sub)complexes and enzymes. Due to this clear mitochondrial malfunctioning, 
peripheral oxygenation will be impaired in this population, with a decreased O2 extraction and 
a hyperdynamic muscle perfusion during exercise. Contrary to MM, there is still a lot of 
controversy about peripheral oxygenation abnormalities in CFS patients. CFS is a disease that 
is based on exclusion of any other disease and can be recognized by a long lasting fatigue 
which endures for at least six months. Inconsistent findings have been reported in this patient 
populations concerning muscle strength, aerobic capacity, mitochondrial functioning and 
skeletal muscle blood flow. These divergences have often been explained by the large 
heterogeneity in responses to exercise within this CFS population. 
Near Infrared Spectroscopy (NIRS) has been recognized as a valid and reliable technique to 
measure microvascular O2 extraction in brain tissue and large muscle groups at rest and during 
exercise. In small muscle groups (e.g. forearm muscles) however, few data are available on 
the reliability of this technique. Moreover, some problems like the influence of subcutaneous 
Adipose Tissue Thickness (ATT) or O2 delivery (blood flow) on NIRS signalling have been 
recognized when using this technique during exercise. Until now, no gold standard has been 
established to measure skeletal muscle blood flow. The most optimal technique described so 
far, for limb blood flow assessment, during exercise, is Doppler Ultrasound. 
The above mentioned techniques, i.e. NIRS and Doppler Ultrasound, could be used as an 
indirect marker to estimate peripheral oxygenation mechanisms in healthy and patient 
populations. A major advantage when using these techniques is the non-invasive character 
and applicability during exercise. However, when using this NIRS technique, there are still 
some methodological issues to overcome before using this device on forearm muscles in 
patient populations. From the MM or CFS patient’s perspective, there is a need for non-
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invasive and non-exhaustive exercise protocols to screen for eventual microvascular or muscle 
abnormalities. 
Aims  
In the construction of a screening tool for microvascular or muscle abnormalities, our first aim 
was to study the reliability of relative NIRS measurements in small forearm muscles during an 
Incremental Cyclic Contraction Protocol (ICCP) (study 1). Moreover, to overcome some 
methodological barriers, we aimed to study the influence of ATT and O2 delivery on relative 
deoxyhaemoglobin and –myoglobin (deoxy[Hb+Mb]) parameters (study 2). In study 3 and 4 
we aimed to study eventual differences in deoxy[Hb+Mb] during and after arterial occlusion 
and during ICCP between healthy control subjects and MM patients, suffering from severe 
mitochondrial malfunctioning. The last step of this research was to identify CFS patients who 
may suffer from muscle or microvascular abnormalities as well (study 5). 
Research and conclusions 
Figure A below provides a schematic overview of the 5 studies carried out in this research 
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Fig A: Overview of the studied population, used techniques and experimental aims in the different 
scientific reports. (Healthy Subjects= HS; Mitochondrial Myopathy patients= MM; Chronic Fatigue 
Syndrome patients= CFS; Deoxyhaemoglobin and –myoglobin= deoxy[Hb+Mb]; Incremental Cyclic 
Contraction Protocol= ICCP; Adipose Tissue Thickness= ATT; Near Infrared Spectroscopy= NIRS). 
 
 
Conclusion 1: By measuring relative deoxy[Hb+Mb] values (in %) during ICCP, it was possible 
to reliably estimate peripheral O2 extraction and to exclude possible influences of 
subcutaneous ATT and O2 delivery. 
Research: In study 1, the reliability of the NIRS parameters during ICCP has been investigated 
in healthy control subjects. In this study, it has been shown that Intraclass Correlation 
Coefficients (ICC’s) were sufficiently high to establish reliability of relative deoxy[Hb+Mb] 
values and O2 saturation (SmO2) during this handgrip exercise protocol. 
To investigate the possible influence of subcutaneous ATT and blood flow (O2 delivery) on 
absolute and relative NIRS parameters, we studied the relationship between these 
parameters (study 2). During this ICCP, all absolute maximal NIRS parameters except total 
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haemoglobin (tot[Hb]) were influenced by ATT, whereas all absolute maximal NIRS 
parameters were affected by O2 delivery. When using relative deoxy[Hb+Mb] values (towards 
the arterial occlusion maximal value) however, no relationship was found with limb blood flow 
and subcutaneous ATT. 
Conclusion 2: By using this experimental set up, it has been shown that a clear distinction could 
be made between healthy subjects and MM patients, suffering from severe mitochondrial 
malfunctioning. 
Research: Deoxy[Hb+Mb] values during and after arterial occlusion, as well as during ICCP, 
were compared between healthy control subjects and MM patients (study 3 and 4). In 
general, three deoxy[Hb+Mb] abnormalities could be identified as a marker for reduced 
muscle oxidative capacity in this MM population. (i) Slower deoxy[Hb+Mb] kinetics during 
arterial occlusion. (ii) A faster decrease in deoxy[Hb+Mb] after cuff release, indicative for an 
earlier reoxygenation. (iii) A significant altered relative deoxy[Hb+Mb] pattern during ICCP.  
Conclusion 3: By using this experimental set up, a subgroup within the CFS population could 
be identified, suffering from mitochondrial abnormalities. These mitochondrial abnormalities 
were confirmed after analysis on skeletal muscle and skin biopsy. 
Research: This ICCP was applied to CFS patients, frequently complaining about muscle 
weakness or pain, exercise intolerance and post-exertional malaise. Significant differences in 
relative deoxy[Hb+Mb] values were found between CFS patients and healthy subjects, but the 
most crucial finding was the identification of 4 subjects with an abnormal relative 
deoxy[Hb+Mb] response (study 5). Skeletal muscle and skin biopsy analysis revealed 
mitochondrial abnormalities in 3 out of 3 CFS patients who agreed for skeletal muscle and skin 
biopsy collection. 
To summarize, we propose the above mentioned non-invasive measurements during a non-
exhaustive ICCP as a tool to screen for muscle and microvascular abnormalities in patients 
complaining about muscle weakness or pain, exercise intolerance and post-exertional malaise. 
A second step in this “screening framework” is the analysis of skeletal muscle ans skin biopsy 
samples in patients with abnormal relative deoxy[Hb+Mb] or limb blood flow responses during 
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ICCP. As such, the quality of this research will be investigated while testing larger cohorts with 
these complaints. 
 
Achtergrond 
In een eeuw vol wetenschappelijke evolutie, is de klassieke visie op perifere oxygenatie, van 
Auguste Krogh en Adolphe Eugene Fick, geëvolueerd. Deze evoluties hebben natuurlijk een 
weerslag op de manier waarop verschillende ziektes, waarvan spier- en microvasculaire 
abnormaliteiten primordiale kenmerken zijn, bestudeerd worden. Twee ziektebeelden 
waarbij dergelijke abnormaliteiten reeds zijn aangetoond, zijn Mitochondriale Myopathie 
(MM) en Chronische Vermoeidheid Syndroom (CVS). De etiologie van deze eerder vernoemde 
MM, zijn mutaties of deleties in enkele cruciale mitochondriale of nucleaire DNA regio’s, die 
verantwoordelijk zijn voor de synthese van de mitochondriale (sub)complexen en enzymen. 
Door deze duidelijke mitochondriale dysfunctie, zal de perifere oxygenatie gehypothekeerd 
worden bij dergelijke patiënten, met een verminderde O2 extractie en een hyperdynamische 
spierperfusie tijdens inspanning. In tegenstelling tot MM, is er nog steeds veel controverse 
omtrent perifere oxygenatie abnormaliteiten bij CVS patiënten. CVS is een ziekte die 
gebaseerd is op exclusie van enig ander ziektebeeld en wordt gekenmerkt door een 
vermoeidheid die standhoudt voor langer dan zes maanden. Er werden reeds veel 
inconsistente bevindingen gerapporteerd bij CVS patiënten met betrekking tot spierkracht, 
aerobe capaciteit, functioneren van de mitochondria en spierdoorbloeding. Deze 
tegenstrijdigheden werden reeds voor een groot deel verklaard door de grote heterogeniteit 
binnen deze CVS populatie. 
Near Infrared Spectroscopy (NIRS) is reeds een valide en betrouwbare techniek gebleken om 
microvasculaire O2 extractie te meten in de hersenen en grote spiergroepen in rust en tijdens 
inspanning. In kleine spiergroepen (bvb. voorarmspieren) daarentegen, werden tot hiertoe 
weinig studies uitgevoerd om de betrouwbaarheid van deze techniek na te gaan. Bovendien 
werden nog enkele variabelen zoals onderhuids vet en O2 levering geïdentificeerd die een 
storende invloed uitoefenen op het NIRS signaal. Tot op heden is er nog geen gouden 
standaard gekend voor het meten van spierdoorbloeding tijdens inspanning. De meest 
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optimale techniek om een accurate inschatting te maken van bloeddoorstroming naar een 
lidmaat, specifiek tijdens inspanning, is gebruik van een Doppler Ultrasound. 
De hierboven vermelde technieken, nl. NIRS en Doppler Ultrasound, kunnen gebruikt worden 
als een indirecte marker voor het inschatten van perifere oxygenatie bij gezonde en 
patiëntenpopulatie ’s. Het grote voordeel bij het gebruik van deze technieken is het non-
invasieve karakter en de toepasbaarheid ervan. Desondanks zijn er nog enkele 
methodologische problemen die opgelost moeten worden alvorens deze NIRS techniek te 
gebruiken op voorarmspieren bij patiënten. Vanuit het klinisch perspectief van de MM en CVS 
patiënten, is er een urgente nood aan non-invasieve en niet intensieve inspanningstests om 
zo patiënten te controleren op eventuele microvasculaire en spier abnormaliteiten. 
Doelstellingen 
In de opbouw van een nieuwe screeningsmethode voor microvasculaire en spier 
abnormaliteiten, was het nagaan van de betrouwbaarheid van deze relatieve NIRS metingen 
op de voorarmspier tijdens een Cyclische Inspanningstest met Toenemende Belasting (CITB) 
ons eerste doel (studie 1). Bovendien werd een poging gedaan om enkele methodologische 
problemen, op te lossen door het gebruik van de relatieve deoxyhaemoglobine en myoglobine 
(deoxy[Hb+Mb]) parameters (studie 2). In studie 3 en 4 was het doel van de studie om 
eventuele verschillen in deoxy[Hb+Mb] tussen MM patiënten en gezonde subjecten na te 
gaan. Ten laatste was het de bedoeling van dit onderzoek (studie 5) om een subgroep CVS 
patiënten te identificeren met eventuele microvasculaire en/of spierproblemen. 
Onderzoek en conclusies 
De onderstaande figuur A geeft een schematische weergave van de 5 studies weer binnen het 
kader van dit onderzoek. 
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Fig A: Overzicht van de bestudeerde populaties, de gebruikte technieken en de experimentele 
doelstellingen bij de verschillende studies. (Gezonde Subjecten= GS; Mitochondriale Myopathie 
patiënten= MM; Chronisch Vermoeidheidsyndroom= CVS; Deoxyhaemoglobine en –myoglobine = 
deoxy[Hb+Mb]; Spier Doorbloeding= SD; Cyclische Inspanningstest met Toenemende Belasting= CITB: 
Near Infrared Spectroscopy= NIRS)  
 
 
Conclusie 1: Door het meten van de relatieve deoxy[Hb+Mb] waarden (in %) tijdens CITB was 
het mogelijk om de perifere O2 extractie op een betrouwbare manier in te schatten en om de 
mogelijke invloed van subcutaan vet en O2 levering uit te sluiten. 
Onderzoek: In studie 1 werd de betrouwbaarheid van bepaalde NIRS parameters nagegaan 
tijdens CITB bij gezonde subjecten. Op die manier werd de betrouwbaarheid aangetoond van 
de relatieve deoxy[Hb+Mb] waarden en de O2 saturatie (SmO2) gedurende 
handknijpinspanning. 
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Om de mogelijke invloed van subcutaan vet en O2 levering na te gaan op absolute en relatieve 
NIRS parameters, werd de relatie tussen deze parameters bestudeerd (studie 2). Er werd 
gevonden dat alle absoluut uitgedrukte NIRS parameters behalve totaal haemoglobine (tHb) 
beïnvloed worden door subcutaan vet. Bovendien werd deze invloed eveneens vastgesteld 
tussen de absolute weergaven van de NIRS parameters en O2 levering. Wanneer de relatieve 
deoxy[Hb+Mb] (t.o.v. de arteriële occlusie maximale waarde) waarden echter werden 
gebruikt, vonden we geen correlatie met spierdoorbloeding en subcutaan vet. 
Conclusie 2: Mits toepassing van dit experimenteel protocol, was het mogelijk om een 
duidelijk onderscheid te maken tussen gezonde subjecten en MM patiënten, waarbij ernstige 
mitochondriale defecten aanwezig waren. 
Onderzoek: Deoxy[Hb+Mb] waarden gedurende en tijdens de arteriële occlusie alsook tijdens 
het CITB werden vergeleken tussen gezonde proefpersonen en MM patiënten (studie 3 en 4). 
Over het algemeen werden er drie duidelijke abnormaliteiten in deoxy[Hb+Mb] signaal 
vastgesteld als marker voor een gereduceerde oxidatieve capaciteit van de skeletspier binnen 
deze MM populatie: (i) Een tragere deoxy[Hb+Mb] kinetiek tijdens arteriële occlusie; (ii) Een 
snellere afname van deoxy[Hb+Mb] direct na het loslaten van de manchet; (iii) Een significant 
ander patroon in relatieve deoxy[Hb+Mb] gedurende CITB. 
Conclusie 3: Mits toepassing van dit experimenteel protocol, was het mogelijk om een 
subgroep te identificeren in de volledige CVS populatie, waarbij mitochondriale 
abnormaliteiten werden vastgesteld na analyse op hun spier- en huidbiopsie. 
Onderzoek: Het CITB werd toegepast op CVS patiënten, waar veelvuldig klachten voorkomen 
van spierzwakte en –pijn, inspanningsintolerantie, en malaise na inspanning in (studie 5). Er 
werden significante verschillen in relatieve deoxy[Hb+Mb] gevonden tussen CVS patiënten en 
gezonde controleproefpersonen. De meest belangrijke bevinding was dat er 4 patiënten 
geïdentificeerd werden met een abnormale deoxy[Hb+Mb] en SD respons, die het gemiddelde 
op die manier vertekenden. Bovendien toonden analyses op spier- en huidbiopsie monsters, 
mitochondriale abnormaliteiten aan bij 3 van de 3 CVS patiënten die toezegden voor afname 
van een spier- en huidbiopsie. 
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Samenvattend kunnen we stellen dat deze non-invasieve metingen tijdens een niet intensief 
CITB gebruikt kunnen worden om te screenen voor microvasculaire en/of spier 
abnormaliteiten bij patiënten met als meest voorkomende klachten spierpijn en/of –zwakte, 
inspanningsintolerantie en malaise na inspanning. Een tweede stap in dit “screeningskader” is 
de analyse op een monster na afname van een spier- en huidbiopsie bij patiënten met een 
abnormale relatieve deoxy[Hb+Mb] of spierdoorbloeding tijdens CITB. Op die manier zal de 
kwaliteit van dit onderzoek geëvalueerd kunnen worden door grotere cohorten te testen met 
dezelfde klachten. 
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